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The microbial world is rich with complexity.  Bacteria have evolved 
several mechanisms to help them survive the harshest environments on 
earth.  These range from complex developmental transformations to the 
synthesis of small molecule antibiotics that can fend off competing species.  
Both of these topics will be the focus of this thesis, specifically the 
regulation of endospore formation in Bacillus and the generation of a 
sulfated small molecule antibiotic from an uncultured soil bacterium.  Using 
standard molecular biology methods and the techniques of X-ray 
crystallography, synthetic chemistry, and protein semisynthesis, we have: 
(1) Solved the X-ray crystal structure of a Geobacillus stearothermophilus 
sporulation histidine kinase in complex with an inhibitor of the kinase 
reaction (Chapter 2). 
(2) Developed an approach using the methods of protein semisynthesis and 
small molecule organic chemistry that will facilitate the study of active 
state conformations of a sporulation histidine kinase (Chapter 3). 
(3) Developed a full-length sporulation histidine kinase expression and 
purification system so that we may gain insights into the signaling 
mechanism of these proteins through crystallography (Chapter 4). 
(4) Developed an expression and purification system for an important stage 
II sporulation protein for future crystallographic studies (Chapter 5). 
(5) Solved the X-ray crystal structures of two sulfotransferases from an 
uncultured soil bacterium in complex with the antibiotic teicoplanin 
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Specialized differentiated cell types are used by many species of bacteria to help 
them cope with harsh environmental conditions.  Endospores produced by a number of 
gram-positive bacteria from the Firmicutes, including the genera Bacillus and 
Clostridium, represent the hardiest class of these specialized cells.  When bacteria sense 
that environmental conditions have become non-conducive for growth and reproduction, 
they will commit themselves to the process of sporulation.  Bacteria sporulate in order to 
store their genetic material as an archived copy.  As early as 1890 it was suggested that 
the onset of sporulation correlated with a decreasing concentration of available nutrients 
in the environment (Buchner, 1890).  We now know that the primary signal for entry to 
sporulation is a lack carbon, nitrogen, and even sometimes phosphorus sources, or in 
other words, starvation (Piggot and Coote, 1976).  It also appears that a high cell 
population density is a requirement for sporulation.  In a resource deficient environment 
that is otherwise conducive to spore formation, bacteria will nevertheless fail to sporulate 
at low population densities (Grossman and Losick, 1988; Ireton et al., 1993).  Secreted 
peptides accumulate in the extracellular medium as a bacterial population increases.  
When these peptides reach a certain threshold concentration, they interact with cell 
surface receptors and inform the bacteria that the environment can support sporulation 
(Waldburger et al., 1993).    
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Endospores have been studied since the earliest days of the field of microbiology.  
Robert Koch and Ferdinand Cohn simultaneously published the first morphological 
descriptions of Bacillus anthracis and Bacillus subtilis endospores in 1876 (Cohn, 1876; 
Koch, 1876).  Koch’s 1876 paper that described B. anthracis sporulation also led to the 
first confirmation of a specific organism as the cause of a specific disease, anthrax.  
Cohn’s work focused more on the basic biology of sporulation, rather than its medical 
implications.  Cohn had made the observation that almost all bacteria could effectively be 
killed at temperatures above 80 °C, but found that B. subtilis was an exception to this 
rule.  His discovery of heat resistant endospores, which survived boiling and could 
resume bacterial growth when cooled, helped to disprove a prevailing theory at the time, 
spontaneous generation.   In all of his experiments on heat sterilized organic materials, B. 
subtilis was the organism that survived sterilization.  Cohn also noted that vegetatively 
growing bacteria, when moved to an environment inhospitable for growth, could switch 
from the vegetative to a spore-like state (Bulloch, 1938).  To this day B. subtilis remains 
the most thoroughly studied of the endospore-forming bacteria, with Clostridium a distant 
second and other less well studied genera (Thermoactinomyces, Sporolactobacillus, 
Sporosarcina) filling out the remainder of spore research. 
The ability to form endospores is thought to have arisen in the pre-oxygen era 
from a common ancestor of Bacillus and Clostridium, and became a characteristic of 
aerobic bacteria when Bacillus diverged from Clostridium.  Bacillus and Clostridium 
have many sporulation regulatory proteins in common (Sauer et al., 1994).  The fact that 
only one known truly gram-negative bacterial species, Sporohalobacter, has the ability to 
form endospores suggests that gram-positives acquired the ability to sporulate at some 
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point after the divergence of gram-positive and most gram-negative species (Sonenshein, 
2000b). 
Many endospore-forming bacteria are important human pathogens.  The 
Clostridium species botulinum and tentani both cause horrific human disease.  
Clostridium perfringens is the third leading cause of food poisoning in the United 
Kingdom and United States, and also the agent behind gas gangrene (Warrell, 2003).  A 
weaponized, highly dispersible form of B. anthracis was used in the 2001 anthrax letter 
attacks in the United States.  The ability of B. anthracis to produce tough endospores 
appears at least in part to play a role in its pathogenicity (Spencer, 2003).    
Endospores are extremely tough.  They can survive environments at the physical 
extremes of those found on earth, and even beyond.  Because of their durability, spores 
have even been used to test the viability of life in space (Lorenz et al., 1968; Lorenz et 
al., 1969).  Endospores are resistant to temperatures above 100 °C, many chemical 
solvents, ultraviolet and gamma radiation, hydrolytic enzymes, extreme desiccation 
including exposure to vacuum, and oxidizing agents (Nicholson et al., 2000).  Physical 
structures of the spore such as the cortex and coat, which are not present in the vegetative 
cell, collectively contribute the spore’s remarkable resistance (Figure 1.1).  For example, 
during sporulation a unique group of proteins called α/β-type small acid-soluble spore 
proteins (SASP) is synthesized in the forespore.  SASP saturate the spore chromosome 
and act to protect the DNA from a variety of chemicals and mutagenic agents.  When the 
spore germinates, it digests the SASP into free amino acids, which in turn are used for 
new protein synthesis (Setlow, 1988). 
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Figure 1.1)  Electron micrograph cross-section showing the main structural features of a Bacillus 
megaterium endospore.  All endospore forming species make a spore coat, core wall, and cortex, while the 
exosporium is specific to certain species.  Adapted from (Beaman et al., 1972). 
 
Sporulation may also serve as a strategy for relocating bacteria to an environment 
where nutrients are more abundant.  Frequently, spores of a particular species are found 
in locations obviously removed from their point of origin.  They can be dispersed by 
wind, flowing water, and living hosts to locations all over the earth, both above and 
below the surface (Priest, 1993).  Spores exhibit incredible longevity.  There have been 
reports of the revival of spores from 100,000 years ago (Gest and Mandelstam, 1987).  In 
1995, a somewhat controversial report detailed the recovery of Bacillus sphaericus spores 
from the gut of a bee fossilized in Dominican amber that were 25 - 40 million years old 
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(Cano and Borucki, 1995).  The most incredible discovery of an ancient spore-forming 
species came in 2000, when Vreeland et al. reported the viability of a Bacillus species, 
designated 2-9-3, from a brine inclusion within a 250-million-year-old salt crystal from 
the Permian Salado Formation in New Mexico.  Though the authors did not have direct 
evidence that the isolated B. 2-9-3 were endospores, the fact that conditions of high 
salinity promote sporulation in vitro at least suggests that the bacteria were able to 
survive for such an extended period of time by existing in the endospore form (Vreeland 
et al., 2000).   
However many advantages sporulation may impart on a bacterial species, there 
are disadvantages to the process as well.  By the time the bacterium has reached stage II 
of sporulation (see below) it is fully committed to the process; there is no turning back 
(Dworkin and Losick, 2005; Freese, 1972; Parker et al., 1996).  In addition to the time it 
takes to make a spore (~8 hr), germination of the spore and the return to the vegetative 
state is also a lengthy process.  If, while the bacterium is in the midst of sporulating, the 
environmental conditions turn favorable again, competing bacterial species may come to 
dominate the local environment in terms of number and utilization of resources.  This 
could explain why sporulation depends in part on a high population density, to ensure 
that there are enough of the same species around before bacteria cut themselves off from 
potential resources for such a long period of time (Sonenshein, 2000b). 
Because the process is so energy intensive and potentially detrimental to the 
bacterium, sporulation is considered a survival mechanism of last resort (Piggot and 
Losick, 2002; Sonenshein, 2000a, b).  In fact, Bacillus has developed a number of ways 
to put off sporulating for as long as possible.  For example, B. subtilis that have entered 
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the sporulation pathway produce an intercellular signaling protein that delays sporulation 
in sister cells.  These same sporulating cells also export a killing factor, to which the 
spore formers are immune, that functions cooperatively with the delaying factor to lyse 
sister cells.  The sporulating bacteria are then able to feed from the nutrients released by 
the lysed sister cells, and reverse their own sporulation (Gonzalez-Pastor et al., 2003).  
Other methods for staving off sporulation exist as well, including the production of 
degradative enzymes (proteases, nucleases, amylases) and antibiotics to kill competing 
bacteria in the local environment, the onset of cell motility to search for nutrients in 
alternate locations, and the uptake of exogeneous DNA through genetic competence 
(Grossman, 1995).  Sporulation is also intimately tied to the cell cycle; cells can only 
make the transition from vegetative growth to sporulation after the initiation of DNA 
replication. 
  Bacillus passes through several distinct morphological stages on its journey to 
becoming an endospore (Figures 1.2 and 1.3).  Numerous studies have documented and 
categorized the morphology of these stages (Kay and Warren, 1968; Ryter, 1965; 
Szulmajster, 1964; Young and Fitz-James, 1959a, b).  The designation into seven distinct 
morphological stages of sporulation put forth by Ryter in 1965 has withstood the test of 






Figure 1.2)  Key stages of B. subtilis sporulation.  Stage 0 is defined as the growing cell.  Stage I, which is 
not depicted in the figure, occurs when the two chromosomes after the final medial septation form an axial 
filament.  This phenomenon is observed even in mutants blocked at stage 0, and may be the result of a 
change in ionic concentration in the cell when the cell encounters nutrient starvation.  Stage II is defined by 
the completion of the asymmetrical division septum at one pole of the cell.  Stage III occurs when the 
burgeoning prespore is fully engulfed by the mother cell.  The deposition of a primordial germ cell wall and 
cortex between the membranes of the prespore defines stage IV.  The two membranes of the prespore are 
derived from both the prespore itself and the mother cell.  The formation of a thick protein coat around the 
cortex is Stage V.  During stage VI the spore loses almost all of its water and acquires the characteristics 
that make it resistant to environmental conditions.  At stage VII the mother cell breaks down and lyses, 
releasing the mature spore to the environment.  From (Errington, 2003). 
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Figure 1.3)  EM micrographs of B. subtilis captured during the various stages of sporulation.  The photos 
mirror the Figure 2 schematic.  Stage 0 - The vegetative cell and medial division (photo 1).  Stage 1 and the 
formation of the chromosomal axial filament is shown (photo 2).  Stages 2 through 7 are represented in 
photos 3 through 8, respectively.  Adapted from (Jin, 1995).    
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The hallmark of sporulation is the presence of an asymmetrical division septum.  
Normally a bacterium will divide precisely in the middle to produce two identical 
daughter cells.  Sporulating bacteria, however, divide asymmetrically into a small 
prespore at one pole of the cell, and a much larger mother cell.  The asymmetric septum 
is thinner than the usual medial septum, but at least some peptidoglycan is generated in 
order to give the septum direction during synthesis.  However, the peptidoglycan is 
digested by enzymes specific to the prespore peptidoglycan once the septum has 
completed and before the mother cell has engulfed the prespore (Guinand et al., 1979).  
Later on, the prespore becomes highly desiccated, mineralized, and acquires several 
protective protein coats that will help it survive exposed in the environment in a dormant 
state.  The success of the prespore is entirely dependent upon the mother cell.  Before 
realizing its own demise, the mother cell will dedicate all of its resources to the spore, for 
example by synthesizing spore coat proteins and assembling them around the forespore 
from its own cytoplasm.  
In the past 40 years many of the genetic pathways governing the various stages of 
sporulation have been discovered.  B. subtilis has been the organism of choice for these 
studies due to its genetic tractability, natural competence, and non-pathogenicity.  Also, it 
is routine to make endospores of B. subtilis in the laboratory simply by starving the cells 
(Sterlini and Mandelstam, 1969).  The activity of cell specific (predivisional, mother cell, 
or forespore) sigma factors and transcriptional regulators is crucial to the development of 
the spore (Figure 1.4).  The stationary phase sigma factor, σH, is responsible for gene 
expression during the earliest stages of sporulation (Grossman, 1995).  After the 
asymmetric division septum has formed, compartment specific sigma factors take over.  
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The first cell specific sigma to become active is σF in the forespore.  The appearance of 
σF is followed shortly after by the mother cell specific σE, whose activation is dependent 
on σF.  σG replaces σF in the forespore following engulfment (Stage III).  Activation of 
the second mother cell sigma, σK is dependent upon the activity σG, and thus also follows 
engulfment (Li and Piggot, 2001).  The dependency of the two mother cell specific sigma 
factors on the activity of forespore sigma factors demonstrates that the two cells are in 
communication with one another, despite the presence of the division septum.  The major 
vegetative sigma factor, σA, is active at all times during sporulation, in both the mother 
cell and forespore (Li and Piggot, 2001).  Non-sigma regulatory factors also play a major 
role in sporulation.  Chief among these is Spo0A.  Every sporulation sigma factor 
depends either directly or indirectly on the activity of Spo0A in its phosphorylated form, 
Spo0A~P.  Chapter two of this thesis describes the atomic resolution structure of a 
histidine kinase that is responsible for maintaining sufficient levels of Spo0A~P at the 
onset of sporulation.  Because entry to sporulation is dependent upon the activity of 
histidine kinases, a brief introduction to them is given next.   
  
Figure 1.4)  Schematic representation of 
compartment specific sigma factors.  The vegetative 
sigma factor, σA, is always active during 
sporulation. σF is the first compartment specific 
sigma to become active, followed closely by σE in 
the mother cell.  Later, σF is inhibited in the 
prespore and σG takes over, while in the mother cell 
σK takes over for σE.  Adapted from (Li and Piggot, 
2001).  
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Histidine Kinases and Two-Component Systems 
 
Components of the System  
 
Two-component systems were first described in the 1980s in the context of 
bacterial chemotaxis, osmo-regulation, and nitrogen regulation.  Protein pairs identified 
in these systems were found to be involved in sensing and responding to environmental 
stimuli (Bourret et al., 1989; Hess et al., 1988; Ninfa and Magasanik, 1986; Nixon et al., 
1986).  Since then, two-component systems have been recognized as the dominant signal 
transduction regulatory systems employed by bacteria and archaea.  The number of two-
component proteins varies between bacterial species.  In E. coli there are 62 two-
component proteins, while in Helicobacter pylori there are only 11 (Mizuno, 1997, 
1998).  They can often make up more than 2% of a bacterial genome, as is the case for 
species of Synechocystis, where there are at least 80 different two-component proteins 
(Mizuno et al., 1996).  However, some bacteria, such as Mycoplasma genitalium, do not 
have any two-component proteins at all. 
Two-component systems are composed of a histidine kinase (HK) - response 
regulator (RR) pair.  The HK senses the environmental signal, while the RR responds to 
this signal to affect gene expression.  Upon receiving the requisite stimulus, the HK will 
utilize the γ-phosphoryl group of ATP to undergo an autophosphorylation event on a 
conserved histidine residue.  The phosphoryl group is subsequently transferred from the 
histidine of the HK to a conserved aspartate on the RR (Figure 1.5). Despite the high 
sequence and structural similarity among HKs and RRs, and the presence of sometimes 
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hundreds of HK-RR pairs in a given species, bacteria maintain an exquisite level of 
signal transmission fidelity in two-component pathways (Laub and Goulian, 2007). 
 
 
Figure 1.5)  Two-component systems are composed of a histidine kinase - response regulator pair.  The 
majority of histidine kinases from two-component systems are of the type I variety.  They have an 
extracellular signal-sensing domain connected via transmembrane helices to a cytoplasmic kinase domain.  
An additional cytoplasmic signal-transducing region termed HAMP may separate the sensor and kinase 
domains.  Histidine kinases autophosphorylate on a conserved histidine within a sequence motif called the 
H-box in the DHp domain.  Other conserved sequence motifs (N, G1, F, G2) within the CA domain are 
responsible for binding ATP.  The response regulator is a two-domain protein that receives phosphate from 
the kinase in its receiver domain.  Phosphorylation induces structural changes in the effector domain, 
typically a DNA binding domain, which functions as a transcription factor to modulate gene expression.  
  
HKs differ from eukaryotic serine/threonine/tyrosine kinases in several respects.  
First of all, HKs universally autophosphorylate, while some Ser/Thr/Tyr kinases donate 
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phosphate directly from ATP to another protein substrate (some, such as receptor tyrosine 
kinases, also autophosphorylate).  Often a given Ser/Thr/Tyr kinase will phosphorylate 
multiple targets, in contrast to the one-to-one specificity of an HK for its cognate RR.   
Secondly, HKs adopt a fold that is entirely different from the Ser/Thr/Tyr superfamily.  
Lastly, HKs catalyze the formation of a phosphoramidate bond, in contrast to the 
phosphoester formed by Ser/Thr/Tyr kinases.  
 The majority of histidine kinases are classified as type I HKs (Dutta et al., 1999; 
Fabret et al., 1999).  They are typically membrane bound proteins comprised of an 
extracellular signal sensing domain and a cytoplasmic catalytic core (CC), or kinase 
domain.  The sensor domains vary greatly among HKs in terms of sequence similarity, 
reflective of the different ligands to which they respond.  In contrast, the CC is highly 
conserved.  The sensor and CC domains are connected via a single transmembrane α-
helix.  Many class I HKs (> 1/5th) have an additional cytoplasmic linker domain, termed 
HAMP (histidine kinase, adenylyl cyclase, methyl-accepting chemotaxis proteins and 
phosphatase) that connects the C-terminus of the transmembrane helix to the N-terminus 
of a conserved sequence motif termed the H-box within the CC.  This linker domain can 
vary in length from about 40 to 180 residues (Figure 1.6).  The transmembrane helix and 
HAMP domain have been implicated in the signal transduction reaction, and the HAMP 
domain offers an additional point of HK regulation (Aravind and Ponting, 1999; Fabret et 
al., 1999; Hulko et al., 2006; Williams and Stewart, 1999; Zhu and Inouye, 2004). 
The CC can be further subdivided into a dimerization and histidine 
phosphotransfer (DHp) domain, and an ATP binding catalytic (CA) domain.  The DHp 
domain mediates HK dimerization when two monomers interact to form a four-helix 
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bundle (Figure 1.7).  The DHp domain contains the invariant histidine residue, which is 
the site of phosphorylation, within the H-box.  Other conserved motifs, the N, G1, F, and 
 
 
Figure 1.6)  (A)  The solution structure of an isolated HAMP domain from Archaeoglobus fulgidus (PDB 
code 2ASW).  A parallel four-helix bundle makes up the dimer.  The two helices of each monomer are 
equal in length and offset in relation to each other by a single helical turn.  In the context of HKs, the 
HAMP domain is interspersed between the transmembrane helices and the DHp domain of the catalytic 
core.  (B)  Hulko et al. have proposed a model for HAMP mediated signal transduction that involves a 
rotary mechanism of the helices.  The schematic illustrates the proposed rotational conversion between 
complementary knobs-to-knobs packing (top) and knobs-into-holes packing (bottom) (Hulko et al., 2006).  
In the knobs-to-knobs orientation, x-layer side chains point straight towards the central supercoil axis, 
while the da-layer side chains point sideways to form an interacting ring of residues enclosing the central 





Figure 1.7)  Two views of HK 0853 from T. maritima.  Dimerization is mediated by the DHp domain.  The 
DHp is connected to the CA domain via a flexible linker.  The side chain of the active site histidine is 
shown as a stick representation.  Also depicted are two molecules of ADPβN bound to each of the CA 
domains.  Adapted from (Marina et al., 2005). 
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G2 boxes, are within the CA domain and define the boundary of the ATP binding pocket 
(Parkinson and Kofoid, 1992). 
CA domains adopt the Bergerat ATP-binding fold seen in members of the GHKL 
superfamily of ATPases (Bergerat et al., 1997; Bilwes et al., 1999; Dutta and Inouye, 
2000).  Prototypical members of this family include the N-terminal domain of the 
topoisomerase GyrB, MutL-like DNA mismatch repair proteins, the N-terminal domain 
in the Hsp90 family of heat shock protein chaperones, and histidine kinases (Ban and 
Yang, 1998; Prodromou et al., 1997a; Prodromou et al., 1997b; Stebbins et al., 1997; 
Wigley et al., 1991).  The Bergerat fold is made up of an α/β-sandwich consisting of five 
antiparallel β strands and three α helices.  Several crystal structures are available for 
individual CA domains, and all show the same overall structure (Marina et al., 2001; 
Song et al., 2004).  In addition, the crystal structures of two intact CC domains, one of 
which is described in detail in chapter 2 of this thesis, reveal the disposition of the CA 
domain relative to the DHp domain, and show how the two domains are connected 
through a flexible linker (Bick et al., 2009; Marina et al., 2005).  Because of the CA 
domain’s similarity to proteins from such diverse organisms, it is likely that the domain 
architecture of the CC is the result of a fusion event of two independently evolved 
domains, the DHp and CA domains. 
 Many of the classic studies that parsed the various enzymatic activities and 
structural features of the CC were conducted on the osmoregulator EnvZ from E. coli.  
EnvZ is a prototypical type I HK.  Along with its cognate RR, OmpR, EnvZ regulates the 
expression of porin genes in response to changes in osmotic pressure (Hall and Silhavy, 
1981; Mizuno et al., 1982).  Results from biochemical experiments performed with EnvZ 
 17 
have since been shown to be applicable to type I HKs in general.  The EnvZ DHp 
subdomain dimerizes on its own, forming an antiparallel four-helix bundle.  The active 
site histidine is located towards the N-terminus of helix 1, where it faces the solvent and 
is accessible to both the CA domain for Phosphorylation and the RR for phosphotransfer 
(Tomomori et al., 1999).  In contrast, the CA domain is monomeric when expressed 
separately.  The kinase activity of the CC resides in the CA domain; in the presence of 
ATP and Mg2+ it is possible to phosphorylate the DHp domain by a non-covalently linked 
CA domain.  A phosphorylated DHp by itself is able to transfer the phosphoryl group to 
its cognate response regulator (Park et al., 1998). 
In addition to their autophosphorylation and phosphotransfer activities, HKs also 
possess a phosphatase activity that helps to regulate the levels of phosphorylated RR 
(Egger and Inouye, 1997; Forst and Roberts, 1994).  The RR is typically a two-domain 
transcription factor, whose N-terminal domain receives the signal from the HK and 
output domain binds DNA as either an activator or repressor of gene expression.  Much 
of the phosphatase activity of HKs can be attributed to the DHp domain, as evidenced 
from the fact that the DHp domain on its own is competent to dephosphorylate its 
cognate RR, but the CA domain is not (Zhu et al., 2000).  However, when the CA domain 
is covalently linked to the DHp domain, the phosphatase activity is enhanced relative to 
the DHp domain alone.  Furthermore, ADP in the reaction mixture further enhances the 
HK phosphatase activity.  This is true whether the DHp and CA domains are separate, or 
whether they are covalently linked, although if they are linked the activity is increased by 
at least 10-fold.  ADP bound in the pocket of the CA domain may induce a 
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conformational change that allows the CA domain to influence the DHp domain and 
stimulate its phosphatase activity (Zhu et al., 2000).   
Dephosphorylation of the RR aspartate generates inorganic phosphate.  The active 
site histidine of the HK in some instances is not crucial for this reaction, but in others, 
such as EnvZ, it does appear to play an essential role.  Generation of phospho-His on the 
HK may be an obligatory intermediate for the phosphatase reaction (Carmany et al., 
2003; Dutta and Inouye, 1996; Hsing and Silhavy, 1997; Kamberov et al., 1994; Zhu et 
al., 2000).  In some cases, a phosphorylated RR is capable of donating the phosphoryl 
group back to its cognate HK to generate a phosphorylated HK (Wang et al., 2001).  
Despite many demonstrations of HK mediated RR dephosphorylation in vitro, the 
importance of the phosphatase reaction in vivo has been called into question in a recent 
review.  The author points out that many of the experiments that established HK 
phosphatase function in vitro were performed with high concentrations of the HK relative 
to the RR, and that in the cell often it is the RR that is in excess (Kenney, 2010).  
Histidine kinases function as homodimers.  Historically, they were believed to 
carry out the autophosphorylation reaction exclusively in trans, meaning that the CA 
domain from one monomer phosphorylates the active histidine within the DHp domain of 
the opposite monomer.  Again, the classic experiments that provided evidence for the 
trans mechanism were carried out on EnvZ.  The first of these involved an EnvZ hybrid 
HK, Taz1.  Taz1 is a fusion of the Tar (a chemotaxis HK which responds to aspartate) 
signal sensing and transmembrane domains with the EnvZ catalytic core.  Taz1 is able to 
respond to aspartate, the Tar ligand, and stimulate the phosphorylation of OmpR.  
Experiments involving co-transformation of two mutant forms of Taz1, one with a valine 
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in place of the active site histidine and the other with a missing CA domain, showed that 
the two mutants were able to complement each other for the autophosphorylation 
reaction.  The authors of the study hypothesized that this result was due to subunit 
exchange between the Taz1 dimers and the formation of heterodimers in the membrane.  
Interestingly, complementation using the two Taz1 mutants did not restore the 
phosphatase activity for OmpR (Yang and Inouye, 1991).  Generation of the Taz1 hybrid 
kinase also demonstrated for the first time the modular nature of the HK domain 
architecture, that the sensor domain from one HK could be fused with the cytoplasmic 
kinase domain of another to create a functional enzyme (Utsumi et al., 1989).  This 
modularity has become a powerful tool in the field synthetic biology in recent years 
(Levskaya et al., 2005; Salis et al., 2009). 
More evidence for trans phosphorylation came about a decade later when it was 
demonstrated that disulfide cross-linked EnvZ heterodimers, in which one monomer was 
defective for binding ATP and the other contained a mutation at the catalytic histidine, 
were still competent for the autophosphorylation reaction through complementation.  For 
the first time, the authors also provided direct evidence that the cis mechanism of 
autophosphorylation, at least for EnvZ, does not occur, and that autophosphorylation does 
not result from dimer - dimer interactions (Cai and Inouye, 2003). 
The dogma of the universality of trans autophosphorylation has recently been 
challenged, however (Casino et al., 2009; Pena-Sandoval and Georgellis, 2010).  Using 
the classic approach of mixed dimers, Pena-Sandoval et al. showed that heterodimers of 
the HK ArcB failed to autophosphorylate, or in other words, there was no trans 
complementation between the two mutant monomers (Pena-Sandoval and Georgellis, 
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2010).  Additional evidence for cis autophosphorylation has come from the recently 
published high-resolution crystal structure of a Thermotoga maritima HK0853-RR468 
complex (Figure 1.8).  In this structure the β-phosphorus of the bound ADPβN from one 
CA domain is less than half the distance to the active histidine εN (~11 Å) of the same 
monomer than it is to the histidine εN of the opposite monomer (~24 Å).  The authors of 
the paper also demonstrate cis autophosphorylation experimentally, again by employing 
heterodimers.  They confirm that HK0853 and a related type I HK, PhoR from 
Staphylococcus aureus, autophosphorylate in cis (Casino et al., 2009).  It appears that at 
least some type I HKs do not obey the rule of trans autophosphorylation.  
 
Figure 1.8)  (A) A view of the HK0853-RR468 complex from T. maritima, looking down the four-helix 
bundle axis of the HK DHp domain.  Shown as black sticks are the HK His 260 side chain, the RR Asp 53 
side chain, the ADPβN bound to each CA domain, and two sulfates which mediate contacts between His 
260 and Asp 53.  (B) Distances determined in Pymol between the εN of His 260 and the β-phosphate of 
ADPβN from both monomers are labeled.  The values calculated by Pymol using the deposited PDB file 
(PDB code 3DGE) differ slightly from the values reported in the publication by Casino et al.  However, the 
proposed cis autophosphorylation mechanism is still valid based on the distance values reported here.  
Adapted from (Casino et al., 2009). 
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Chemistry of Two-Component Systems 
 
The chemistry carried out by the HK and RR of two-component systems can be 
summarized by the following equations: 
 
1.  Autophosphorylation: HK-His + ATP      HK-His~P + ADP 
2.  Phosphotransfer:  HK-His~P + RR-Asp      HK-His +RR-Asp~P 
3.  Dephosphorylation: RR-Asp~P + H2O      RR-Asp + Pi   
 
All three reactions require a divalent cation, with Mg2+ presumably filling that role in 
vivo (Stock et al., 2000).  Phosphorylation of histidine occurs in all branches of life, and 
is not restricted to bacterial two-component systems (Steeg et al., 2003).  Both the N3 and 
N1 positions of the histidine imidazole ring can be phosphorylated (Hultquist et al., 
1966), and both forms have been found in proteins (Figure 1.9).  However, 
phosphorylation of N3 is the most commonly observed site for modification (Surette et 
al., 1996).  N3-phosphohistidine is thermodynamically more stable than N1-
phosphohistidine, as measured by their respective rates of hydrolysis (Hultquist et al., 
1966).  N1-phosphohistidine at pH 2.4 (46 ºC) has a half-life of 5 min, while N3-
phosphohistidine has a 25 min half-life under the same conditions (both isoforms are 
fairly stable under basic conditions).  The only known example of a protein containing N1 
phosphohistidine comes from the bacterial phosphoenolpyruvate:sugar phosphotransfer 




Figure 1.9)  Chemical structures of 1 (left) and 3 (right) phosphohistidine.  3-phospho-His is almost always 
observed in proteins. 
 
Phosphohistidine and phosphoaspartate are both considered ‘high-energy’ 
molecules as free amino acids.  The difference between the two arises when they are 
viewed in the context of a protein.  In a protein, the phosphoramidate bond has a free 
energy of hydrolysis between -12 and -14 kcal/mol, making phospho-His much more 
unstable than phospho-Ser, phospho-Thr, and phospho-Tyr and the corresponding 
phosphoester bond (Stock et al., 1990) (Table 1.1).  This negative free energy is not much 
different for the phosphoramidate of a free amino acid (-8 to -10 kcal/mol).  Likewise, the 
free energy for phosphoaspartate as the free amino acid is -10 to -13 kcal/mol.  But unlike 
phospho-His, phospho-Asp has a free energy of +2 in the context of a protein (Table 1.1).  
These values make sense when considering the role of phospho-His primarily as a short-
lived catalytic donor, with its free energy capable of driving phosphorylation of a 
substrate (e. g. a response regulator).  Phosphorylation of Asp on the other hand often 
promotes large, long-range conformational changes in a protein, as in the case of 
response regulators.  The difference observed for the free energies of phospho-Asp 
implies that in the context of a protein, the free energy of phospho-Asp is heavily 
dependent on its interactions with the protein of which it is a part (Cho et al., 2001).  This 
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leads to an interesting observation for two-component systems, specifically the back 
reaction from the RR to the HK in two-component systems, and in particular, the 
sporulation phosphorelay in B. subtilis, for in that system phosphoryl transfer occurs from 









Phosphoserine -3 -6.5 
Phosphotyrosine N/A -9.5 
Phosphohistidine -8 to -10 -12 to -14 
Phosphoaspartate -10 to -13 +2 
 
Table 1.1)  The free energies of hydrolysis for the most common phospho amino acids.  ∆G values are 
given for the free amino acid, and for the same in the context of a protein.  Based on (Fukami and Lipmann, 
1983; Hubler et al., 1989; Jencks, 1968; Pickart and Jencks, 1984; Shizuta et al., 1975; Weigel et al., 1982; 






HK Sensor Domains and Signaling 
Now that much is understood about how the catalytic core functions, attention has 
turned to HK sensor domains.  Unlike the CC domain of HKs, sensor domains vary 
greatly both in sequence and structure, a consequence of the different signals to which 
sensor domains respond.  The signaling molecules that bind to sensor domains also show 
tremendous diversity.  Typically they are small molecule ligands (Cheung and 
Hendrickson, 2008, 2009; Emami et al., 2009; Sevvana et al., 2008), but can also be 
divalent cations (Cho et al., 2006), peptides (Geisinger et al., 2008), oxygen (Gilles-
Gonzalez et al., 2008), and even light (Purcell et al., 2007; Swartz et al., 2007) and 
temperature (Aguilar et al., 2001). Whereas the HK kinase domain is always cytoplasmic, 
sensor domains can be extracellular, cytoplasmic, or membrane embedded.   
Extracellular sensor domains can be classified according to the three dimensional 
structure they adopt.  Currently three classes exist: those that adopt the PDC (PhoQ-
DcuS-CitA) fold, a mixed α/β structural motif with topological similarities to the PAS 
Per/ARNT/Sim) domains found in many signal transduction pathways (Cheung and 
Hendrickson, 2008; Moglich et al., 2009; Reinelt et al., 2003), those that are entirely α-
helical (Moore and Hendrickson, 2009), and those that have a similar fold to periplasmic 
binding proteins (Cheung et al., 2009) (Figure 1.10). 
There are no currently available structures of membrane embedded sensor 
domains, though biochemical studies on a number of HKs have shown that signals are 
indeed sensed within the transmembrane segments (Albanesi et al., 2009; Jensen et al., 
2008).  It is possible that KinB from the sporulation phosphorelay detects signals via its 
transmembrane segments.  HKs with several membrane spanning regions and no obvious 
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extracellular domain are the most likely candidates to utilize this mechanism of signal 
sensing.  Based on secondary structural predictions (Rost et al., 2004), KinB fits this 
description.  
Cytoplasmic sensors often contain PAS domains (Ayers and Moffat, 2008; Gong 
et al., 1998).  These sensors can be found in the context of entirely cytoplasmic HKs, at 
the very N-terminus of membrane bound HKs, or in between the last transmembrane 
segment and the CC.  The cytoplasmic HKs KinA and KinE of the sporulation 
phosphorelay are predicted to encode three and four PAS domains in their sensor regions, 
respectively.  Other structural motifs found in cytoplasmic sensor domains are the GAF 
(Ho et al., 2000) and PHY (phytochrome) folds (Yang et al., 2008).  Regardless of the 
domain structure, sensor domains, and HKs overall, form homodimers.  It is presumed 
that the signaling step requires the dimer state.  However, it has been shown for some 
sensors that binding of a single ligand to only one protomer of the dimer is sufficient to 
induce signaling (Yeh et al., 1996).  Because there is no available structure of a full-
length HK, either cytoplasmic or membrane associated, we know comparatively little 
regarding the mechanism of HK signal transduction.  How signaling occurs can only be 
inferred based on the structures of isolated CCs and sensor domains, and from what is 
known about other transmembrane signaling proteins, such as chemoreceptors.  In 
chemoreceptors, very small (1-2 Å) conformational changes induced by ligand binding 
are transmitted from a sensor domain membrane-spanning helix to the cytoplasmic 
catalytic domain by a relative piston-like displacement mechanism between helices 








Figure 1.10 (adjacent page)  Four representative HK sensor domain crystal structures.  (Top Left) Citrato-
molybdate bound structure of the extracellular sensor domain of CitA from Klebsiella pneumoniae (PDB 
code 1P0Z) in its monomeric form.  CitA is a member of the PDC group of HK sensor domains.  (Top 
Right) The PAS-containing sensor domain of FixL (PDB code 2VV6) from Bradyrhizobium japonicum in 
its dimeric ferric form.  The FixL sensor domain is cytoplasmic, and is located directly N-terminal to the 
kinase domain (C-terminal to the transmembrane helices).  (Bottom left) The nitrate periplasmic sensor 
domain of NarX (PDB code 3EZH) from Escherichia coli.  The NarX dimer contains a single ligand-
binding site at the dimer interface.  (Bottom right) The TorS (PDB code 3I9Y) extracellular sensor domain 
from Vibrio parahaemolyticus.  TorS is entirely helical.  Adapted from (Ayers and Moffat, 2008; Cheung 









Two recent structures of HK sensor domains with and without ligand bound 
suggest that HKs also transmit their signals via a piston displacement movement of the 
transmembrane helices (Cheung and Hendrickson, 2009; Moore and Hendrickson, 2009) 
(Figure 1.11).  However, structures of full-length HKs are needed to confirm this 
hypothesis.  Chapter 4 of this thesis lays the foundation for obtaining the structure of a 
full-length cytoplasmic HK.  It is possible that the signaling mechanism is the same for 
all HKs, both cytoplasmic and membrane-bound, because for both the signaling and 
kinase domains are connected by a long helix. 
 
Figure 1.11)  (A) Depiction of the N- and C-terminal helices of the periplasmic sensor domain from the 
aspartate receptor Tar, in the unliganded (grey) and liganded (red) form.  A piston-like displacement of the 
C-terminal helix is induced upon binding aspartate to one of the monomers.  (B) Nitrate induced piston 
displacement of the C-terminal signaling helix in the periplasmic sensor domain of NarX.  Nitrate bound 
NarX is shown in red, unliganded in grey.  (C) Crystal structures of the apo form of the N and C-terminal 
helices of the TorS sensor domain from V. parahaemolyticus (grey) and E. coli (red).  A piston-like 
displacement is observed in the C-terminal helix between the two structures. 
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In the 1990s, phosphotransfer pathways resembling two-component systems were 
discovered in lower eukaryotes, including a system in Saccharomyces cerevisiae that 
regulates an osmosensing MAP kinase cascade (Maeda et al., 1994).  The presence of 
additional intermediate response regulators and phosphotransferases in the eukaryotic 
systems led to the term phosphorelay in order to describe them.  Phosphorelays allow for 
greater levels of fine-tuning the flow of phosphate than do simple two-component 
systems because of the presence of additional domains; these additional domains offer 
more targets for positive and negative regulation.  HKs in eukaryotic phosphorelays 
appear to be exclusively of a hybrid type; the C-terminus of the HK catalytic core is fused 
directly to the RR.  Regardless of domain organization or number of proteins in the 
signaling system, the sequence of phosphoryl transfer is always the same between 
prokaryotes and eukaryotes.  In prokaryotes, phosphoryl transfer proceeds from His to 
Asp, whereas in eukaryotes this transfer is merely duplicated to His-Asp-His-Asp.  
Phosphorelays are not restricted to unicellular eukaryotes.  Arabidopsis thaliana has an 
ethylene inducible signal transduction system that is mediated by a phosphotransfer event 
involving a hybrid HK, etr1 (Chang et al., 1993).  To date, however, there have not been 
any reports of two-component or phosphorelay systems in animal species.  In addition, 
the frequency of phosphorelay systems for any given eukaryote is much lower than two-
component systems in bacteria.  Sometimes only a single system is present, as in the case 
of S. cerevisiae. 
 30 
 
Figure 1.12)  The Bacillus sporulation phosphorelay.  Signals are sensed by one of five histidine kinases, 
KinA through KinE, resulting in an autophosphorylation event in the DHp domain.  The phosphoryl group 
is passed to Spo0A via the response regulator Spo0F and the phosphotransferase Spo0B.  Spo0A is the 
master regulator of sporulation gene expression. 
 
Though prokaryotic phosphorelays occur with less frequency, they do exist 
(Zhang and Shi, 2005).  In fact, the first described phosphorelay was not eukaryotic, but 
rather the phosphorelay controlling entry to sporulation in B. subtilis (Burbulys et al., 
1991) (Figure 1.12).  The gatekeepers of the sporulation phosphorelay are a group of five 
type I HKs, KinA through KinE (KinA-KinE are not hybrid HKs as in eukaryotic 
phosphorelays) (Jiang et al., 2000b).  KinB, KinC, and KinD are membrane bound HKs, 
while KinA and KinE are cytoplasmic.   
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As type I HKs, the sporulation kinases bind and utilize ATP to autophosphorylate 
on a histidine residue in their DHp domains after sensing certain environmental cues.  
The phosphoryl group is then transferred to an Asp residue of the single domain RR 
Spo0F (Spo0F lacks the DNA binding domain present in many RRs), then to a His 
residue of the phosphotransferase Spo0B.  Spo0B resembles the catalytic core of type I 
HKs; it shares a dimeric structure with a central four-helix bundle, containing the active 
His residue, flanked by two CA-like domains that are unable to bind ATP (Varughese et 
al., 1998).  Finally, Spo0B donates the phosphoryl group to an Asp residue of the RR 
Spo0A, the master transcription factor that regulates expression of sporulation genes in 
the predivisional cell (Figure 1.12). 
Phosphorylated Spo0A (Spo0A~P) binds to “0A boxes” on the chromosome 
(Hoch, 1993), and acts either as an activator or repressor of gene expression.  Spo0A~P 
has 121 genes under its direct control, and at least 500 under indirect control (Fawcett et 
al., 2000; Molle et al., 2003).  One notable member of the proteins whose expression is 
regulated by Spo0A~P is the forespore specific sigma factor, σF.  Genes under the control 
of Spo0A~P can be roughly divided into two categories, those that require a low-
threshold level of Spo0A~P, and those that require a high-threshold level.  Interestingly, 
the low-threshold genes appear to be those that would act to avert sporulation, such as 
genes for cannibalism or fruiting body formation (Branda et al., 2001; Fujita et al., 2005; 
Gonzalez-Pastor et al., 2003).  In order for the bacterium to sporulate, levels of Spo0A~P 
must accumulate gradually, and this accumulation must be mediated by the phosphorelay; 
overexpression of KinA, KinB, or KinC is sufficient to induce sporulation, but 
overexpression of a constitutively activate form of Spo0A, Spo0A-Sad67, is not (Fujita 
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and Losick, 2005; Ireton et al., 1993).  It is believed the reason for this is the fact that in 
normally sporulating cells, low-threshold genes are expressed before high-threshold 
genes, and that immediate induction or repression of both low- and high-threshold genes 
via the activity of Spo0A-Sad67 inhibits sporulation (Fujita and Losick, 2005).  
Accumulation of Spo0A~P not only depends upon the activity of KinA-KinE, but 
also on an increased rate of synthesis of Spo0A, and the neutralization of various 
antagonists of the phosphorelay and repressors of Spo0A-dependent genes (Burbulys et 
al., 1991).  Antagonists exist for each member of the phosphorelay.  The small protein 
Sda has been shown to inhibit the autophosphorylation of KinA and KinB, and most 
likely KinC-KinE (discussed at length in Chapter 2) (Bick et al., 2009; Burkholder et al., 
2001; Rowland et al., 2004).  Three of the eleven B. subtilis Rap (response regulator 
aspartate phosphatase) family members, RapA, RapB, and RapE, promote 
dephosphorylation of phosphorylated Spo0F (Spo0F~P), possibly by stimulating the 
Spo0F autophosphatase activity (Jiang et al., 2000a; Perego et al., 1996; Perego et al., 
1994).  The sporulation kinases themselves have phosphatase activity against Spo0F~P.  
The well-studied Spo0E phosphatase, along with two of its homologs, YisI and YnzD, 
dephosphorylate Spo0A~P; overexpression of Spo0E abolishes the ability to sporulate 
(Ohlsen et al., 1994; Perego, 2001).  
The signals to which KinA-KinE respond are currently unknown, although KinA, 
KinC, and KinE of B. subtilis possess PAS domains in their signal sensing regions 
(Stephenson and Hoch, 2002).  PAS domains are known to sense the overall energy level 
of a cell, redox potential, and oxygen levels, in addition to serving other functions 
(Taylor and Zhulin, 1999).  The amino-terminal most PAS domain of KinA is a catalytic 
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ATP-binding domain with nucleoside diphosphate kinase-like activity and is essential to 
the activity of KinA (Stephenson and Hoch, 2001; Wang et al., 2001).  PAS domains B 
and C are involved in dimerization of the KinA signal-sensing domain (Wang et al., 
2001). 
Crystal structures of phosphorelay members have provided great insight regarding 
the propagation of phosphate in the system.  Spo0F has been crystallized in both its metal 
free and metal bound states (Mn2+, and Ca2+) (Madhusudan et al., 1997; Madhusudan et 
al., 1996; Mukhopadhyay et al., 2004; Varughese et al., 2006; Zapf et al., 2000) (Figure 
1.13).  Upon binding metal, the active site of Spo0F is rearranged to create a divalent 
cation binding site.  The phosphotransfer reaction from HKs to RRs, and in the 
phosphorelay from Spo0B to Spo0A, is divalent cation dependent (Lukat et al., 1990).  
Spo0F and Spo0A provide the metal for the transfer.  Mn2+ is believed to be the preferred 
metal for the HK to Spo0F phosphotransfer reaction because of its higher affinity for 
Spo0F compared with Mg2+ (Kd of 2.5 mM vs. 20 mM), and because of the presence of 
several nitrogen-containing side chains in the Spo0F active site, for which Mn2+ ions 




Figure 1.13)  Comparison of the metal-free and metal-bound forms of Spo0F.  On the left is the structure 
of the wild-type Spo0F molecule.  The active site side chains are shown along with Y13 and R47 from the 
neighboring molecule.  D54 is the site of phosphorylation from KinA.  On the right is a superposition of the 
non-metal and the Ca2+ bound forms of Spo0F.  Note that the metal-bound Spo0F in this figure has a 
mutation from Y13S.  The regions where the two structures differ significantly, around the β1-α1 loop, the 
β3-α3 loop, the β3-α4 loop, and the β4-α4 loop, are designated A-D, respectively.  Taken from 
(Madhusudan et al., 1997).  
 
The structure of Spo0F, with the active site Asp either unphosphorylated or as a 
berylloflouride (BeF3-) phospho-Asp mimic, in a complex with the phosphotransferase 
Spo0B has also been solved (Figure 1.14) (Varughese et al., 2006; Zapf et al., 2000).  
Until the recently published structure of an HK-RR pair (Casino et al., 2009), the Spo0F-
Spo0B structures had been used as a model of HK-RR interactions.  Spo0F shows 
significant deviations in two loop regions around its active site when in a complex with 
Spo0B compared with the Spo0F structure on its own.  The primary contact surface 
between Spo0F and Spo0B is composed of hydrophobic residues from each protein, 









Figure 1.14 (adjacent page)  Interaction between Spo0F and Spo0B.  (A) Steareoview of the Spo0B-Spo0F 
interaction looking down the axis of the four-helix bundle.  The Spo0B dimer is shown in blue and green, 
while the two molecules of Spo0F are shown in magenta.  The sites of phosphorylation are colored red.  (B) 
View of the four-helix bundle along with the two Spo0F molecules (magenta).  The ribbon diagram in cyan 
on the right-hand side of the molecule is a fourth Spo0F molecule from the asymmetric unit of the crystal 
(the AU had two Spo0Bs and 4 Spo0Fs), shown displaced by ~9° with respect to the other molecules.  This 
fourth Spo0F had a lower occupancy and was oriented differently compared with the other three molecules 
of Spo0F.  Interacting surfaces of Spo0F and Spo0B are shown in gold on the left.  (C) Steareoview of the 
interaction of helix α1 of Spo0F with the four-helix bundle of Spo0B.  Shown are the side chains that 
associate through hydrophobic interactions, as well as the active-site residues His30 from Spo0B and 





Spo0F occur around the active site Asp 54 residue.  Recognition specificity is then gained 
through interaction outside of the hydrophobic patch among non-conserved residues in 
the β4-α4 loop. 
The structures of the various members of the phosphorelay have been known for 
some time now, but the histidine kinases from this system have eluded structural 
determination.  HKs are notoriously difficult to crystallize, primarily because they are 
often membrane bound proteins, but also because of the flexibility between the CA and 
DHp domains of the catalytic core.  In the next chapter of this thesis, we describe the 2.0 
Å crystal structure of the cytoplasmic catalytic core of KinB from the moderate 
thermophile, Geobacillus stearothermophilus, in a complex with the autophosphorylation 
inhibitor Sda.  This structure takes us one step further towards understanding an 
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How to Switch Off a Histidine Kinase: Crystal 
Structure of Geobacillus stearothermophilus KinB with 




Bacillus will go to great lengths to avoid sporulation, including even killing its 
own kind to scavenge their nutrients (Gonzalez-Pastor et al., 2003).  However, if the 
environment becomes too inhospitable for growth, sporulation will ensue.  If a bacterium 
is forced to sporulate, then it must also ensure that the spore is endowed with a high 
fidelity copy of the chromosome.  Nothing could be worse for a spore than having to use 
a defective chromosome when it returns to vegetative growth.  Therefore, Bacillus will 
confirm the integrity of its genome before sporulating (Ireton and Grossman, 1994; 
Lemon et al., 2000; Mandelstam et al., 1971).  If there are defects, the cell will prevent 
sporulation, regardless of the environmental nutritional availability.  One way cells do 
this is through the action of a protein called Sda (suppressor of dnaA). 
 Sda was first identified in mutants of B. subtilis that were defective for DNA 
replication but nevertheless could still form endospores (Burkholder et al., 2001).  
Through a series of elegant genetic experiments a previously unannotated intergenic 
region of the B. subtilis chromosome was shown to encode a 46 amino acid protein, Sda, 
which was overexpressed in dnaA, dnaB, and dnaD mutants.  DnaA is essential for 
replication initiation; it binds to specific sites within the chromosomal origin and 
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promotes assembly of the replisome (Moriya et al., 1999; Yoshikawa, 1993).  The roles 
of DnaB and DnaD in replication initiation are not well understood.  The presence of 
consensus DnaA binding motifs directly upstream of the sda open reading frame led to 
the hypothesis that DnaA directly regulates sda expression (Burkholder et al., 2001). 
Burkholder et al. determined that Sda prevents the accumulation of Spo0A~P by 
directly inhibiting the autophosphorylation reaction of KinA, and likely also KinB 
(Burkholder et al., 2001; Rowland et al., 2004), providing a developmental checkpoint to 
ensure that the forespore receives an intact copy of the chromosome.  The molecular 
mechanism of KinA inhibition by Sda has been studied using biochemical and 
biophysical approaches (Rowland et al., 2004; Whitten et al., 2007).  Rowland et al. 
(Rowland et al., 2004) used NMR to determine that Sda adopts a helical hairpin fold in 
solution.  A cluster of conserved, primarily hydrophobic residues exposed on one face of 
the hairpin was shown to mediate the interaction with KinA, which occurs via the 
KinA DHp domain with a stoichiometry of Sda2/KinA2.  Analysis of the effects of Sda on 
KinA functions led to the conclusion that Sda acts as a molecular barrier to block KinA 
reactions that require communication between the CA and DHp domains 
(autophosphorylation, dephosphorylation), but that Sda does not interfere with 
phosphoryl transfer from KinA~P to Spo0F (Rowland et al., 2004). 
A subsequent structural study (Whitten et al., 2007) used a combination of small-
angle X-ray scattering (SAXS) and neutron scattering to derive a structural model of the 
Sda/KinA-CC complex in which Sda binds to the KinA DHp domain at the end distal to 
the DHp-CA linker.  Contrary to Rowland et al. (Rowland et al., 2004), Whitten et al. 
(Whitten et al., 2007) concluded that Sda inhibition of KinA involves a conformational 
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change within the DHp domain that allosterically affects the DHp-CA 'hinge', rather than 
a simple molecular barricade. 
In this chapter we investigate the structural basis for Sda inhibition of a 
sporulation HK, KinB from Geobacillus stearothermophilus (Gst).  We determined a 2.0 
Å resolution X-ray crystal structure of the intact cytoplasmic CC of KinB complexed 
with Sda.  Structural and biochemical analyses reveal that Sda inhibits 
autophosphorylation, phosphotransfer, and phosphatase activities of the HK by acting as 
a simple molecular barricade to sterically block access to the phosphoacceptor His-




Crystallization and Structure Determination 
of Sda/KinB-CC 
KinB, Sda, and Spo0F were identified by sequence-
based searches of the incomplete Geobacillus 
stearothermophilus strain 10 genome database 
(http://www.genome.ou.edu/bstearo.html), and the 
coding sequences were PCR sub-cloned from Gst strain 10 genomic DNA.  A 
combination of secondary structure predictions (Rost, 1996) and the results of limited 
proteolysis and mass-spectrometry led to the identification of a stable structural core of 
KinB comprising KinB residues 195-434(C-term), (KinB-CC for Catalytic Core).  The 
Figure 2.1)  KinB Trypsinolysis. 
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proteolysis results were the same in the presence or absence of Sda (Figure 2.1), 
indicating that Sda is unlikely to interact with the membrane-proximal end of the DHp 
domain. 
Genetic results in Bsu strongly suggest that Sda effectively inhibits KinB as well 
as KinA (Rowland et al., 2004; Trach and Hoch, 1993), but KinB inhibition was not 
shown directly in vitro.  In the presence of γ-[32P]ATP, Gst KinB-CC underwent 
spontaneous autophosphorylation (Figure 2.4B, lane 1), and this reaction was inhibited by 
addition of purified Gst Sda (Figure 2.4B, lanes 2-4).  The effectiveness of Gst Sda 
inhibition of Gst KinB autophosphorylation was similar to Bsu Sda inhibition of 
Bsu KinA (Rowland et al., 2004).  The coexpressed (Campbell and Darst, 2000) and 
purified Sda/KinB-CC complex, comprising full-length Gst Sda (residues 1-46) and 
residues 195-434 of Gst KinB plus four N-terminal vector-derived residues (GPHM), 
crystallized in space group P3221.  The crystals diffracted to better than 2.0 Å resolution 
(Figure 2.2, Table 2.1).  Crystals only formed in the presence of ADP-Mg2+, but not with 
ATP or the non-hydrolyzable ATP analog, AMPPNP, and not in the absence of 
nucleotide.  The structure was solved using MIRAS phases obtained from a methyl-
mercury derivative (Table 2.1), combined with subsequent phased molecular replacement 
solutions that placed the individual DHp and CA domains from HK TM0853 (Marina et 
al., 2005) (Figure 2.3).  An atomic model of Sda/KinB-CC was built and refined to an 
R/Rfree of 20.0/21.5 at 2.0 Å resolution (Figure 2.4C).  Electron density for the 18 C-
terminal residues of each KinB monomer (residues 417-434), internal loop residues 198-
206 (monomer A) or 201-205 (monomer B), and the 4 C-terminal residues of Sda 









Figure 2.2)  (A) KinB 195-CT/Sda crystals, grown in a 5 Molar excess of ADP relative to the protein, and 
















































Crystal space group:         P3221             
Unit cell:                                a = b = 66.11 Å, c = 315.57 Å 
Figure of Meritc (45-2.7 Å);   0.18 
Refinement (against Native data set) 
Resolution:                               42.41-2.03 Å 
Rcryst/Rfreed                                  0.200/0.215 
rmsd bond lengths:                    0.008 Å 
rmsd bond angles:                     1.096° 
rmsd B factor (all atoms):         0.832 
Number of water molecules:     373 
Residues in favored/allowed/disallowed regions of the Ramachandran plot: 463 (98.5%)/6 (1.3%)/1 
(0.2%) 
aBoth data sets were collected at the NE-CAT beamline 24ID-C, APS, Argonne National Laboratory, 
Argonne, IL; bRsym = Σ|I - <I>|/ΣI, where I is observed intensity and <I> is average intensity obtained from 
multiple observations of symmetry-related reflections; cFigure of merit as calculated by SHARP; dRcryst = 




Figure 2.3)  Electron density maps.  Views of experimental (A) and final 2.0 Å resolution 2|Fo| – |Fc| (B) 
maps, contoured at 1σ and sectioned at key locations in the Sda/KinB-CC structure.  The model is shown 
as sticks and colored according to Figure 2.4.  Nitrogen and oxygen atoms are colored blue and red, 
respectively.  Water molecules are represented as red stars.  Left Panel - The MPD vestibule at the top of 
the DHp domain. Shown is a view looking from the N-terminus down the four-helix-bundle axis.  MPD 
molecules are colored green.  Middle Panel - Nucleotide binding site in the CA domain.  ADP carbons are 
colored yellow.  The Mg2+ ion coordinating the α- and β-phosphates of the ADP is represented as a 
magenta sphere.  Right Panel - Face-to-side Phe-Phe interaction between KinB Phe225 and Sda Phe25. 
Also shown is Met1 of Sda.  The sulfur atom of Met1 is colored yellow. 
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Overall Structure 
The Sda/KinB-CC structure reveals the expected homodimer of KinB-CC 
(Marina et al., 2005), but bound to only one Sda molecule (Figure 2.4C).  This 
stoichiometry of Sda1/KinB-CC2 was unexpected, as the results of previous biophysical 
studies (Rowland et al., 2004; Whitten et al., 2007) were consistent with an Sda2/KinA-
CC2 stoichiometry in solution.  We used nanoflow electrospray ionization-mass 
spectrometry (ESI-MS) (Sharon and Robinson, 2007) to precisely measure the mass of 
the purified Sda/KinB complex in solution.  We found that the complex consisted 
predominantly (>90%) of an Sda2/KinB-CC2 complex (Table 2.2, Figure 2.5).  Instead of 
binding a molecule of Sda, the KinB-CC chain B DHp domain (Figure 2.4C) makes a 
crystal packing interaction with a crystallographic symmetry-related copy of itself, 
sterically occluding the Sda binding site (Figure 2.14), likely explaining the discrepancy.  
Although the affinity of the Sda/sporulation-HK interaction has not been measured, it is 
expected to be quite high (Rowland, 2004).  This is confirmed by our ability to purify the 
in vivo assembled Sda/KinB-CC complex through four chromatographic steps (see 
Methods) without the addition of extra Sda.  Since the stability of the Sda/KinB-CC 
interaction appears to be due primarily to hydrophobic interactions (see Rowland, 2004, 
as well as below), it may be that it is destabilized by the high concentration of methyl-






Figure 2.4 (adjacent page)  The Gst Sda/KinB-CC complex.  (A) Schematic diagram illustrating structural 
features of the Bacillus sporulation HK KinB.  The colored domains (DHp and CA domains), comprising 
the cytoplasmic CC, have been crystallized in this study.  The HK functions as a homodimer (one monomer 
is colored dark red, the other orange).  Autophosphorylation is believed to occur in trans, with the orange 
CA domain phosphorylating the phosphoacceptor-His residue (labeled 'H') of the red DHp domain, though 
this has not been confirmed for KinB.  (B) Sda inhibits spontaneous autophosphorylation of KinB-CC. 
Incubation of KinB-CC with γ-[32P]ATP results in autophosphorylation, as monitored by SDS-PAGE and 
phosphorimagery (lane 1).  Addition of increasing concentrations of Sda (1, 5, or 25-fold molar excess over 
KinB-CC, lanes 2-4, respectively) inhibits the autophosphorylation reaction.  (C) Structure of the 
Sda/KinB-CC complex.  Ribbon diagrams, with each protein chain color-coded: KinB-CC monomer A, 
dark red; KinB-CC monomer B, orange; Sda, blue.  The KinB DHp and CA domains are labeled. ADP 
molecules bound to the CA domains are shown in stick format, with carbon atoms colored yellow.  The 
associated Mg2+ ions are shown as grey spheres.  The side chain of the phosphoacceptor His213 is also 
















Figure 2.5)  ESI-MS of Sda/KinB-CC.  Mass spectrum of Sda/KinB-CC complex (lower panel) showing 
that most of the complex (~ 90 %) is present in 2:2 stoichiometry (dark blue circles), approximately 10% is 
present in 1:2 stoichiometry (green circles), and a small fraction of the complex comprises 1:1 
stoichiometry (orange circles).  In the region of 1000-2000 m/z there are peaks present for free Sda 
molecules (light blue circles) and very low intensity peaks for free KinB-CC (red circles).  The 
stoichiometry of the major Sda2/KinB-CC2 complex was confirmed by tandem MS (upper panel).  Shaded 
in blue is the isolated 16+ charge state of the Sda2/KinB-CC2 complex, which gave rise to dissociated Sda 





Protein/complex Theoretical mass, Da Experimental mass, Da 
Sda 5,486 5,468 ± 0 
KinB-CC 26,977 26,891 ± 2 
Sda:KinB-CC/1:1 32,463 32,460 ± 44 
Sda:KinB-CC/2:1 59,440 59,407 ± 13 
Sda:KinB-CC/2:2 64,926 65,018 ± 66 
 
Table 2.2)  Nanoflow ESI-MS of Sda, KinB-CC, and Sda/KinB-CC. 
 
The KinB-CC homodimer shares similarities with the HK TM0853 structure (Marina et 
al., 2005), but significant differences are also noted (Figure 2.6A).  The overall structure 
of the KinB CA domain is nearly identical to the HK TM0853 CA domain (1.01 Å root-
mean-square-deviation over 116 α-carbon positions).  Most of the KinB DHp domain 
superimposes well with that of HK TM0853, revealing that the disposition of the CA 
domains with respect to the DHp domains is very different (Figure 2.6A).  Alignment of 
the KinB CA domains with the HK TM0853 CA domains requires a rotation of 85° about 
an axis roughly perpendicular to the axis of the DHp domain helices, and a translation of 
the CA domain outward away from the KinB homodimer 2-fold axis by 11 Å (Figure 
2.6A).  This 'pinched-in' disposition of the CA domains of KinB may be stabilized by the 
binding of two solvent MPD molecules at the top of the DHp domain, in between the two 
CA domains (Figure 2.6B).  Both secondary structure prediction (Rost, 1996) and 








Figure 2.6 (adjacent page)  Unusual structural features of KinB-CC.  (A) Comparison of the CC's of KinB 
(orange/red/yellow) and TM0853 (green/cyan/blue).  The two structures, shown as backbone worms, were 
superimposed on overlapping helices of the DHp domains, which superimpose closely (1.12 Å rmsd over 
43 α-carbon positions corresponding to KinB chain B residues 211-231 and 239-260).  The superposition 
reveals the different paths of the DHp-CA linkers (KinB-CC, red; TM0853, cyan) and the misalignment of 
the CA domains (KinB-CC, yellow; TM0853, blue).  (B) Solvent MPD molecules (shown in CPK format 
with carbon atoms in green) bound in a vestibule at the top of the DHp helices (orange), and surrounded by 
the DHp-CA linkers (red) and the CA domains (transparent yellow).  The MPD molecules hydrogen bond 
to the carbonyl oxygens of Tyr260, disrupting the second DHp α-helix.  (C) Disordered N-terminal arm of 
KinB-CC.  Rather than forming an α-helix at the N-terminus (as in TM0853, see Figure 6.2A), the N-
terminal 17 residues of KinB-CC form a sixth β-strand at the end of the CA domain β-sheet, which is 





α-helix should continue to at least residue 263, but the MPD molecules hydrogen bond to 
the carbonyl oxygens of Tyr260 (MPD-O2:Tyr260-O distance, 2.7 Å), apparently 
prematurely disrupting the second DHp α-helix (Figure 2.6B). 
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The MPD molecules bind in an 
otherwise hydrophobic vestibule 
formed by the top of the DHp α-
helices, the DHp-CA linker, and the 
CA domains, and are completely 
buried inside the protein (Figure 2.7).  
Moreover, secondary structure 
prediction (Rost, 1996) and structural 
alignment with HK TM0853 (Figure 
2.6A) also indicates that the first DHp 
α-helix should extend through to the 
N-terminus of the KinB-CC construct, 
corresponding to KinB residue 195, 
but the extension of the α-helix N-
terminal to KinB residue 211 is incompatible with the presence of the MPD molecules.  
Instead, the N-terminal segments of the KinB-CC construct (four vector-derived residues, 
plus KinB residues 195-210) form a partially disordered loop that allows the N-terminal 
arms to add a sixth β-strand onto the conserved five-stranded β-sheet of the CA domains 
(Figure 2.6C). 
 A large-scale conformational change is required to reposition the CA domain with 
respect to the DHp domain for autophosphorylation to occur (Marina et al., 2005).  We 
entertained the idea that the structural differences described above were somehow a 
consequence of Sda binding, and that the extra β-strand, allowed by the unstructured N-
Figure 2.7)  Surface view of MPD vestibule. KinB-
CC is shown as a molecular surface (DHp domain, 
orange; DHp-CA linker, red; CA domain, yellow) 
and cross-sectioned to show the MPD vestibule.  
MPD molecules are represented in CPK format, 




terminal tail, played a role in Sda-mediated inhibition of autophosphorylation, perhaps by 
tethering the CA domain to the DHp domain and restricting its motion.  Two structural 
observations argue against this hypothesis.  First, N-terminal residues participating in 
forming the sixth β-strand include vector-derived residues (magenta in Figure 2.6C), and 
second, the sequence register of the sixth β-strand with respect to the CA domains is 
different for the two KinB-CC monomers, indicating that this interaction is not specific. 
Nevertheless, we tested this hypothesis by comparing Sda inhibition of KinB-CC and an 
N-terminal truncation of KinB-CC beginning at residue 208, termed ∆N-KinB-CC, that 
lacks the N-terminal arm and therefore would not be able to form the putative tethering 
sixth β-strand.  There was no obvious difference in the effectiveness of Sda inhibition of 
KinB-CC or ∆N-KinB-CC, indicating that the KinB-CC N-terminal arm does not play a 
role in Sda-mediated inhibition of autophosphorylation activity (data not shown).    
 
Sda and the Sda/KinB Interface 
Sda adopts the antiparallel helical hairpin structure as reported for the NMR 
structure of Bsu Sda (Rowland et al., 2004).  Sda α-helix 1 (residues 6-19) connects to α-
helix 2 (residues 23-36) by a short interhelical loop (residues 20-22).  The N-terminal 
loop (residues 1-5) curves back towards KinB, where it is wedged between Sda and KinB 
and participates in interactions with the KinB DHp domain.  The C-terminal loop 
(residues 37-46) folds back on the opposite face of the hairpin, away from KinB.  
Electron density for the C-terminal four residues (43-46) is missing, and this region is 
presumed to be disordered.  This C-terminal tail is required for degradation of Sda by the 
ClpXP protease, which in turn is required for efficient induction of sporulation after 
transient replicative stress (Ruvolo et al., 2006). 
 73 
 
Figure 2.8)  Structural and functional features of the Sda/KinB interface.  (A) The KinB binding surface of 
Sda, viewed from the KinB perspective.  The KinB chain A DHp helices are shown as a dark red backbone 
worm.  Sda is shown as a blue backbone worm, along with a transparent molecular surface.  Side chains 
that contact KinB (≤4 Å) are shown and color-coded (carbon, light grey; nitrogen, blue; oxygen, red; sulfur, 
orange), except the carbon atoms of three residues (Leu21, Phe25, and Leu28) shown to be important for 
Bsu KinA binding (Rowland et al., 2004) are colored yellow.  (B) The Sda binding surface of KinB, viewed 
from the Sda perspective.  Sda is shown as a blue backbone worm.  KinB is shown as a backbone worm 
(chain A, dark red; chain B, orange), along with a transparent molecular surface. Side chains that contact 
Sda (≤4 Å) are shown and color-coded (carbon, light grey; nitrogen, blue; oxygen, red), except the carbon 
atoms of three residues (Gly224, Phe225, and Leu228) shown to be important for Sda binding (Figure 
2.11A) are colored yellow. 
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Figure 2.9 (adjacent page) (left) Sequence conservation among 16 Sda orthologs.  The sequence at the top 
shows the consensus sequence, while the histogram above it denotes the level of sequence conservation at 
each position (red bar, 100% conserved; dark blue bar, less than 20%).  The sequences are shown in one-
letter amino acid code and identified by species at the left (annotation of the species codes shown is given 
at the end of the Discussion).  The numbers at the beginning of each line indicate amino acid positions 
relative to the start of each protein sequence.  The numbers at the top (underneath the consensus) indicate 
the amino acid position in Gst Sda.  Positions in the alignment that share >50% identity with the consensus 
are indicated by red shading, while positions that share >50% homology are indicated by blue shading.  The 
α-helices in the Gst Sda structure are indicated above the Sda sequences as blue rectangles, connecting 
loops are indicated by a continuous blue line.  Gst Sda positions that contact KinB (≤4 Å) are denoted by 
grey dots, with the three residues shown to be important for Sda binding to Bsu KinA (Rowland et al., 
2004) denoted by yellow dots.  (right) Sequence conservation within the DHp domains of Bacillus 
sporulation HKs (top set of sequences) and other two-component, homodimeric sensor HKs (bottom set of 
sequences).  The consensus sequence is shown on top, while the histogram above it denotes the level of 
conservation at each position for just the sporulation HKs (red bar, 100% conserved; dark blue bar, less 
than 20%).  The histogram at the bottom denotes sequence conservation among all the HKs.  The sequences 
are shown in one-letter amino acid code and identified by species at the left (Sco, Streptomyces coelicolor).  
The numbers at the beginning of each line indicate amino acid positions relative to the start of each protein 
sequence.  The numbers at the top (underneath the consensus) indicate the amino acid position in Gst KinB.  
Positions in the alignment that share >50% identity with the consensus are indicated by red shading, while 
positions that share >50% homology are indicated by blue shading.  The α-helices in the Gst KinB structure 
are indicated below the Gst KinB sequence as orange rectangles, connecting loops are indicated by a 
continuous orange line.  Gst KinB positions that contact Sda (≤4 Å) are denoted by grey dots, with the three 
residues shown to be important for KinB binding to Sda (Figure 2.11A) denoted by yellow dots.  The H-
box, a sequence motif conserved among all the HKs, is denoted by the horizontal purple line above and 
below the top and bottom histograms, respectively.  The Sda binding motif conserved only among the 




The Sda/KinB interface buries 726 Å2 of predominantly hydrophobic surface 
(total for both proteins), and the most highly conserved and functionally important 
residues involved in the interface are non-polar (Figure 2.8).  Rowland et al. (Rowland, 
2004) investigated a number of amino acid substitutions in Bsu Sda at positions revealed 
by the Gst Sda/KinB-CC structure to be involved in the Sda/KinB interface (Figure 
2.8A), including substitutions at Sda positions 8, 11, 12, 15, 21, 24, 25, and 28 (Bsu and 
Gst Sda numbering is identical; Figure 2.9).  Leu21 and Phe25 were found to be essential 
for Sda binding to KinA and inhibition of KinA autophosphorylation, while substitution 
of Leu28 resulted in partial loss of function (Rowland et al., 2004).  These three residues 
(Leu21, Phe25, Leu28; yellow in Figure 2.8A) form a prominent, contiguous 
hydrophobic patch on one face of Sda, and are universally conserved among Sda 
homologs (Figure 2.9).  Also contributing to the hydrophobic patch is the side-chain of 
Met1, which is wedged between KinB and the rest of Sda and makes Van der Waals' 
interactions with Phe225 of KinB.  Bsu Sda-Met1 interactions with KinA were noted by 
Rowland et al. (Rowland, 2004) from NMR chemical-shift experiments.  Rowland et al. 
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also noted that substitutions of Bsu Sda Met19 resulted in partial loss of function.  A 
shorter Leu side-chain is found at this position in Gst Sda, and it does not make Van der 
Waal's contact (using a cutoff of ≤4 Å) with KinB, suggesting that the role of the 
hydrophobic residue found at position 19 in Sda function is species specific. 
Sda binds at the bottom of the KinB DHp domain, distal to the membrane, near 
the turn connecting the two KinB DHp 
helices, with the axes of the Sda helices 
roughly perpendicular to the KinB DHp 
helices (Figure 2.4C).  Sda interacts with 
residues from both DHp α-helices, as 
well as from the turn connecting them.  
Sda does not interact with the KinB 
phosphoacceptor His213 (the closest 
approach of any Sda atom to His213 is  
Figure 2.10)  Comparison of DHp helices with and without Sda.  Superimposition of KinB-CC DHp 
domains from KinB-CC chain A (bound to Sda), KinB-CC chain B (no Sda), and TM0853 (no Sda).  The 
portion of the three DHp domains used in the alignment is colored magenta.  Chain B aligns quite well with 
TM0853.  The bottom of the first DHp α-helix of the DHp domains from TM0853 and KinB-CC chain B 
(both without Sda) splay outward, while the same region of KinB-CC chain A (bound to Sda) is parallel 
with the second DHp domain α-helix.  In the absence of Sda, a Leu residue (KinB-CC Leu234, TM0853 
Leu283) in the loop connecting the DHp α-helices point towards the hydrophobic core of the four-helix 
bundle.  In the presence of Sda, the first DHp α-helix adopts a more parallel structure, and Leu234 flips out 
towards the solvent.  
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about 7 Å (Figure 2.8B)), does not interact with any residues in the conserved H-box, and 
also does not interact with any CA-domain residues. 
The KinB chain B (not bound to Sda) DHp α-helices superimpose very well onto 
TM0853 (Figure 2.6A), but superimposition of KinB chain A (bound to Sda) reveals a 
small conformational change in the first DHp α-helix (Figure 2.10).  In the two proteins 
in the absence of Sda, the bottom two turns of the first DHp α-helix splay outward away 
from the second DHp α-helix, while the same portion of KinB chain A (bound to Sda) is 
straight and parallel with the second DHp α-helix (Figure 2.10).  In order to 
accommodate the inward bend of the first α-helix, KinB chain A Leu234, in the middle of 
the loop connecting the two DHp α-helices, flips out, while in KinB chain B and TM0853 
the corresponding Leu points in between the two α-helices to occupy the space created 
by the outward bend of the first DHp α-helix (Figure 2.10).  We believe this 
conformational change induced by Sda binding is highly localized and does not propagate 
to other parts of the structure, since α-carbons of the KinB DHp α-helices, excluding 
residues that interact with Sda, superimpose extremely closely with HK TM0853 (rmsd 
of 0.18 Å over a total of 21 α-carbons; residues 211-219 of the first DHp α-helix, 
including the phosphoacceptor His213, and residues 246-260 of the second α-helix; 
Figure 2.10).    
As expected from the hydrophobic nature of the KinB binding determinants on 
Sda (Figure 2.8A), the KinB surface buried by the interaction with Sda is also 
predominantly hydrophobic (Figure 2.8B).  Among the residues of KinB that interact 
with Sda (Figure 2.8B), sequence analysis reveals a motif uniquely conserved among the 
sporulation HKs, immediately following the H-box, which is conserved among all HKs 
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(Figure 2.9).  KinB residues Gly224, 
Phe225, and Leu228 make the majority 
of contacts with Sda.  Substitutions at 
these positions confer strong resistance to 
Sda inhibition (Figure 2.11A, 2.12), and 
the mutant KinB proteins do not bind Sda 
in vitro, as judged by native gel 
electrophoresis mobility shift analysis 
(not shown), while substitutions at other 
positions (Thr220, Gln227, Glu231) are 
relatively benign (Figure 2.11A, 2.12).  
All of these mutants, with the exception    
Figure 2.11)  An Sda binding motif on the HK.  (A) Effect of Ala substitutions in KinB on Sda inhibition.  
Single Ala substitutions were introduced at residues of KinB making extensive contacts with Sda.  
Autophosphorylation of wild-type KinB-CC (blue) and mutants was monitored in reactions containing 
increasing concentrations of Sda (0, 1, 5, and 25-fold molar excess over KinB-CC).  The results are 
expressed as normalized histograms (autophosphorylation activity in the absence of Sda for each HK was 
used as reference), with error bars denoting the standard error from a minimum of three experiments for 
each histogram.  KinBs harboring Q227A (red) or E231A (yellow) substitutions were essentially as 
sensitive to Sda inhibition as wild-type KinB, while G224A (purple), F225A (orange), and L228A (brown) 
were highly resistant (T220A was intermediate).  (B) Three-residue Sda binding motif.  
Autophosphorylation by the CC of the homodimeric HK TM0853 is insensitive to Sda (1, 5, and 25-fold 
molar excess Sda, lanes 1, 2, and 3, respectively), while the triple-mutant TM0853* 
(A271G/Y272F/T275L, introducing side-chains corresponding to KinB G224, F225, and L228) is inhibited 
very effectively. 
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of Gly224Ala, expressed to wild-type levels, were soluble, and exhibited normal 
autophosphorylation activity.  The KinB-CC-Gly224Ala substitution expressed to lower 
levels and was less soluble than wild-type KinB-CC suggesting a mild folding defect, but 
was otherwise normal in its 
autophosphorylation activity.  KinB-
Phe225 participates in a face-to-side Phe-
Phe interaction with Phe25 of Sda (Hunter 
et al., 1991) (Figure 2.3C), while the Gly 
at position 224 of KinB allows the close 
approach of Sda-Phe25.  Any side-chain 
at this position of KinB would clash with 
Sda-Phe25.  Surprisingly, a KinB-
Gln227Ala substitution did not 
significantly affect binding to, or  
Figure 2.12)  Effect of Ala substitutions in KinB on Sda inhibition.  Ala substitutions in KinB were 
generated based on contacts with Sda observed in the crystal structure.  Autophosphorylation reactions 
were carried out for 1 hr at 25°C.  Reactions were quenched and analyzed by SDS-PAGE and 
phosphorimagery.  The leftmost column shows the autophosphorylation level of each mutant in the absence 
of Sda. Columns 2, 3, and 4 contained a 1, 5, and 25-molar excess of Sda, respectively (with respect to 
KinB-CC).  KinB-CC mutants G224A, F225A, and L228A were strongly resistant to Sda inhibition. 
inhibition by, Sda (Figure 2.11A, 2.12).  Gln 227 is highly conserved among sporulation 
HKs (Figure 2.9) and makes several contacts with the crucial Leu21 of Sda.  Less 
surprisingly, substitution of KinB-Glu231 also resulted in wild-type levels of Sda binding 
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and sensitivity.  This residue makes contacts primarily with Sda-Lys15, a residue shown 
not to be important for binding KinA (Rowland et al., 2004). 
To underscore the importance of KinB residues Gly224, Phe225, and Leu228 for 
Sda function, and to test whether these three side chains are sufficient for Sda binding 
and inhibition of autophosphorylation activity, we constructed a triple-mutant of 
Tma HK TM0853 (Ala271Gly, Tyr272Phe, Thr275Leu, hereafter termed HK TM0853*), 
placing the GFXXL motif into the context of an HK not normally subject to Sda 
inhibition.  While autophosphorylation activity of wild-type HK TM0853 was completely 
unaffected by Sda, HK TM0853* was inhibited at least as effectively as KinB (Figure 
11B).  Thus, the sporulation kinase GFXXL motif (Figure 2.11B) appears to be sufficient 
for Sda binding and inhibition of autophosphorylation.  
 
Sda/KinB Stoichiometry 
The unexpected 1:2 stoichiometry of Sda:KinB-CC observed in the crystal 
structure led us to investigate the functional stoichiometry of autophosphorylation 
inhibition by Sda.  One molecule of Sda may only inhibit one monomer of the KinB 
homodimer, so that two Sda molecules bound to the KinB homodimer would be required 
for complete inhibition of autophosphorylation.  Alternatively, one molecule of Sda may 
be sufficient to inhibit autophosphorylation by both KinB monomers within the 
homodimer.  Furthermore, since HK autophosphorylation occurs in trans (i.e. the chain 
A-CA domain phosphorylates His213 of chain B, and vice versa; (Ninfa et al., 1993; Qin 
et al., 2000; Yang and Inouye, 1991)), a molecule of Sda bound to chain A could inhibit 
chain A-CA domain function, inhibiting phosphorylation of chain B-His213 by the chain 
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A-CA domain, or it could inhibit chain A-DHp domain function by inhibiting 
phosphorylation of chain A-His213 by the chain B-CA domain (research published 
subsequent to the completion of the work described in this chapter has called into 
question the universality of HK trans phosphorylation (Casino et al., 2009; Pena-
Sandoval and Georgellis), and we have not shown whether KinB phosphorylates in cis or 
in trans, see discussion).   
To address these questions, we generated mixed dimers of KinB-CC, in which 
one monomer was resistant to Sda binding and inhibition (SdaR), while the other was 
wild-type.  The KinB-Phe225Ala mutation was used to generate SdaR KinB-CC 
(Figure 2.11A, 2.12).  KinB-CC proteins (wild-type and SdaR), either with or without an 
N-terminal His6-tag, were co-expressed in Eco.  Co-expression was expected to produce 
three dimeric KinB-CC species, homodimers of His6-KinB-CC or KinB-CC, as well as 
the desired heterodimer (His6-KinB-CC/KinB-CC).  Purification of the heterodimers was 
achieved using Ni2+-affinity chromatography and elution with a shallow imidazole 
gradient.  Untagged KinB-CC homodimers flowed through the column, while the 
heterodimer eluted earlier in the gradient than the tagged homodimers.  The purified 
heterodimers were tested in autophosphorylation assays.  Autophosphorylation of the 
heterodimers was not fully inhibited, even in the presence of a 25-fold molar excess of 
Sda (Figure 2.13).  Instead, only phosphorylation of the monomer that was competent to 
bind Sda was inhibited, while phosphorylation of the SdaR monomer was unaffected 
(Figure 2.13).  Heterodimers in which both of the monomers were Sda-sensitive were 
inhibited to wild-type levels (data not shown).  We conclude that Sda directly inhibits 
phosphoacceptor function of the DHp domain to which it is bound.  In other words, Sda 
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bound to the chain A-DHp domain inhibits phosphorylation of chain A-His213 by the 
chain B-CA domain without significantly affecting phosphorylation of chain B-His213 
by the chain A-CA domain.   
 
Figure 2.13)  Sda inhibits DHp function only of the DHp domain to which it is bound.  Mixed dimers of 
His6-KinB-CC and KinB-CC, containing either wild-type (Sda-sensitive) or SdaR monomers, were 
generated and purified.  The His6-KinB-CC had a slightly lower mobility by SDS-PAGE, allowing the 
autophosphorylation of each monomer to be monitored as a function of Sda concentration (0, 1, 5, and 25-
fold molar excess, left to right).  In the left panel, the His6-KinB-CC (orange monomer in the schematic) is 
SdaR due to an F225A substitution (illustrated in the schematic by the magenta 'X'), while the KinB-CC 
(dark red) is competent to bind Sda.  Phosphorylation of KinB-CC is inhibited by Sda, while 
phosphorylation of His6-KinB-CC is resistant.  In the right panel, the His6-KinB-CC is competent to bind 
Sda, while the KinB-CC harbors the SdaR mutation.  In this case, phosphorylation of His6-KinB-CC is 
inhibited by Sda, while phosphorylation of KinB-CC is resistant. 
 
We also conclude that the Sda/KinB-CC complex is 2:2 in solution, and 
presumably the Sda/KinB complex is 2:2 in the normal biological context at the plasma 
membrane in vivo, since an Sda molecule bound to each KinB monomer is required for 
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the complete inhibition of autophosphorylation activity that is observed.  The 1:2 
stoichiometry observed in the crystal structure is likely due to a crystal packing artifact 




Figure 2.14)  Symmetry-related KinB-CC occludes the Sda binding site on one KinB-CC monomer.  Three 
orthogonal views are presented, showing the location of a symmetry-related KinB-CC DHp domain 
(colored green, chain A; yellow, chain B).  The KinB-CC DHp domain chain B makes a crystal packing 
interaction with a crystallographic symmetry-related copy of itself.  When Sda is modeled on to the KinB-
CC DHp domain chain B (KinB-CC chain B, orange; modeled Sda, grey), clear steric clashes between the 
modeled Sda and the symmetry-related KinB-CC DHp domain are revealed.  This feature of the crystal 
packing likely explains the Sda1/KinB-CC2 stoichiometry observed in the crystal structure. 
 
 
Mechanism of Autophosphorylation Inhibition by Sda 
In both available structures of intact HK CC's, this structure and HK TM0853 
(Marina et al., 2005), the disposition of the catalytic CA domain with respect to the 
phosphoacceptor DHp domain is inappropriate for the autophosphorylation reaction; the 
side chain of the phosphoacceptor His and the β-phosphate of the nucleotide bound to the 
CA domain are about 25 Å apart and incorrectly oriented for the phosphorylation 
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reaction.  Marina et al. (Marina, 2005) constructed a model for the autophosphorylation 
reaction by docking the CA domain onto the DHp domain in a manner consistent with 
phosphotransfer from ATP to the His phosphoacceptor.  Superimposition of the KinB CA 
and DHp domains onto the HK TM0853 autophosphorylation model reveals steric 
clashes between the positioned CA domain and Sda (Figure 2.15A).  These clashes would 
be expected to inhibit the autophosphorylation reaction.  
 
Sda Inhibits Phosphotransfer to Spo0F 
Rowland et al. (Rowland et al., 2004) reported that Sda inhibited HK 
autophosphorylation by blocking communication between the CA and DHp domains, a 
conclusion consistent with our structural analysis (Figure 2.15A).  Rowland et al. 
(Rowland et al., 2004) also reported that Sda did not interfere with phosphotransfer from 
the HK phospho-His residue to the Asp residue of Spo0F, the next protein in the 
sporulation phosphorelay.  This finding is inconsistent with structural analysis based on a 
SAXS/neutron scattering model of the Sda/KinA-CC complex and a model of the 
Spo0F/KinA-CC complex, which indicated that binding of Sda or Spo0F to the KinA-
DHp domain were mutually exclusive due to steric clashes (Whitten et al., 2007).  We 
constructed a structural model of the Spo0F/KinB-CC complex (with the Spo0F-Asp 
approaching KinB-His213) based on the crystal structure of the Spo0F/Spo0B complex 
(PDB ID 1F51) (Zapf et al., 2000).  Such a model is expected to be fairly representative 
since Spo0F binds to a His-containing four-helix bundle on Spo0B that is structurally 
similar to the HK-DHp domain.  The precise details of the Spo0F/KinB-CC model are  
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Figure 2.15)  Mechanism of Sda inhibition of autophosphorylation and phosphotransfer.  (A) Mechanism 
of Sda inhibition of autophosphorylation.  The KinB DHp domain is shown as a ribbon diagram, with the 
side chain of the phosphoacceptor His213.  Sda is shown in stick format.  Superimposed on the Sda/KinB-
DHp structure is a KinB CA domain (shown in stick format but with the ADP and Mg2+ shown as CPK 
spheres) poised for the autophosphorylation reaction (modeled according to Marina et al. (Marina et al., 
2005)).  Sda is colored blue, except atoms within 4 Å of the modeled CA domain are colored green.  The 
KinB CA domain is colored orange, except atoms within 4 Å of Sda are colored magenta.  The green and 
magenta atoms on Sda and KinB-CA, respectively, illustrate the extent of steric clash between the bound 
Sda and the modeled CA domain, indicating that phosphorylation of His213 by the CA domain would be 
sterically blocked by the bound Sda.  (B) Mechanism of Sda inhibition of phosphotransfer to Spo0F.  Sda 
(blue) and the KinB DHp domain (dark red and orange) are shown as a ribbon diagram, with the side chain 
of His213.  Superimposed on the Sda/KinB-DHp structure is Spo0F (yellow ribbon, with the side chain of 
the phosphoacceptor Asp54) poised for phosphotransfer (modeled based on the Spo0F/Spo0B crystal 
structure (Zapf et al., 2000)).  Extensive steric overlap between Sda and Spo0F indicates that the 
phosphotransfer reaction would be sterically blocked by the bound Sda.     
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not critical, however, as the superposition of the modeled position of Spo0F and the 
crystallographically observed position of Sda on the KinB DHp domain result in severe 
steric overlap (Figure 2.15B).  Thus, our structural modeling predicts that Sda binding to 
the KinB-DHp domain should interfere with phosphotransfer from KinB-His213 to 
Spo0F, consistent with the modeling of Whitten et al., but inconsistent with the 
conclusions of Rowland et al (Rowland et al., 2004). 
To address these inconsistencies, we measured the effect of Sda on the time 
course of phosphotransfer from KinB-CCP to Spo0F in an in vitro assay.  In this assay, 
KinB-CC was allowed to autophosphorylate by incubation with γ-[32P]ATP, excess 
[32P]ATP was removed by rapid gel filtration over a desalting column, then Spo0F, and 
Sda, when present, was added.  The time course of transfer of [32P] from KinB-CC~P to 
Spo0F was monitored by SDS-PAGE and autoradiography (Figure 2.16).  The results 
indicate the occurrence of two expected reactions, phosphotransfer from KinB-CC~P to 
Spo0F:                                     k1f 
1)  KinB-CC~P + Spo0F  ↔  KinB-CC + Spo0F~P 
                                                 k1r 
with forward and reverse rate constants k1f and k1r, respectively, and dephosphorylation 
of Spo0F~P by the phosphatase activity of KinB-CC (Hsing and Silhavy, 1997; Russo 
and Silhavy, 1993; Stock et al., 2000; Zhu et al., 2000): 
                                               k2f 
2)  Spo0F~P + KinB-CC  ↔  Spo0F + KinB-CC + Pi 
                                               k2r 
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The phosphotransfer reaction (reaction 1) causes the rapid disappearance of KinB-CC~P 
and the appearance of Spo0F~P, while the phosphatase reaction (reaction 2) causes the 
disappearance of Spo0F~P over a longer period of time.  This is particularly evident in 
the absence of Sda (Figure 2.16).  
 
Figure 2.16)  Sda inhibits the rate of phosphotransfer from KinB-CCP to Spo0F, as well as KinB 
phosphatase activity towards Spo0F~P.  (upper left panel) Autoradiographs showing the time course of 
phosphotransfer from KinB-CC~P to Spo0F in the absence (top) and presence (bottom) of a 25-fold molar 
excess of Sda.  These experiments were repeated and quantitated in triplicate, and the results plotted in the 
lower panel (data points).  The plot on the left shows the full time course (up to 0.5 hr), while the plot on 
the right shows the same data but with an expanded time scale.  The lines show the results of the best-fit 
rate parameters (shown in the table) assuming the reaction scheme described in the text. 
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In the presence of saturating Sda, the kinetics were slow enough to capture with 
the 15 s time points.  The rate constant k1f was estimated from the rate of the initial 
disappearance of KinB-CC~P to be approximately 0.015 mM-1s-1.  This matches well 
with best-fit kinetic parameters (Figure 2.16).  In the absence of Sda, phosphotransfer to 
Spo0F, as judged by the disappearance of KinB-CC~P, was essentially complete by the 
first time point of 15 seconds.  It was not possible to collect shorter time points reliably 
using our protocol.  A lower bound for k1f was estimated to be about 0.1 mM-1s-1, but this 
value is likely to be significantly in error.  Indeed, best fit kinetic parameters yield a value 
for k1f of 330 mM-1s-1, more than three orders of magnitude higher than our lower bound 
estimate, and more than four orders of magnitude higher than the rate in the presence of 
Sda (Figure 2.16).  However, the fitted parameters are not reliable due to the absence of 
time points shorter than 15 seconds.  Nevertheless, it is clear that the presence of Sda 
inhibits the rate of phosphotransfer from KinB-CC~P to Spo0F by a minimum of one 
order of magnitude and possibly up to four orders of magnitude.  Note also that the 
presence of Sda inhibits the forward rate of the phosphatase reaction (k2f) as well, by 
about two orders of magnitude, which is not surprising since this reaction likely involves 
the interaction of Spo0F~P with the KinB-CC-DHp domain in a manner similar to the 








Sda is a potent inhibitor of KinB autophosphorylation (Figure 2.4B), a potent 
inhibitor of phosphotransfer from KinB~P to Spo0F, as well as a potent inhibitor of KinB 
phosphatase activity toward Spo0F~P (Figure 2.16).  Our structural and biochemical 
analyses reveal that Sda binds at the end of the KinB-DHp domain, distal to the 
membrane, and prevents molecular transactions with the DHp domain to which it is 
bound by acting as a simple molecular barricade to sterically block communication 
between the KinB CA and DHp domains required for autophosphorylation, as well as to 
sterically block communication between Spo0F and the KinB DHp domain required for 
the phosphotransfer and phosphatase activities (Figure 2.16).  The Sda/KinB molecular 
interface observed in the crystal structure (Figure 2.8) explains the effects of amino acid 
substitutions previously studied in Sda (Rowland et al., 2004) as well as substitutions 
introduced into KinB (Figure 2.11A).  
In agreement with our conclusions, Rowland et al. (Rowland et al., 2004) 
concluded that Sda inhibits KinA autophosphorylation activity by acting as a molecular 
barricade to block the required communication between the HK DHp and CA domains.  
Contrary to our findings, however, Rowland et al. (Rowland et al., 2004) concluded, 
based on measurement of a single time point and not rate measurements, that Sda does 
not interfere with phosphotransfer to Spo0F, and proposed that Sda binds to the top of the 
DHp domain (proximal to the membrane) and interacts with the DHp-CA linker region, a 
binding site that would not interfere with Spo0F binding but could hinder the 
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conformational mobility of the CA domain required for autophosphorylation.  Our 
structural analysis indicates that binding of Sda and Spo0F to the DHp domain must be 
mutually exclusive (Figure 2.15B).  Consistent with this, we show that Sda strongly 
retards the rate of phosphotransfer from KinB-CC~P to Spo0F (Figure 2.16). 
 Whitten et al. (Whitten et al., 2007) used a combination of SAXS and neutron 
scattering data to generate a structural model of the Sda/KinA-CC complex.  Analysis of 
their model in the context of a structural model of DHp/CA domain communication 
during autophosphorylation led Whitten 
et al. to conclude that Sda did not present 
significant steric interference to DHp/CA 
domain communication, but rather that 
Sda inhibition activity must arise from 
allosteric effects on the HK structure.  
While the gross features of the Whitten 
et al. model, in which Sda binds to the 
KinA DHp domain at the end distal to 
the DHp-CA linker, with the Sda α-
helices roughly perpendicular to the DHp α-helices, agree with the Sda/KinB-CC crystal  
Figure 2.17)  Superimposition of the Sda/KinB-CC crystal structure (KinB-CC chain A, red; KinB-CC 
chain B, orange; Sda, blue) with the SAXS/neutron scattering model of Sda/KinA (Whitten et al., 2007).  
Superimposition was by the HK DHp domain only.  In the SAXS/neutron scattering model, Sda is bound in 
a different position on the DHp domain, and the orientation of Sda is rotated by approximately 180° (about 
an axis perpendicular to the DHp domain helices. 
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structure, the precise positioning of Sda, as well as the orientation of Sda with respect to 
the DHp domain, significantly differ due to the low resolution of the SAXS/neutron 
scattering method (Figure 2.17).  The positioning and orientation of Sda observed in our 
crystal structure presents significant steric clashes with the CA domain modeled in 
position for the autophosphorylation reaction (Figure 2.15A), consistent with Sda acting 
as a simple steric block of CA domain communication with the DHp domain.   
Also consistent with this conclusion are two additional observations from our 
study.  First, conformational changes in the DHp domain induced by Sda binding appear 
to be restricted to residues that directly interact with Sda and are not propagated to other 
parts of the structure (Figure 2.6A), and second that a small set (three) of amino acid 
substitutions directly within the HK binding surface for Sda confers Sda sensitivity to an 
otherwise insensitive HK (Figure 11B). 
 In their SAXS/neutron scattering analysis, Whitten et al. (Whitten et al., 2007) 
observed that binding of Sda to KinA-CC, an 11% increase in mass, resulted in no 
significant change in the radius of gyration but caused a significant decrease in the 
maximum linear dimension of the complex.  In the structural modeling, this was realized 
through a 'compaction' of the KinA CA domains in towards the homodimer two-fold axis 
compared with KinA alone (Whitten et al., 2007).  We observe a qualitatively similar 
'compaction' of the CA domains in our crystal structure of the Sda/KinB-CC complex 
(Figure 2.6A).  It is tempting to propose that this compaction is a consequence of Sda 
binding, and that the compaction plays a role in the inhibition of autophosphorylation 
activity.  We do not believe this to be the case for the following reasons.  Sda binding to 
KinB in our crystal structure is asymmetric (i.e. an Sda molecule is bound to only one 
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monomer of the KinB dimer; Figure 2.4C), and we have shown that Sda inhibition is also 
asymmetric (i.e. Sda inhibits DHp function of only the DHp domain to which it is bound, 
not both DHp domains of the KinB dimer (Figure 2.13)).  The compaction of the CA 
domains in our crystal structure, however, is symmetric (Figure 2.4C); even though Sda 
is bound to only one KinB-CC monomer in the crystal, both CA domains are compacted 
in an essentially symmetric KinB-CC dimer.  If the CA domain compaction seen in our 
crystal structure was a consequence of asymmetric Sda binding and played a role in 
asymmetric Sda inhibition of autophosphorylation, the symmetry of the compaction 
would be expected to match the symmetry of the inhibition, which is not the case.  We 
believe the crystallization conditions stabilize the compacted CA domain architecture 
seen in our crystal structure (Figure 2.6B). 
  If the Sda functional mechanism is to bind the HK DHp domain and sterically 
block CA domain and Spo0F communication with the phosphoacceptor His, it might 
seem that Sda could be a more effective and direct inhibitor if it bound directly at the His 
residue, rather than peripheral to it (Figure 2.4C).  However, the phosphoacceptor His is 
located within a sequence motif that is highly conserved among all two-component HKs, 
the H-box (Figure 2.9), so a small protein like Sda would not be able to achieve 
specificity for the sporulation HKs if its binding determinant included the H-box.  In fact, 
Sda does not interact with any residues within the H-box but instead interacts with a 
region adjacent to the H-box at the base of the DHp domain that is conserved among 
Bacillus sporulation HKs, but not among all HKs (Figure 2.9).  Specificity of Sda for the 
sporulation HKs is derived from at most three residues within this region (the GFXXL 
motif), since substitution of three residues within this region into a HK not normally 
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inhibited by Sda gives rise to robust Sda inhibition (Figure 2.11B).  Sda has been shown 
to inhibit the sporulation kinases KinA (Burkholder et al., 2001; Rowland et al., 2004) 
and KinB (Figure 2.4B), but the high conservation of the GFXXL motif among the 
sporulation HKs (Figure 2.9) suggests that Sda inhibits all of the sporulation HKs. 
Response regulators (such as Spo0F) interact directly with the phosphoacceptor His but 
still achieve exquisite specificity for their cognate HKs, but these proteins cover a much 
larger surface of the HK-DHp domain that includes the H-box region as well as the base 
of the DHp (where Sda binds, Figure 2.15B), explaining how specificity is achieved 
(Skerker et al., 2008). 
 In the KinB structure the disposition of the CA domain with respect to the DHp 
domain is inappropriate for the autophosphorylation reaction.  The structure gives little 
support to either a cis or trans mechanism of autophosphorylation for KinB.  However, 
the ε nitrogen of the side chain of the phosphoacceptor His is approximately 5.5 Å closer 
to the β-phosphate of the nucleotide bound to the CA domain of the same monomer than 
it is to the same atom of the opposite monomer (19.3 Å compared with 24.8 Å, 
respectively).  In addition, the length of the DHp - CA linker would appear to allow either 







Structure coordinates and structure factors have been deposited in the Protein 
Data Bank under ID code 3D36. 
 
Annotation of Bacterial Species Names in Figure 3A 
 
Bacterial species names corresponding to the abbreviations in the left column are 
annotated below, along with the NCBI GenInfo (gi) number for the protein sequence:  
Gst (Geobacillus stearothermophilus); Gka (Geobacillus kaustophilus HTA426, 
gi[56421062]); Gth (Geobacillus thermodenitrificans NG80-2, gi[138896100]); BB-
14911 (Bacillus sp. NRLL B-14911 gi[89100817]); Bam (Bacillus amylolequefaciens 
FZB42, gi[154686829]); Bli, (Bacillus licheniformis ATCC 14580, gi[52081119]); Bsu, 
Bacillus subtilis subsp. Subtilis str. 168, gi[50812270]); Bha, (Bacillus halodurans C-
125, gi[15613884]); Bpu, (Bacillus pumilus SAFR-032, gi[157693071]); BSG-1, 
(Bacillus sp. SG-1, gi[149183160]); Bce (Bacillus cereus G9241, gi[47569333]); Bth 
(Bacillus thuringiensis serovar israelensis ATCC 35646, gi[75761262]; Ban (Bacillus 
anthracis str. Ames, gi[30264409]); Bwe (Bacillus weihenstephanensis KBAB4, 
gi[8920636]); Oih (Oceanobacillus iheyensis THE831, gi[22777674]); Bcl (Bacillus 




Materials and Methods 
 
Cloning and Mutagenesis 
KinB derivatives, Spo0F, and Sda were PCR amplified from Gst strain 10 
genomic DNA.  KinB derivatives were cloned into the NdeI and BamHI sites of both 
pET21a (Novagen) and a pET28a-based vector containing an N-terminal PreScission™ 
Protease (GE healthcare) cleavable His6-tag.  Spo0F was cloned into the NdeI and 
BamHI sites of a pET28-based vector.  Sda was cloned into pET21a.  KinB(208-CT) was 
subcloned from KinB-CC into the NdeI and BamHI sites of the pET28a-based vector.  
For coexpression, KinB-CC and Sda were subcloned into the pET28a-based vector such 
that the two proteins were coexpressed from a single promoter (Campbell and Darst, 
2000).  In the resulting vector, KinB-CC contained an N-terminal, PreScission™ Protease 
cleavable His6-tag and Sda was untagged.  After cleavage with PreScission™ Protease, 
KinB-CC harbors four vector derived residues (GPHM) at its N-terminus.  KinB-CC 
mutants (Figure 2.11A) were generated using the megaprimer method (Perrin and 
Gilliland, 1990). 
Plasmid pET24c-TM0853 was kindly provided by Dr. Alberto Marina (Marina et 
al., 2005).  A single megaprimer containing three amino acid substitution sites was used 





Expression and Purification 
KinB derivatives, Spo0F, Sda, and Sda/KinB complexes were all expressed in 
Eco Rosetta2 DE3 (Novagen).  Cultures were grown at 37°C to an OD600 of 0.6.  Cells 
were then transferred to 16 °C, IPTG was added to 0.1 mM, and the cells were incubated 
overnight.  Cells were harvested by centrifugation, resuspended in lysis buffer 
(20 mM Tris-HCl, pH 7.0, 150 mM NaCl, 10 mM MgCl2, 5 mM imidazole, 5% glycerol) 
and stored at -80 °C. 
For purification, phenylmethylsulfonyl fluoride and β-mercaptoethanol were 
added (each to 1 mM), and the cells were lysed using a continuous flow French press 
(EmulsiFlex-C5, Avestin) and clarified by centrifugation.  For Sda purification, the 
supernatant was heat-treated at 65 °C for 15 min, and aggregated material was removed 
by centrifugation.  This yielded an Sda preparation that was more than 95% pure as 
judged by SDS-PAGE.  Heat-treatment of KinB derivatives and Spo0F resulted in 
aggregation and was not used.  Instead, KinB derivatives and Spo0F were applied to a 
Ni2+-charged HiTrap metal chelating column (GE Healthcare), the column was washed 
extensively with loading buffer, then His6-tagged proteins were eluted with lysis buffer 
containing 200 mM imidazole.  To cleave the His6-tag, PreScission™ Protease was added 
in a 1:100 mass:mass ratio and the protein was dialyzed overnight at 4°C against 2 L of 
20 mM Tris-HCl, pH, 7.0, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT.  Protein for 
crystallization was further purified to homogeneity by passing the sample over a GST-
affinity column (to remove the GST-tagged PreScission protease), followed by anion 
exchange chromatography (HiTrap Q, GE Healthcare) and size exclusion 
chromatography.  TM0853 (and TM0853*) was expressed and purified as previously 
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described (Marina et al., 2005), with the exception that aliquots were made following the 
heat treatment step. 
 
Crystallization and Structure Determination 
Purified Sda/KinB-CC complex was concentrated to 10 mg/ml by centrifugal 
filtration (Vivascience), and a 5-fold molar excess of ADP (Sigma) was added.  Crystals 
of the Sda/KinB-CC complex were grown at 4 °C in sitting drops using vapor diffusion 
by mixing equal volumes of protein solution (1 ml at 10 mg/ml in 20 mM Tris-HCl, pH 
7.0, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT) and crystallization solution (200 mM 
LiCl, 40% MPD).  Crystals (small hexagonal plates) appeared overnight and grew to a 
maximum size of about 50 X 50 X 20 µm in one week.  Microseeding techniques were 
employed to grow larger crystals (about 150 X 150 X 50 µm).  Methyl-HgCl derivatized 
crystals (Table 2.1) were prepared by soaking crystals for 10 min. in crystallization 
solution supplemented with 2.5 mM methyl-HgCl (Sun and Radaev, 2002).  Both native 
and methyl-HgCl crystals were directly flash frozen in liquid ethane and stored in liquid 
nitrogen prior to data collection.  Diffraction data was processed using HKL2000 
(Otwinowski and Minor, 1997).  The structure was phased with data from the methyl-
HgCl derivative (Table 2.1).  Two Hg sites were located within the asymmetric unit using 
SHELX (Sheldrick, 2008).  Heavy atom refinement, phasing, and density modification 
calculations were performed using SHARP (de La Fortelle et al., 1997).  SAD phases 
alone, calculated from the single-wavelength methyl-HgCl data, yielded an 
uninterpretable electron density map, but gave a SIRAS map with clear elements of 
secondary structure when combined with the isomorphous signal from the native dataset.  
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The SIRAS phases were used as the basis for phased molecular replacement searches 
(http://zonker.bioc.aecom.yu.edu/cgi-bin/inhouse/bruteptf/bruteptf.cgi)                       
using BRUTEPTF (Strokopytov et al., 2005), which placed the individual DHp and CA 
domains from HK TM0853 (Marina et al., 2005).  An excellent MIRAS experimental 
electron density map (Figure 2.3) was obtained by combining the SIRAS phases with the 
phases calculated from the molecular replacement solution, along with subsequent 
density modification using RESOLVE (Terwilliger, 2000).  
A partial model was built into the 2.0 Å resolution MIRAS map using RESOLVE 
(Terwilliger, 2003).  Additional model building was carried out using O 10.0.3 (Jones et 
al., 1991).  Iterative cycles of refinement and model building were carried out using CNS 
(Adams et al., 1997), with final rounds of refinement using RefMac (Murshudov et al., 
1997).  The final model was refined to an R/Rfree of 20.0/21.5.  Structure validation using 
MolProbity (Davis et al., 2007) gave an overall clash score of 5.74 (98th percentile for a 
structure at 2.0 Å resolution), revealed 98.5% of residues in the most favored regions of 
the Ramachandran plot, with 1 residue (0.15%) in a disallowed region (Leu207 of chain 
B, adjacent to a disordered loop). 
 
ESI-MS 
The Sda/KinB-CC complex was analyzed using a modified Q-ToF 2 mass 
spectrometer (Waters, Manchester, UK).  For the analysis the complex was buffer 
exchanged into 200 mM ammonium acetate (pH 7.5), and aliquots of ~2 ml were 
introduced into the mass spectrometer via nanoflow capillaries.  The following 
experimental conditions were used: capillary voltage, 1.6 kV; RF Lens, 65 V; cone 
 99 
voltage, 65 V; accelerating voltage, 8 V.  Pressure at the ion transfer stage was 




Plasmid pET21a-KinB-CC (no affinity tag, ampicillin resistance) and pET28a-
KinB-CC (N-terminal His6-tag, kanamycin resistance) were co-transformed into 
Eco Rosetta2 DE3 and expressed as described for the Sda/KinB-CC complex.  Following 
lysis, the supernatant was passed over a Ni2+-charged HiTrap metal chelating column 
(GE Healthcare), allowing any untagged homodimer KinB-CC to flow through.  The 
column was then eluted with a linear gradient from 5 mM to 200 mM imidazole, allowing 
the separation of His6-KinB-CC/KinB-CC heterodimers from His6-KinB-CC 
homodimers.  Glycerol was added to 15% and aliquots were snap frozen in liquid 
nitrogen and stored at -80 °C. 
 
Autophosphorylation Assays 
For the KinB-CC mutant and mixed-dimer assays, 50 pmol of KinB-CC was 
incubated in kinase buffer (50 mM 3- 4-(2-Hydroxyethyl)-1-piperazinyl propanesulfonic 
acid [HEPPS], pH 8.5, 20 mM KCl, 5 mM MgCl2, 5% glycerol) at 25 °C with either 0, 1, 
5, or 25-fold molar excess of Sda for 15 min in 10 µl reactions.  Next, 1 µl of a 1:1 
mixture of 50 mM ATP:3000µCi/µmol γ-[32P]ATP was added and the 
autophosphorylation reaction was carried out for 1 hr at 25 °C.  Reactions were quenched 
with 2.5 µl 5X SDS loading buffer with 50 mM EDTA and immediately subjected to 
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PAGE analysis on a 4-20% gradient tris-glycine polyacrylamide gel.  Gels were dried for 
1.5 hr at 55 °C and analyzed by phosphorimagery (Molecular Dynamics).  
 
Phosphotransfer Assays 
KinB-CC (500 pmol) was phosphorylated for 1 hr at 25 °C as described in the 
autophosphorylation assays.  Excess nucleotide was removed from the KinB-CCP using a 
0.8 ml microspin desalting column (BioRad).  The KinB-CCP was split into two equal 
reaction volumes.  A 25-fold molar excess of Sda was added to one reaction, while the 
same volume of Sda storage buffer was added to the other.  The reactions were then 
incubated at 25 °C for an additional 15 min.  Spo0F (250 pmol) was then added to each 
reaction.  At timed intervals, 10 µl aliquots were removed and mixed with 2.5 µl of 
5X SDS loading buffer plus 50 mM EDTA, then snap frozen and stored in liquid nitrogen 
until all time points were ready for analysis by 17% SDS-PAGE.  The portion of the gel 
below the 10 kDa molecular-weight marker was removed in order to reduce background 
radioactive signal.  The gels were then analyzed and quantitated by phosphorimagery.  To 
estimate the rate constants for the phosphotransfer and phosphatase reactions (Figure 
2.16), the data were fit using least squares to the reaction scheme and Runge-Kutta 4th 
order numerical integration using the program Berkeley Madonna v8.3.21 
(www.berkeleymadonna.com).  The R-factors [(R = S|Cobs – Ccalc|)/SCobs, where Cobs is 
the observed concentration, and Ccalc is the concentration calculated from the curve-fit 
parameters) for the curve-fits are: KinB-CC-P-SDA (cyan line in Figure 2.16), 0.22; 
Spo0F-P-SDA (red line in Figure 2.16), 0.097; KinB-CC-P+SDA (blue line in Figure 16), 
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CHAPTER 3 




One of the long-standing questions in the field of histidine kinase biology 
concerns the structural rearrangements necessary to transition an HK from the inactive to 
active state of autophosphorylation.  Currently available crystal structures of intact HK 
catalytic cores (CCs, containing both the DHp and CA domains) are in the “off” 
conformation, where the γ-phosphoryl of the ATP bound in the CA bound domain is far 
removed from the phosphoacceptor His of the DHp domain (Bick et al., 2009; Marina et 
al., 2005).  It is presumed that the autophosphorylation event is highly transient in nature, 
and hence difficult to trap and study using traditional methods of crystallography.  
Moreover, CCs separated from their signal sensing domains possess an unregulated basal 
level of autophosphorylation, such that the CA and DHp domains are in constant 
positional flux with respect to one another. 
The mechanism of phosphotransfer from the HK to the RR is another unresolved 
topic of interest.  The unstable nature of the phospho-His N-P bond, with its low free 
energy of hydrolysis between -12 and -14 kcal/mol, has stifled the structural investigation 
of HKs in their phosphorylated forms.  Phospho-His has a half-life under acidic 
conditions on the order of seconds, though it is much more stable in alkaline conditions 
(Severin and Yudelovich, 1947).  Simple chemical mimics of phospho-Asp (Chabre, 
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1990) have been used to study phosphorylated RRs (Casino et al., 2009; Gardino et al., 
2003; Zhao et al., 2008), but no analogous phospho-His mimic is currently available. 
Co-crystal structures of Spo0F in both the unphosphorylated form and as a 
phospho-Asp mimic (BeF3-) in complex with the phosphotransferase Spo0B have been 
used as models of the HK-RR interaction (Varughese et al., 2006; Zapf et al., 2000).  
Indeed, alanine scanning mutagenesis has shown that both Spo0B and KinA share the 
same Spo0F interacting surface (Tzeng and Hoch, 1997).  However, there are several 
reasons to believe that these structures may not be representative of a true phospho-His 
HK-RR interaction.  First of all, because of the directionality of the HK-RR 
phosphotransfer step, if anything the BeF3--Spo0F-0B structure describes how an 
unphosphorylated HK recognizes a phosphorylated RR for dephosphorylation.  Secondly, 
as mentioned in the introduction of this thesis, it is unclear whether phospho-His is an 
intermediate of HK induced dephosphorylation of the RR, such that phosphotransfer from 
Spo0F to 0B may occur by a different mechanism.  Lastly, despite the fact that Spo0B 
has an HK-like four-helix bundle, it does not possess autokinase activity, and hence is not 
a real HK.  
The recently reported co-crystal structure of HK 0853 from T. maritima in 
complex with its cognate RR 468 has greatly advanced our understanding of the 
structural determinants required for HK-RR partner specificity (Casino et al., 2009).  
Though the TM0853-468 complex does provide information regarding HK to RR 
phosphotransfer, the structure is more representative of an HK poised for RR 
dephosphorylation.  If we are to understand the precise mechanism of phosphotransfer, 
the structure of a phosphorylated HK will be necessary.  
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Keeping the restraints of HK domain flexibility and phospho-His instability in 
mind, we have chosen to pursue a hybrid approach for investigating the active 
conformations of an HK.  By employing the methods of stepwise solid phase peptide 
synthesis (SPPS) for the introduction of His analogs into the DHp, protein semisynthesis, 
and native chemical ligation (NCL), we hope to trap transient active states of KinB.   
Solid phase peptide synthesis (SPPS) (Merrifield, 1986; Merrifield, 1963) has 
been used to incorporate non-biologically encoded amino acids into peptides at site-
specific locations.  In principle, any unnatural amino acid can be used in SPPS.  Proteins 
containing amino acids with modifications to either the side chain or peptide backbone 
have been reported (Valiyaveetil et al., 2002; Valiyaveetil et al., 2004, 2006b), and for 
several cases crystal structures of these semisynthetic proteins have been solved (Chacko 
et al., 2004; Qin et al., 2002; Rak et al., 2003; Valiyaveetil et al., 2006a).   
 SPPS involves the attachment of the C-terminal amino 
acid to a solid support resin, and the subsequent addition of 
amino acids in a stepwise manner; the peptide is synthesized 
from C- to N-terminus (Figure 3.1).  Peptides made using 
current SPPS technology are roughly limited to 50 amino acids 
or less (Dawson et al., 1997).  This is because, despite the high 
efficiency of the coupling reaction, it is not 100%; truncated 
byproducts do carry through from previous coupling steps.  As 
an example, for a 50-mer peptide, where ideally each coupling 
reaction is at least 99% efficient, 0.9950 would still only yield 60.5% full-length product.  
In practice coupling reactions are often less than 99% efficient.   
Figure 3.1) SPPS 
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Amino acids for SPPS must have their reactive functional groups protected during 
synthesis.  This is true of the both the α-amino group and side chain functionalities, the 
difference being that protective groups are removed from the α-amino group after each 
amino acid coupling, while the side chain protecting groups are left in place until the 
peptide has been fully assembled.  The choice of side chain protecting chemistry is 
entirely dependent upon which of two possible α-amino group protecting chemistries, 
either Boc or Fmoc, will be used for the synthesis (Carpino, 1957, 1973; Chang and 
Meienhofer, 1978).   
 Native chemical ligation allows two or more unprotected peptides to be joined by 
a natural peptide bond at the ligation site (Dawson et al., 1994).  Peptide segments for 
NCL may come from either synthetic or recombinant sources.  The principle of NCL lies 
in the chemoselective reaction that takes place between the α-cysteine of one peptide and 
the α-thioester of the second (Figure 3.2).  The first step of the NCL reaction involves a 
thiol/thioester exchange, which can occur at any Cys residue within the peptide.  This 
reaction is fully reversible under the aqueous conditions used for NCL.  The second step 
of the reaction involves the formation of a native peptide bond via intramolecular 
nucleophilic attack.  Unlike step one, this reaction is irreversible under the same 
conditions, and so over time the thiol/thioester intermediates are depleted, resulting in a 
highly regiospecific product (Dawson et al., 1997).  It is therefore of no consequence if 
additional Cys residues are present in either peptide fragment.   
Along those lines, any unprotected peptide may be used for NCL, as long as the 
chemical requirements of an α-cysteine and α-thioester at the termini of the peptides are 
met; the amino acid composition of the peptides is immaterial to the ligation reaction.  Of 
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course, many proteins do not possess a conveniently located Cys in their coding 
sequence.  In such cases it is necessary to introduce a Cys by mutagenesis. 
 
Figure 3.2)  The mechanism of native chemical ligation.  The initial step is a reversible 
transthioesterification reaction involving the thiol group of the N-terminal Cys-polypeptide (C-terminal 
fragment) and the α-thioester moiety of the N-terminal polypeptide fragment.  This intermediate undergoes 
a spontaneous rearrangement to form a natural peptide bond at the ligation site.  Taken from (Camarero and 
Muir, 2001). 
 
The present chapter describes the semisynthesis of the KinB catalytic core, using 
stepwise SPPS and native chemical ligation to generate a full-length KinB-CC with 
amino acid analogs of histidine at the site of phosphorylation.  The preliminary steps 
required (protein refolding, Cys mutagenesis) to carry out a successful semisynthetic 
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experiment are also reported.  The work described in this chapter was carried out in 
collaboration with the Muir Laboratory at The Rockefeller University, and in particular 
with Dr. Jung-Min Kee, a postdoc in the Muir lab, as well as with Professor J. David 
Warren, head of the Abby and Howard P. Millstein Synthetic Chemistry Core Facility at 
Weill Cornell Medical College.  Katharina Häußermann, a master’s student from 
Germany performing her thesis work in the Darst lab, carried out many of the peptide 
inhibition experiments.  Only a brief description of the chemical synthesis of the amino 
acid analogs will be given for archiving purposes, as much of this work was performed 
by Dr. Kee and Dr. Warren, and is outside the expertise of the thesis author. 
 
Results and Discussion 
 
Establishing the Native Chemical Ligation Site in KinB 
 In the crystallized KinB-CC construct, the active site histidine of KinB, His 213, 
is conveniently located a mere 19 amino acids from the N-terminus, making it easily 
accessible for modification by stepwise SPPS.  Because the total length of the KinB-CC 
is 240 amino acids, we chose to pursue a semisynthetic strategy for generating full-length 
KinB-CC, wherein a short peptide comprising the KinB N-terminal portion would be 
synthesized chemically, and the C-terminal portion would be expressed recombinantly. 
The KinB-CC sequence contains two naturally occurring Cys residues, the closer of 
which is 101 amino acids from the N-terminus.  It was therefore necessary to introduce a 
Cys into KinB-CC at a point that was both compatible with ligation to an N-terminal 
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Figure 3.3)  (Top) The KinB dimer, colored according to the semisynthetic scheme described in this 
chapter.  The green region corresponds to residues that will be synthesized by SPPS.  The remainder of the 
protein (orange) will be expressed recombinantly in E. coli.  The region colored magenta corresponds to 
vector derived residues observed in the KinB/Sda crystal structure.  These will not be included in the 
peptide synthesis.  The cysteine mutant introduced to facilitate the native chemical ligation reaction is 
labeled grey.  (Bottom) The KinB 195-CT sequence.  The Ala position mutated to Cys is highlighted with 
an asterisk.  Colored residues correspond to conserved sequence motifs: H-box (red), Sda box (purple), N-
box (blue), G1-box (olive), and G2-box (cyan).  
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peptide of less than 50 residues, and yet downstream of His 213.  His 213 is located in a 
region of high sequence conservation, the H-box (residues Ile 211 to Leu 219), 
preventing us from engineering a Cys into this motif.  In addition, Sda makes contacts 
with KinB residues immediately following the H-box, three of which, Gly 224, Phe 225, 
and Leu 228, are indispensable for this interaction.  We chose a conservative Ala to Cys 
mutation at position 221 as a trade off between mutating a residue that contacts Sda and 
keeping the peptide length relatively short (26-mer, KinB Val 195 to Thr 220).  Position 
221 of KinB is conserved as an Ala in sensor HKs, although serine and cysteine also 
occur, including a Cys in B. subtilis KinC.  Ala 221 is solvent exposed in the KinB/Sda 
structure, occurring at roughly the midpoint of α-helix 1 of the DHp domain (Figure 3.3).  
Only the backbone α-carbon and carbonyl oxygen of Ala 221 make contacts with Sda 
Phe 25, so presumably the side chain is unimportant for the KinB/Sda interaction. 
 We first tested KinB A221C in an autophosphorylation assay to determine if the 
Cys mutation affected the enzymatic activity of the protein.  To our surprise, rather than 
inhibit autophosphorylation, the A221C mutant instead showed enhanced levels of 
labeling when compared with wild-type (Figure 3.4).  We initially reasoned that the new 
Cys 221 was forming a disulfide bond with Cys 317 of the CA domain, effectively 
locking the active conformation.  In our KinB active state model (see Chapter 2), Cys 317 
is within a reasonable distance to Ala 221 (Cys 221).  However, when we performed the 
autophosphorylation assay in the presence of reducing agent (10 mM DTT), increased 
levels of labeling were still observed (data not shown).  The fact that position 221 of 
KinB not only offers a convenient location for NCL, but also that a Cys at this site seems 
to promote autophosphorylation should prove to be advantageous for stabilizing the KinB 
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active conformation.  Sda mediated inhibition of the autophosphorylation reaction was 
unaffected by the Cys substitution (Figure 3.4). 
 
   
  
 
KinB is Active Following Denaturation and Refolding 
Our NCL strategy is carried out under denaturing conditions.  Because of this, we 
needed to ensure that KinB-CC could be properly refolded and still maintain its 
enzymatic activity.  Denatured KinB, at approximately 3mg/ml in 6 M guanidine-HCl, 
was rapidly diluted 1:20 (final [KinB] of ~150µg/ml) with a refolding buffer (Burgess, 
2009).  We saw little to no signs of protein aggregation when the absorbance at 320 nm 
was determined on a sample of the refolded protein solution (protein aggregates tend to 
scatter 320 nm light (see methods) (Burgess, 2009)).  Our initial refolding experiments 
produced an active enzyme, but we observed what appeared to be KinB multimers 
following an autophosphorylation assay and SDS-PAGE analysis (Figure 3.5A).  We 
attributed this to the formation of aberrant disulfides while the protein was in the 
denatured state.  Addition of 10mM DTT to the refolding buffer greatly reduced the KinB 
multimeric species (data not shown).  Refolded KinB migrated as a monodisperse species 
on a size exclusion column (Figure 3.5C).  When assayed for autophosphorylation, 
Figure 3.4)  Autophosphorylation 
assay performed on KinB 195-CT 
wild-type (WT) and A221C.  The 
A221C mutation does not hinder 
the activity of Sda. 
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refolded KinB showed no discernible loss of enzymatic activity compared with native 
(non-denatured) KinB (Figure 3.5B). 
 
Figure 3.5)  (A) Two time points, 15 and 60 min, from an autophosphorylation assay performed with KinB 
195-CT that had been denatured in 6 M guanidine-HCl, and subsequently refolded in 4 different solutions 
from the FoldIt™ screen (Hampton) (see Materials and Methods).  As the FoldIt™ screen has been 
discontinued for some time, solutions were homemade.  Refolded KinB 195-CT phosphorylated to near 
wild-type levels, with the exception of protein refolded with solution 3.  Higher molecular weight bands 
seen in the autoradiogram were suspected to be multimers of KinB formed by disulfides during the 
refolding process.  (B) Time course of autophosphorylation comparing native (non-denatured) and refolded 
KinB 195-CT after a size exclusion chromatography step.  The protein used in this assay was taken from a 
stock after the folding conditions on a large (~3.5 mg) scale had been optimized using FoldIt™ solution 13 
(see Figure 3.5A).  (C) Chromatogram of the size exclusion chromatography step used to purify the 
refolded protein from (B).  Refolded KinB 195-CT had the expected retention time on the column, and 




Generation of the Reagents for Native Chemical Ligation 
 After we established a suitable ligation site within KinB, and showed that the 
KinB-CC maintains its activity after refolding, we turned our attention to the design of 
the necessary reagents for KinB-CC semisynthesis.  KinB Val 195 to Thr 220 (26-mer) 
was synthesized on a 3-mercapto-propionamide-MBHA (4-Methylbenzhydrylamine) 
solid support resin using standard Boc-SPPS techniques (Camarero and Muir, 2001).  The 
remaining carboxy-terminal KinB fragment, containing the Ala 221 Cys mutation, was 
expressed as a C-terminal PreScission™ Protease cleavable His6-tagged protein.  
Expression in the pET21a system produces an N-terminal Met upstream of Cys 221.  We 
designed this construct with the idea that removal of the N-Met would occur 
spontaneously in the cell as a result of the activity of endogenous E. coli methionyl-
aminopeptidases (MetAPs), leaving a free α-Cys (Gentle et al., 2004).  The efficiency of 
Met removal is heavily dependent upon the side chain of the penultimate amino acid.  
Reports vary from complete (100%) to only partial (71%) removal of N-Met when the 
next amino acid is Cys (Boissel et al., 1988; Hirel et al., 1989).  During our original 
expression trials of the α-Cys fragment, in addition to removal of the N-Met we also 
observed partial cleavage of the Cys as judged by mass spectrometry (data not show).  
This was most likely due to overly active MetAPs.  We also observed possible small 
molecule modification of the α-Cys.  To combat these issues, the expression time was 
shortened from ~4 to 2 h to limit over-activity of the MetAPs, and free cysteine was 
added to the expression cultures in order to scavenge any Cys reactive small molecules in 
the cell (Gentle et al., 2004). 
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 The α-Cys protein expressed to high levels, but partitioned almost entirely to the 
insoluble fraction (Figure 3.6).  The protein was solubilized from inclusion bodies using 
6 M guanidine-HCl, and initially purified using Ni2+ affinity chromatography under 
denaturing conditions.  The Ni2+ step purified the protein to greater than 80% as judged 
by SDS-PAGE, and from 4 L of bacterial culture yielded 73.5 mg (Figure 3.6).  
Electrospray ionization (ESI) mass spectrometric analysis indicated that an unidentified 
small molecule was still modifying the α-Cys (Figure 3.7A).  Treatment of the protein 
with tris(2-carboxyethyl)phosphine (TCEP) did not correct this modification (Figure 
3.7B).  However, when treated with O-methylhydroxylamine (MeONH2), the 
modification was reversed, and yielded the expected protein mass within the error limits 
of the mass spectrometer (Figure 3.7D).  Following Ni2+ affinity purification, the 
MeONH2 treated protein was purified to nearly 100% homogeneity via size exclusion 
chromatography (Figure 3.6).  A band of roughly double the molecular weight of the α-
Cys was observed during the purification.  We attributed this to the formation of a 
disulfide bond between the N-terminal Cys residues from two fragments (Figure 3.6).  
Treatment of the protein with TCEP abolished the putative disulfide (Figure 3.6). 
 An additional α-Cys construct covering KinB residues 221 to 416, and also fused 
to a PreScission™ Protease cleavable His6-tag, has been designed.  This construct 
removes the 18 C-terminal residues that were disordered in the KinB/Sda crystal structure 
(see Chapter 2).  We will likely use this construct for future ligation and crystallization 
experiments.  A semisynthetic KinB 195-416 may crystallize more readily due to the 
absence of an unstructured region at its C-terminus.  We have expressed and purified 
KinB A221C-416 using the same protocol as for KinB A221C-CT (Figure 3.6).  
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Figure 3.6)  SDS-PAGE analysis of the various stages of the KinB α-Cys fragment purification.  All 
chromatography steps were performed under denaturing conditions (6M guanidine-HCl).  The size 
exclusion gel shows protein from the peak fractions.  TCEP gel (1) - protein prior to TCEP treatment; (2) 
post TCEP treatment.  WM - protein weight marker; Un - total E. coli protein levels prior to IPTG 












Figure 3.7 (next two pages)  ESI mass spectrometric analysis of the α-Cys KinB A221C-CT at various 
stages of the purification.  (A) KinB following Ni2+ affinity, prior to treatment with either MeONH2 or 
TCEP.  (B) KinB after the Ni2+ column, treated with TCEP, but not with MeONH2.  (C) KinB after the Ni2+ 
column, treated with MeONH2, but not TCEP.  (D) KinB after the size exclusion step (MeOHN2 treated) 
and treated with TCEP.  The expected mass of Gst KinB A221C-CT plus the PreScission™ Protease 





Figure 3.7 continued 
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Synthesis of Histidine Analogs 
 In order to trap the KinB active states, autophosphorylation and phosphotransfer, 
we synthesized stable analogs of 3-phospho-His (1-phospho-His as well) for trapping a 
KinB-Spo0F complex, and His covalently linked to ATP-γ-S (Figure 3.9), which will 
serve to bind the CA domain and lock the autophosphorylation conformation (Figure 
3.10).  Analysis of bisubstrate analog inhibitors of tyrosine kinases (essentially peptide 
substrates incorporating phospho-Tyr analogs) indicate that the tightest binding inhibitors 
incorporate a phospho-Tyr analog with a short spacer connecting the Tyr to the 
phosphate, rather than the direct linkage of phospho-Tyr (Figure 3.8) (Hines et al., 2005).  
This design exploits the fact that phosphoryl transfer involves a dissociative transition  
 
Figure 3.8)  Comparison of ATP-γ-S conjugated tyrosine and histidine.  Compound 1, phospho-Tyr; 2, Tyr 
analog designed to mimic the phosphorylation transition state (Parang et al., 2001); 3, phospho-His; 4, 
analogs designed to mimic the phosphorylation transition state of His.  The final product depends on the 
linker length (n) of the starting amino acid, diaminopropionic acid for n=1, diaminobutanoic acid for n=2, 
ornithine for n=3, and lysine for n=4. 
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state in the case of the eukaryotic tyrosine kinases.  It is unknown whether HKs use a 
dissociative or associative mechanism for autophosphorylation.  In the associative 
mechanism (analogous to an SN2 reaction) the phosphoryl group would adopt a 
pentavalent intermediate state bound to both the CA and DHp domains, before 
transferring completely to the DHp His.  In contrast, by a dissociative mechanism the 
phosphoryl group would briefly dissociate from the CA domain completely to form an 
unstable metaphosphate intermediate (analogous to an SN1 reaction) before binding to the 
DHp His.   
Following the reasoning behind the design of phospho-Tyr analogs, we initially 
wanted to investigate a series of His analogs conjugated to ATP-γ-S with different linker 
lengths between the α-carbon and side chain amine (Figure 3.8).  However, we have 
found it difficult to increase the number of carbons in the linker beyond what is outlined 
in Figure 3.9.  Attachment of the alkyne with an additional carbon to ATP-γ-S did 
produce the correct product when analyzed by HPLC and mass spectrometry (data not 
shown).  However, the product was unstable and we could neither purify nor characterize 
it.  Thus, we are left with a His-ATP analog with a single carbon linker between the side 
chain and ATP-γ-S.  This may not present a problem, as we have demonstrated that a 
peptide consisting of the KinB H-box motif with the histidine conjugated to ATP-γ-S by 
a single carbon linker (Figure 3.9) is an effective inhibitor of the autophosphorylation 





Figure 3.9 (adjacent page)  An overview of the synthetic schemes developed by Dr. Jung-Min Kee for the 
generation of phospho-His analogs (top) and a His-ATP conjugate (bottom).  (Top-(a)) Stable (non-
hydrolyzable) analogs of phospho-His have been designed by replacing the labile P-N bonds with stable P-
C bonds.  Since both 3-phospho-His and 1-phospho-His are found in biological systems, both isomers have 
been prepared.  Significantly, both analogs are readily synthesized in preparative scale from commercially 
available Boc-Ser-OH in less than 5 chemical steps (Top-(b)).  Boc-azidoalanine is treated with an 
ethynylphosphonate in the presence of copper iodide catalyst in DMF to afford the 3-phospho-His analog 
(Diethylphosphono-triazolylalanine).  Alternatively, the same starting material (Boc-azidoalanine) can be 
converted to the 1-phospho-His analog by utilizing a ruthenium catalyst.  Both 3-phospho-His and 1-
phospho-His analogs have been successfully utilized in solid phase peptide synthesis.  (Bottom-(a)) Overall 
synthetic scheme for introducing a His-ATP analog into a peptide.  (Bottom-(b)) Detailed synthetic scheme 
for generating the ATP-γ-S alkyne conjugate and the His-ATP peptide.  First, a peptide with an 
azidoalanine in place of the active His is synthesized.  Commercially available ATP-γ-S is treated with 
propargyl bromide in methanol to give the alkyne conjugate.  The alkyne conjugate is then added to the 
azido-peptide itself via click chemistry in the presence of a copper sulfate catalyst and sodium ascorbate, 
converting the azidoalanine to the His-ATP conjugate.  To date, the ATP conjugate has only been 
introduced to a peptide comprising the KinB H-box, not the complete 26-mer that will be used for the NCL 







Figure 3.10)  (A) Schematic showing the final, semisynthetic native chemical ligation products.  Only the 
linker plus ATP-γ-S is shown in the figure (the triazole analog in place of the His is not shown).  Initially, 
different chain lengths (n) linking residue 213 to ATP-γ-S were to be pursued, but we have experienced 
difficulty adding extra carbons to the linker.  Red indicates the synthetic peptide.  The ligated recombinant 
α-Cys fragment is colored black.  (B) Structural cartoon illustrating the desired NCL products trapped in 
the act of autophosphorylation.  ATP-γ-S covalently linked to His213 should bind the KinB CA domain, 
thereby locking its position in the active conformation.  The synthetic and recombinant parts of one 
monomer are colored orange and yellow, respectively, and the other monomer is colored red/green.  The 
DHp domain α-helices are illustrated as cylinders.  
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  An additional analog of phospho-His, (4’-phosphoryl-2’-furyl)-alanine, based on 
the work of Schenkels et al. (Schenkels et al., 1999) has been synthesized in the 
laboratory of Dr. J. David Warren of Weill Cornell Medical College (Figure 3.11).  
Matthew Bick carried out the initial steps of the synthesis (steps 1-4).  Dr. Guangtao 
Zhang, a postdoc in the Warren laboratory, developed the final synthetic scheme 
involving pseudoephedrine (Figure 3.12). 
 
Figure 3.11)  Comparison of 3-phospho-His (differing nomenclature leads some researchers to name the 
amino acid on the left 1-phospho-His) and phosphofurylalanine.  Adapted from (Schenkels et al., 1999). 
 
We had planned to use phosphofurylalanine as an analog of phospho-His in order 
to stabilize a complex between KinB and the response regulator Spo0F.  It was assumed 
that after incorporation of the intermediate 8 (Figure 3.12) into a peptide, removal of the 
ethyl protecting groups from the phosphonate would occur spontaneously during HF 
cleavage of the peptide from the solid support resin.  However, this has proven to be 
more complicated than we originally anticipated.  We have in fact not been able to 
remove the ethyl groups from the amino acid, either by treatment with HF or with 
trimethylsilyl iodide, a standard deprotection method for phosphonate.  Therefore, the 
usefulness of phosphofurylalanine as a tool for trapping an HK-RR complex is uncertain.  
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More likely, the 3-phospho-His analog described in Figure 3.9A, diethylphosphono-
triazolylalanine, will be our analog of choice for investigating a KinB-Spo0F complex.  
 
Figure 3.12)  Synthesis of N-Boc-L-(4’phosphoryl-2’-furyl)alanine via pseudoephedrine mediated 
alkylation (Zhang and Warren, 2009).  Synthesis of the phosphonate furyl bromide (steps 1-4) and 
precursors have been previously reported (Harvey, 1966; Schenkels et al., 1999).  The use of 
pseudoephedrine (5a) to generate the intermediate precursor pseudoephedrine glycinamide (5b) for reaction 
with the alkyl bromide (4) (Myers et al., 1997) represents a departure from the synthetic scheme published 
by Schenkels et al. (Schenkels et al., 1999).  As a result, the method described here avoids the tedious 
enzymatic resolution step reported by Schenkels at al. (Schenkels et al., 1999).  The intermediate furyl 
phosphonate (8) has been incorporated into a peptide using Boc-based SPPS.  a. LiCl, Pseudoephedrine, 
LiOMe, THF; b. LDA, LiCl, 5b, -78 to 0 ºC, THF; c. 0.5 M NaOH/dioxane/MeOH (v/v/v=1:1:1), ∆; d. 





KinB Native Chemical Ligation 
 With the necessary reagents in hand, we next turned to working out the KinB-CC 
NCL reaction.  We first carried out the ligation reaction with a wild-type KinB 26-mer 
peptide (without His analogs) in order to preserve the precious amounts of His analogs.  
The KinB NCL reaction conditions were established by Dr. Jung-Min Kee (see methods).  
Ligated semisynthetic KinB, refolded from a lyophilized state, demonstrated 
approximately 50% activity in an autophosphorylation assay compared with wild-type 
(data not shown).  Optimized refolding conditions had not yet been worked out at the 
time of the NCL reaction.  We anticipate greater recovery of active protein from future 
ligation reactions using optimal refolding conditions (see above).  The ligation product 
was not resolved on HPLC from the α-Cys fragment.  However, mass-spectrometric 
analysis of the HPLC peak confirmed the product formation.  To facilitate the 
purification of the product from the α-Cys fragment, it was necessary to drive the 











An H-box Peptide With the His-ATP Analog in Place of the Active Site His is 
an Effective Inhibitor of the KinB Autophosphorylation Reaction   
 Crystallization experiments often require large amounts of protein in order to 
maximize the chance of obtaining crystals.  Before scaling up the semisynthesis of KinB 
for crystallization trials, we first needed to establish whether our strategy for capturing 
the autophosphorylation active state using the His-ATP was sound.  Because we have 
been unable to generate His-ATP analogs with varying linker lengths, our only choice for 
this amino acid is the one described in Figure 3.9, which has a single carbon between the 
triazole ring and the ATP-γ-S.  In order to lock the active state conformation, the linker 
should be just the right length, and this length would be different depending on the 
mechanism of autophosphorylation, either associative or dissociative.  If the linker is too 
long, the ATP moiety may bind the nucleotide pocket of the CA domain, but residues 
from the DHp domain that normally make CA contacts may not be able to reach the CA 
domain (Figure 3.13B).  The opposite is also true.  If the linker is too short, DHp residues 
may make CA contacts, but the ATP would not reach the back of the nucleotide pocket 
(Figure 3.13A).  
We reasoned that a short peptide comprised of the KinB H-box sequence 
(SISHEIRNPL) and containing the His-ATP analog with the correct linker length could 
be used as an inhibitor of the autophosphorylation reaction.  Presumably, a peptide with a 
linker that is too short would inhibit only as well as the same peptide without the His-
ATP analog (unmodified peptide), and a peptide with a linker that is too long would only 
inhibit as well as ATP-γ-S.  A peptide with the correct linker would inhibit to a greater 
degree than both the unmodified peptide and ATP-γ-S. 
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Figure 3.13)  An exaggerated cartoon illustrating the potential effects of non-ideal linker lengths between 
the triazole histidine analog of the DHp domain and conjugated ATP-γ-S.  Hypothetical contacts are 
represented by red spheres.  (A) If the linker is too short, the ATP will be unable to bind the CA domain 
nucleotide pocket.  (B) If the linker is too long, residues from the DHp domain will be unable to make 
contacts with the CA domain.  
  
 We carried out in vitro autophosphorylation assays with KinB 195-CT and 
varying concentrations of either unmodified H-box peptide, the ATP-γ-S alkyne 
conjugate (Figure 3.9, bottom), and the H-box peptide with the histidine analog 
conjugated to ATP-γ-S.  We found that the ATP-conjugate H-box peptide is an effective 
inhibitor of the autophosphorylation reaction, with an IC50 value of 5.1 µM (Figure 3.15).  
The ATP-alkyne inhibited the autophosphorylation of KinB with approximately 2.5-fold 
lower efficiency (IC50 of 13 µM).  In stark contrast, the inhibition potency of the 
unmodified H-box peptide (without ATP-γ-S conjugated to the histidine analog) was 
lower by at least three logs (IC50 of 6.50 mM) when compared with the ATP-conjugate 
H-box peptide (although the data for the unmodified peptide does not fit a well defined 
curve, it is clear that it is not an efficient inhibitor of KinB autophosphorylation).  The 
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results of these experiments suggest that the linker length between the triazole side chain 
and the ATP-γ-S of our analog is at least close to optimal.  This analog should prove to be 
competent for trapping the KinB active state of autophosphorylation. 
 In addition, we calculated a Hill curve, which measures the cooperativity of 
ligand binding to different regions of a protein, for the ATP-conjugate H-box peptide.  In 
our case, we are measuring the influence that an ATP-conjugate H-box peptide bound to 
one CA domain has on the binding of an ATP-conjugate H-box peptide to the other CA 
domain.  The result of a Hill coefficient of 1 indicated independent binding of the peptide 




Figure 3.14)  Hill coefficient calculated for the KinB ATP-conjugate H-box peptide.  The value of 1 








Figure 3.15 (adjacent page)  Autophosphorylation time course inhibition assays performed with KinB 195-
CT and either the ATP-alkyne, unmodified H-box peptide, or ATP-conjugate H-box peptide.  The ATP-
conjugate peptide is at least an order of magnitude more efficient as an inhibitor of the autophosphorylation 
reaction than the same peptide without a conjugated ATP, and is approximately 2.5 times as efficient as the 
ATP-alkyne alone.  The protein concentration for each reaction was 6 µM.  Values that bracket 4 lanes 
each indicate the fold inhibitor concentration above the protein concentration.  Time points at 15 s, 1 min, 5 
min, and 15 min were taken for each concentration.  To generate the inhibition curves, bands were 
quantified by phosphorimagery using ImageQuant™ software (GE Life Sciences).  Experiments were 





Conclusions and Future Directions 
 
The reagents necessary for pursuing structural studies of a semisynthetic KinB-
CC have been established.  We have shown that KinB 195-CT maintains its activity when 
refolded from the denatured state, a crucial preliminary piece of information needed 
before embarking on in-depth semisynthetic studies.  A 26-mer peptide composed of the 
N-terminal residues of KinB 195-CT can be joined by NCL to the remaining C-terminal 
portion of KinB to produce a functional enzyme.  Analogs of phospho-His and His-ATP 
have been synthesized that will allow us to trap HK active state conformations, both 
autophosphorylation and phosphotransfer, when incorporated into a full-length 
semisynthetic KinB-CC.  The His-ATP analog has been incorporated into a peptide 
comprising the KinB H-box (though not the full-length 26-mer), while the 3-phospho-His 
analog has been incorporated into the 26-mer.  The KinB H-box peptide containing the 
His-ATP analog is an effective inhibitor of the KinB autophosphorylation reaction, 
indicating that this analog is well suited to trap the autophosphorylation state.  Mutation 
of DHp-CA domain interface residues in the context of the His-ATP semisynthetic KinB-
CC should further promote the autophosphorylation state (see below). 
Our primary concern is that we will not be able to obtain enough semisynthetic 
KinB-CC, and at a level of purity high enough to conduct a sufficient number of 
crystallization trials.  The presence of a C-terminal His6-tag on the recombinant portion 
of KinB should facilitate purification of the ligated KinB-CC product away from any 
unliganded N-terminal peptide (the N-terminal peptide is in excess during the NCL 
reaction, so the presence of free α-Cys protein should be minimal) if the full-length 
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product cannot be resolved by HPLC.  The use of automated crystallization robots will 
also help us conserve material by allowing us to set up sub-µl crystallization drops.   
 The inactive conformation observed in the TM0853 (Marina et al., 2005) structure 
is stabilized by a significant (1250 Å buried surface) interface between the CA and DHp 
domain of one monomer (Figure 3.16).  Mutations designed to destabilize this interface 
resulted in increased rates of autophosphorylation, indicating that the interface must be 
broken during the autophosphorylation reaction (Marina et al., 2005).  Through sequence 
alignment, we have identified the corresponding DHp-CA interface residues in KinB that 
when mutated should disrupt the DHp-CA interface and promote autophosphorylation.  
These mutants will be actively pursued in the context of a semisynthetic KinB. 
 
 
Figure 3.16)  Close-up of the TM0853 DHp-CA domain interface (Marina et al., 2005).  The DHp domain 
(green), the CA domain (yellow), and the linker (grey) are all from the same monomer.  Side chains of 
residues that form the interface (mostly hydrophobic) are shown.  Disruption of the DHp-CA interface 
through the introduction of mutant residues increased the rate of autophosphorylation in TM0853. 
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Materials and Methods 
 
Cloning and Protein Expression 
 KinB A221C-CT was PCR (30 cycles of 95 ºC for 30 s, 55 ºC for 30 s, and 68 ºC 
for 55 s, followed by a final extension step of 275 s at 68 ºC) amplified from plasmid 
pET21a-KinB 195-CT using primers MB-44 (NdeI) and MB-94 (XhoI).  MB-94 adds a 
PreScission™ Protease site, followed by an XhoI site, directly after KinB Leu 434.  The 
reaction was purified with a PCR clean up kit (Qiagen), and the amplicon was digested 
for 2 h at 37 ºC with NdeI and XhoI.  The digested DNA was ligated into NdeI/XhoI 
digested pET21a at 15 ºC overnight, using T4 DNA ligase (NEB), to afford the C-
terminally PreScission™ Protease cleavable His6-tagged KinB construct.  Following 
digestion to remove the His6-tag, the vector-derived sequence EVLFQ remains at the C-
terminus of KinB.  Ligation reactions were transformed and selected on LB agar 
supplemented with 150 µg/ml ampicillin.  A nearly identical cloning strategy was used 
with primer MB-115 to make a C-terminally His6-tagged construct truncated after KinB 
416, which may be used in future experiments (residues 417 to 434 were disordered in 
the KinB/Sda structure.  Removal of these residues may aid in crystallization). 
For expression of the α-Cys fragment, pET21a-KinB A221C (C-term His6-tag) 
was expressed in E. coli Rosetta2 (DE3) (Novagen).  Cultures were grown at 37 ºC with 
shaking at 200 RPM.  At an OD600 = 0.6, 10 mM L-cysteine (1 M stock buffered to pH 
7.0 with NaOH) was added to the cultures.  Protein expression was induced at an OD600 = 
1.2 with 1 mM IPTG, and an additional 5 mM cysteine was added.  Expression was 
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carried out for 3 hr at 37 ºC with shaking at 200 RPM.  Cultures were spun at 4,000 RPM 
for 30 min at 4 ºC.  The bacterial pellet from 4 L of culture was resuspended in 25 ml of 
250 mM NaCl and 100 mM sodium phosphate buffer, pH 6.0, and stored at -80 ºC. 
 
Purification of the KinB α-Cys Fragment 
 Cells carrying the KinB α-Cys fragment were lysed in between 12,000 and 
14,000 psi at 4 ºC using an EmulsiFlex-C5™(Avestin) high-pressure homogenizer.  The 
crude lysate was spun at 16,000 RPM, 4 ºC for 30 min in order to pellet the insoluble 
fraction containing KinB α-Cys.  KinB α-Cys was solubilized from inclusion bodies by 
resuspension of the pellet in 40 ml of Ni2+ column buffer A (250 mM NaCl, 100 mM 
sodium phosphate, pH 8.0, 5 mM imidazole, 6 M guanidine-HCl), and passage through a 
type A dounce homogenizer (10 passes each with a loose and tight fitting pestle).  The 
sample was spun again at 16,000 RPM, 4 ºC for 30 min in order to pellet out any 
remaining insoluble material.  The supernatant was passed over two 5 ml Ni2+ chelating 
column in series, equilibrated with Ni2+ buffer A.  KinB α-Cys was eluted from the 
column using a step gradient to 100% Ni2+ B (250 mM NaCl, 100 mM sodium 
phosphate, pH 6.0, 200 mM imidazole, 6 M guanidine-HCl).  (Note that despite the 
presence of an N-terminal cysteine, DTT was kept from the protein buffers because of the 
possibility of exchange with the thioester of the N-terminal KinB peptide, which could 
lead to hydrolysis.)  Following the Ni2+ step, KinB α-Cys was treated overnight at room 
temperature, and shielded from light, with O-Methylhydroxylamine-HCl (MeONH2 stock 
made up to 1.5 M in 250 mM NaCl, 100 mM sodium phosphate, pH 5.0, 6 M guanidine-
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HCl) at a final concentration of 250 mM.  Adjustment of the protein sample to pH 5.0 
with HCl was required.  The following day the protein was concentrated, using 15 ml 
5000 MWCO Vivaspin concentrators (Vivascience), to 10 mg/ml and passed over a 
Superdex™ 75 (16/60) gel filtration column, equilibrated with 250 mM NaCl, 100 mM 
sodium phosphate, pH 6.0, 6M guanidine-HCl, at 0.3 ml/min.  The protein eluted 
immediately after a 30 ml void volume.  All protein samples for SDS-PAGE analysis 
were first purified from guanidine via ethanol precipitation.  Samples were taken pre and 
post MeONH2 treatment, and after treatment with TCEP on a small scale, for analysis by 
ESI mass spec.  The protocol detailed above was also used to purify KinB A221C - 416 
(C-term PreScission™ Protease His6). 
 
Refolding Denatured KinB 195-CT 
 For initial refolding experiments, G. stearothermophilus KinB 195-CT in storage 
buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris, pH 7.0, 15% glycerol) at 1 mg/ml 
was concentrated to 11mg/ml using a 10,000 MWCO Vivaspin concentrator from 
Vivascience.  The protein was diluted with 8 M guanidine-HCl to a final concentration of 
2.9 mg/ml (6 M guanidine final).  To 10 µl of protein, 190 µl of FoldIt™ (Hampton) 
solution was quickly added (16 solutions were tested in total), and the solution was mixed 
by gentle pipetting.  The protein concentration following dilution was approximately 150 
µg/ml.  The protein was incubated for 60 min at RT in the refolding solution.  A sample 
from each refolded protein solution was taken for light scattering analysis at 302 nm.  
Four solutions that gave the lowest absorbance values (showed the lowest levels of 
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turbidity due to protein aggregation) were chosen for subsequent autophosphorylation 
activity assays.  Refolded protein was concentrated to between 1 and 2 mg/ml, using 500 
µl Vivaspin concentrators, and the buffer was exchanged three times on the concentrator 
to storage buffer (see above) plus 1 mM DTT.   
 The same protocol was used for large-scale (~3.5 mg of KinB 195-CT) refolding 
trials, except that 10 mM DTT was added to refolding solution.  FoldIt™ solution 13 (55 
mM MES, pH 6.5, 264 mM NaCl, 11 mM KCl, 550 mM guanidine-HCl, 1.1 mM EDTA) 
was chosen for the large-scale experiments, as it produced the best results from our initial 
trials.  After refolding, the protein was concentrated to 6.3 mg/ml in a 300 µl volume.  
This solution was passed over an Supderdex™ 200 column (16/60) (GE Life Sciences), 
equilibrated with 150 mM NaCl, 20 mM Tris-Cl, pH 7.0, 10 mM MgCl2, 1 mM DTT, at 
0.3 ml/min.  Peak fractions were collected, and the protein from these fractions was used 
in an autophosphorylation activity assay.  The activity assays were performed the same as 
described in Chapter 2 of this thesis.   
 
SPPS of the N-terminal (Val195-Thr220) KinB Thioester Peptide 
Matthew Bick conducted the initial peptide synthesis studies.  Final optimization of 
the 26-mer peptide synthesis was achieved by Dr. Jung-Min Kee, PhD (Muir Laboratory, 
Rockefeller).  The KinB thioester peptide (VIRAEKMEAVTHLAASISHEIRNPLT) was 
synthesized according to the protocol developed by Muir and coworkers, with minor 
modifications (Camarero and Muir, 2001).  The underlined His residue was either regular 
His or phospho-His analog.  The steps followed for the synthesis were as follows: 
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1. 1 g of MBHA resin (1.0 mmol/g) was placed into the peptide synthesis vessel, and 
enough DMF was added to cover the dry resin (<5 ml).  Incubated for 30 min. 
2. The resin was drained, covered with 5% DIEA/DMF, incubated for 1 min, then 
drained again.  This process was repeated twice, and then three 20-sec flow washes 
with DMF were performed. 
3. 1.222 g 3-bromopropionic acid (8 mmol) were dissolved in a minimal volume of 
DCM (<1 to 2 ml), and then 630 μl of 99% DIPC (4 mmol) was added.  The solution 
was shaken vigorously and left to incubate for 10 min. A white precipitate 
corresponding to the diisopropyl urea appeared during the activation reaction.  The 
solution was filtered through a Pasteur pipette containing glass wool to remove the 
precipitate. 
4. The filtered solution from step 3 was added to the MBHA resin in the peptide 
synthesis vessel.  800 μl of DIEA (4.5 mmol) was added plus the minimal amount of 
DMF (1 to 2 ml) required to achieve a uniform slurry.  The coupling reaction was 
incubated for 30 min with occasional stirring using a glass rod. 
5. The resin was drained and washed thoroughly with three 20 s DMF flow washes. 
6. The coupling process (steps 3 to 5) was repeated two more times. 
7. 5 ml of Ac2O/DIEA/DMF solution was added to the resin and incubated for 10 min. 
The resin was drained and three DMF flow washes were performed, as in step 3. 
8. 5 ml AcSH/DIEA/DMF solution were added to the resin and incubated for 20 min. 
The resin was drained and three DMF flow washes were performed.  This entire 
process was repeated two more times. 
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9. 5 ml BME/DIEA/DMF solution were added to the resin and incubated for 20 min.  
The resin was drained and three DMF flow washes were performed. 
10. Step 9 was repeated two more times. 
11. 3 molar equivalents of Boc-Thr-OSu were dissolved in approximately 6 ml DMF, and 
this solution was added to the 3-mercaptopropionamide-MBHA resin.  714 μl of 
DIEA (4 molar equivalents, 4 mmol) was added and the coupling reaction was 
incubated for 3 to 4 hr with occasional stirring. 
12. Three DMF flow washes were performed.  5 ml of Ac2O/DIEA/DMF solution was 
added to the resin and incubated for 10 min.  Next, three 20 s flow washes were 
performed with dichloromethane (DCM).  At this stage, the resin was dried under 
vacuum and stored in a vacuum desiccator. 
13. ~5 mg of dry resin was removed, put in a microcolumn, and deprotected with TFA 
for 2 min.  The column was drained, and first a flow wash was performed with DMF 
and then with DCM.  The resin was drained and dried again under vacuum. 
14. A ninhydrin test was performed to check the loading on the resin, which was found to 
be 0.2 mmol/g. 
15. The resin that had been stored was re-swollen in DMF for 1 h and the synthesis of the 
complete 26-mer KinE peptide was continued using the in situ neutralization/HBTU 
activation protocols for Boc-SPPS (Schnolzer et al., 2007).  
16. Once the synthesis was complete, a flow wash with DMF and DCM was performed, 
as in step 12.  The resin was dried under vacuum and stored in a vacuum desiccator.  
17. The α-thioester resin from step 16 was cleaved by treating with 10 ml of HF:p-cresol 
solution for 1 hr at 4 °C in an HF cleavage apparatus.  
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18. The HF was removed under vacuum and both the peptide and resin were resuspended 
in <40 ml cold diethyl ether with gentle stirring for 10 min.  The suspension was 
filtered on a glass fritted funnel under vacuum. 
19. The material was washed in the filter (containing the cleaved peptide and the resin) 
three times, each time with 10 ml of cold diethyl ether.  
20. 10 ml freshly degassed 50% acetonitrile in water containing 0.1% TFA was added to 
the filter to dissolve the cleaved peptide, and then filtered.  This process was repeated 
two more times, and then the material was recovered and the filtrates were 
lyophilized.  
21. The lyophilized propionamide α-thioester KinB peptide was purified by preparative 
C18 RP-HPLC (26-35% solvent B over 1 h). 
 
KinB Native Chemical Ligation 
Conditions for the NCL reaction were established by Dr. Jung-Min Kee, PhD 
(Muir Laboratory, Rockefeller University).  Gel filtration purified KinB α-Cys fragment 
was provided at a concentration of 880 µM.  70 µl of KinB α-Cys peptide solution (0.06 
µmol in guanidine buffer) was added to a 5-fold excess (1.0 mg or 0.3 µmol) of 
lyophilized N-terminal α-thioester KinB 26-mer (unmodified histidine at position 213) in 
an eppendorf tube in order to dissolve the thioester.  Mercaptophenylacetic acid (MPAA) 
and TCEP were added to the solution to a final concentration of 200 mM and 50 mM, 
respectively.  At this point the pH of the solution dropped to ~ pH 2, and some MPAA 
remained undissolved.  The solution was adjusted to pH 7.0 using 2N NaOH.  The pH of 
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the solution was monitored throughout the ligation to ensure it remained below 8.0.  The 
atmosphere of the eppendorf was flushed with nitrogen gas and the tube was sealed and 
incubated at RT.  Progression of the NCL reaction was monitored periodically by 
analytical reverse-phase HPLC (RP-HPLC, C18 Vydac column, 0-73% solvent B in 
solvent A gradient over 30 min).  The eppendorf tube was flushed with nitrogen or argon 
after each sampling to maintain an oxygen-free atmosphere.  After 24 h the reaction 
mixture was purified by semi-preparative HPLC.  
 
KinB-CC Autophosphorylation Inhibition Assays 
Autophosphorylation reactions were performed in vitro as described (KinB-CC 
monomer, 6 µM; α-[32P]ATP, 0.5 µM), with the indicated concentrations of inhibitor 
(NP, no inhibitor; other concentrations denote fold concentration over the KinB-CC 
concentration).  Aliquots were taken after 15 s, 1, 5, and 15 min of incubation at 25 ºC.  
Reactions were halted by the addition of 5X SDS loading buffer plus 50 mM EDTA, and 
the 32P-phosphorylated KinB-CC was quantitated by [4-15]% SDS-PAGE and 
phosphorimagery (ImageQuant™).  An apparent forward rate constant for each time 
course was determined by fitting, using least squares, to the reaction scheme: 
HK + ATP ↔ P~HK + ADP 
with Runge-Kutta 4th order numerical integration using the program  Berkeley Madonna 
v8.3.21 (www.berkeleymadonna.com).  The '% inhibition' was calculated as follows: 
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CHAPTER 4 
Structural and Biochemical Studies of a Full-Length 




 We now have a detailed understanding of how the catalytic and sensor domains of 
histidine kinases function.  However, we know comparatively little about how the two 
domains communicate with each other, how a sensor domain transduces a perceived 
signal to the catalytic core to affect conformational changes and rates of 
autophosphorylation.  Recently published structures of sensor domains have provided 
clues as to how signaling may occur.  Evidence points towards a piston-like displacement 
of sensor domain helices as the mechanism of signal transduction (see the Introduction 
Chapter of this thesis for a more in depth discussion).  However, the structure of an intact 
histidine kinase comprising the sensor domain, catalytic domain, and the linker region 
between the two will be essential if we are to fully understand how HK signaling works.   
This chapter describes the steps taken towards achieving that goal.  Because membrane 
proteins are notoriously difficult to express and crystallize, we have chosen to focus on 
solving the structure of a full-length cytoplasmic HK.  Presumably the mechanism of 
signal transduction is similar, if not the same, for both membrane and cytoplasmic HKs, 
as the sensor and kinase domains of both are connected by a long helix.  The sporulation 
pathway from Bacillus contains two cytoplasmic HKs, and therefore offers an excellent 
system for probing the structure of a full-length HK.  
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Results and Discussion 
 
Search for Thermophilic Sporulation Histidine Kinases 
 
We initially set out to determine the structure of full-length KinA, as it is the best 
characterized of the sporulation kinases.  We sought to crystallize a thermophilic KinA, 
as our experience has been that proteins from thermophilic species tend to crystallize 
more readily.  Using the GFXXL Sda binding sequence motif and its conserved 
proximity to the H-Box allowed us to probe the completed genomes of Bacillus and 
Geobacillus species in search of sporulation HKs (Figure 4.1).  Our results showed that 
thermophilic homologues of B. subtilis KinA do not exist.  Two of the five sporulation 
kinases in B. subtilis, KinA and KinE, are fully cytoplasmic.  Geobacillus only have one 
of these, KinE.  This finding has significance in regard to the role each individual 
sporulation kinase plays during spore production.  KinA and KinB have been identified 
as essential for sporulation in B. subtilis.  Single knockouts of either KinA or KinB show 
a modest defect for sporulation, whereas a double knockout is unable to sporulate (Jiang 
et al., 2000; Trach and Hoch, 1993).  But KinA can’t possibly be important for species of 
Geobacillus, as they don’t have KinA (they do have KinB).  There are two non-mutually 
exclusive explanations for this.  KinA may be essential for sporulation only under 
laboratory settings, and/or the signals to which KinA responds may not be present in the 
environments where Geobacillus species reside. 
The domain structure of KinA and KinE are very similar.  Both are entirely 









Figure 4.1 (adjacent page)  Phylogenetic tree, constructed using Proml from the Phylip suite of programs 
(Felsenstein, 1981), of sporulation histidine kinases from fully sequenced Bacillus and Geobacillus 
genomes (Geobacillus stearothermophilus strain 10 genome has not yet been fully sequenced).  Sporulation 
kinases were identified by the presence of the Sda sequence motif, GFXXL, and its proximity to the H-box 
and then grouped based on their sensor domains.  Sequences outside colored boxes could not be grouped as 












three putative PAS domains, while KinE has four (Figure 4.2).  The fact that KinA and 
KinE are similar but that thermophilic species only contain KinE suggests that he 
appearance of KinA in mesophilic species of Bacillus may have been the result of a gene 
duplication event of KinE at some point in evolutionary history.  Unlike KinA, little is 
known about KinE (previously ykrQ).  It is the most recent of the sporulation kinases to 
be identified (Jiang et al., 2000). 
 
 
Figure 4.2)  BLAST results outlining the domain organization of B. subtilis KinA and G. 
thermodenitrificans strain 466 KinE.  KinA is predicted to have three PAS domains in its sensor domain, 








Identification of Proteolytically Stable Domains of KinE 
Full-length KinE from Gst, when expressed on its own in E. coli was found to be 
100% insoluble.  (see below, Figure 4.4A).  Several attempts were made to purify KinE 
from inclusion bodies under denaturing conditions using 6 M guanidine-HCl, and we 
were able to achieve decent levels of purity.  However, we found that full-length KinE, 
even in the context of Sda, tended to aggregate badly during the concentration step; the 
highest concentration we were able to achieve with full-length KinE was 8.8 mg/ml, and 
this only after a full day of concentrating and after several high-speed centrifuge spins to 
remove aggregated material.  To achieve concentrations higher than 8.8 mg/ml, 10% 
glycerol was required in the protein solution.  We did manage to perform crystallization 
trials on full-length KinE/Sda from Gth strain 466 (Table 4.1). 
 
 
Table 4.1)  Crystallization trials performed to date on full-length Gth KinE/Sda.  Protein crystals have not 
been obtained from any screen.   
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Therefore, due to the issues of protein aggregation, we sought to identify shorter, 
more stable constructs of KinE that might be more amenable to crystallization.  We have 
used this technique previously with success (Bick et al., 2009).  We carried out limited 
trypsinolysis on full-length Gth 466 KinE.  Stable tryptic fragments were identified via 
Edman sequencing (Figure 4.3).  The N-terminal sequence of a prominent band, which 
migrated slightly below the 50 kDa weight marker, was identified as KinE residues 269-
274.  This region of KinE is predicted to be an α-helix that connects the second and third  
 
 
Figure 4.3)  (A) Peak fractions from a size exclusion chromatography column of full-length KinE from Gth 
466 co-purified with Sda.  The prominent contaminant observed around 50 kDa co-purified with KinE/Sda 
through all chromatography steps during the purification.  (B) Results of limited trypsinolysis on Gth 466 
KinE/Sda.  Lanes from left to right:  Protein weight marker, uncut control sample (band 2 is the 
contaminant), 1:10 ratio of Trypsin to KinE.  (C) Purified Gst KinE/Sda.  A similar contaminant as the one 
observed during Gth 466 purification was also present in the Gst sample.  
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putative PAS domains (Figure 4.7).  The molecular weight of the fragment indicated that 
in addition to the cleavage site in the sensor domain, KinE had also been cleaved at its C-
terminus.  Because the C-terminus of KinE encompasses the CA domain of the catalytic 
region, we reasoned that a construct based wholly on the trypsinolysis results, which 
would contain only a portion of the CA domain, would not be ideal for structural studies.  
We therefore chose to design expression constructs based only on the N-terminal results. 
Table 4.2 
Proteolytic Fragment N-Terminal Sequence 
Contaminant (Band 3) 
Tryptic Fragment 4 
Tryptic Fragment 5 
Contaminant (Gst gel) 
SEERFR (Gth KinE 272-277) 
LQKSEE (Gth KinE 269-274) 
IIHEFL (Gth KinE 149-154) 
LQKSE (Gst KinE 269-273) 
 
Table 4.2)  N-terminal Edman sequencing results of tryptic fragments corresponding to Figure 4.3. 
 
The contaminant observed around 50 kDa during full-length KinE purification 
(Figure 4.3B) was also sequenced, and identified as KinE 272-277.  The fact that a 
naturally occurring proteolytic fragment is generated at the same location as our 
trypsinolysis experiments suggests that the helix connecting PAS domains 2 and 3 is 
solvent exposed, and highly susceptible to digestion by residual amounts of proteases 
carried over during the purification.  Indeed, when Gst KinE was purified under 
denaturing conditions, no degradation product was observed around 50 kDa, likely 
because contaminating proteases had been inactivated.  We decided that this region of 
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KinE represented an ideal location for generating truncated KinE expression constructs.  
In addition, the naturally occurring proteolytic fragment appeared to have a fully intact 
CA domain, based on its approximate molecular weight above 50 kDa on SDS-PAGE 
(the predicted mass of Gth 466 KinE 282-CT is 53,670 Daltons) (Figure 4.3B).  A similar 
proteolytic fragment was also observed during purification of Gst KinE/Sda (residues 
269-273 by N-terminal sequencing (Figure 4.3C). 
 
Establishment of a KinE/Sda Expression System 
Full-length KinE from Gst, when expressed on its own at either 16, 30, or 37 ºC, 
was found to be 100% insoluble (Figure 4.4A).  We therefore reasoned that, based on our 
experience with KinB (Bick et al., 2009), KinE would behave better when co-expressed 
with Sda.  We concurrently pursued expression trials of KinE from three different 
thermophilic bacilli, Gst, Gth 465, and Gth 466.  The Sda protein sequence is identical 
for these three strains, and therefore Gst Sda was used for all of our co-expression 
studies.  Based on a combination of trypsinolysis (see above) and secondary structural 
prediction (Rost et al., 2004), a construct beginning at KinE residue 282, which removes 
the first two putative PAS domains of the sensor region, was chosen as the most 
promising candidate for crystallization.  Gth 466 expressed to higher levels than both Gth 
465 and Gst KinE and proved to be the most soluble, approximately 50% (Figure 4.4B).  
In addition, the KinE protein sequence from Gth 466 is more divergent than Gth 465 in 
comparison with Gst KinE, which proved to be the most problematic of the three. 
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Figure 4.4)  (A) KinE from Gst was 100% insoluble when in expressed in E. coli at three different 
temperatures (16, 30, and 37 ºC).  (B) Gth strain 466 KinE expressed to the highest levels when compared 
with Gst and Gth strain 465 KinE.  When expressed in the context of Sda, KinE was approximately 50% 
soluble.  WM - protein weight marker.  S - soluble fraction following lysis.  I - insoluble fraction following 
lysis.  U - pre-induction. 
 
Gth grows at 60 ºC in its natural environment.  It is common practice when 
heterologously expressing thermophilic proteins in E. coli, a mesophile, to carry out a 
heat-treatment purification step in order to aggregate and remove contaminating E. coli 
proteins.  Proteins from thermophilic species are resistant to denaturation at higher 
temperatures, and hence remain soluble.  However, our experience with the Gst KinB 
catalytic core suggested that the sporulation HKs might not obey this rule (KinB-CC 
tended to aggregate when treated at 60 ºC, perhaps because it was separated from its 
sensor domain, and hence from the membrane).  We carried out a heat-treatment time 
course experiment at 60 ºC on crude E. coli lysate following full-length KinE/Sda 
expression (Figure 4.5A).  20 min of treatment at 60 ºC caused many of the soluble E. 
coli proteins to aggregate and partition to the insoluble fraction, while KinE remained 
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approximately 50% soluble.  By 40 min, however, KinE had become almost entirely 
insoluble.  Interestingly, treatment of KinE 282-CT/Sda for 20 min at 60 ºC made the 
protein entirely insoluble (Figure 4.5B).  Therefore, a heat treatment step was not used 
for KinE 282-CT (Again, as with KinB-CC, it may be that only the full-length kinase is 
resistant to heat treatment). 
 
Figure 4.5)  (A) 60 ºC heat treatment time course experiment on crude full-length KinE/Sda lysate.  Heat 
treatment for 20 min gave the best balance of removing contaminating E. coli proteins while maintaining 
the solubility of KinE.  WM - protein weight marker.  S - soluble fraction following lysis.  I - insoluble 
fraction following lysis.  (B) Heat treatment of KinE 282-CT/Sda caused KinE to become insoluble.  Lanes 
from left to right: WM- protein weight marker, 1 - Gst KinE 282-CT/Sda post induction, 2 - Gth 466 KinE 
282-CT/Sda post induction, 3 - Gth 466 total lysate, 4 - Gth 466 soluble fraction following lysis, 5 - Gth 
insoluble fraction following lysis, 6 - Gth 466 soluble fraction following heat treatment at 60 ºC for 20 min, 
7 - Gth insoluble fraction following heat treatment at 60 ºC for 20 min. 
 
KinE 282-CT/Sda was purified by nickel affinity, anion exchange, and size 
exclusion chromatography to above 95% homogeneity, as judged by SDS-PAGE (Figure 
4.6).  KinE 282-CT/Sda was soluble to at least 27 mg/ml (full-length KinE/Sda was 
soluble to only approximately 8.8 mg/ml, and only after many hours of concentration).  
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During the anion exchange chromatography step, we 
observed two distinct KinE species that eluted from the 
column at different ionic strengths, one at around 100 
mM NaCl and the other at around 250-300 mM NaCl.  
We suspected that the Q column was retaining 
phosphorylated and unphosphorylated KinE with 
different affinities.  EDTA was added to the protein 
solution prior to anion exchange step in order to prevent the autophosphorylation reaction 
(autophosphorylation is dependent upon the presence of a divalent cation).  When EDTA 
was present in the buffer, the majority of KinE eluted from the column at 250-300 mM 
NaCl; the 100 mM NaCl species was greatly reduced.  The opposite was observed when 
EDTA was not present in the Q buffer; the species shifted more towards the 100 mM 
NaCl species. 
Despite the fact that we were able to purify KinE 282-CT/Sda to above 95% 
homogeneity, and that it is highly soluble, we have been unable to crystallize the complex 
as the ADP bound form (Table 4.3).  The KinE 282-CT sequence contains 5 cysteines (7 
for full-length KinE).  For future crystallization trials it may prove to be advantageous to 
remove the non-conserved cysteines through mutagenesis (Figure 4.7).  SDS-PAGE 
analysis of KinE/Sda under non-reducing conditions suggests that cysteines do not play a 
part in KinE dimerization (Figure 4.7). 
Figure 4.6)  Peak fractions of  
Gth 466 KinE 282-CT/Sda 









Figure 4.7 (adjacent page)  Sequence alignment of KinE from Bacillus and Geobacillus.  Cysteines are 
highlighted with red ovals.  Bars above the sequence represent the results of secondary structure prediction 
(Rost et al., 2004), with red representing helices, blue representing strands, and green representing loops.  
Only residues with a confidence score of 5 or more (based on a scale from 1-10) were assigned a secondary 
structure.  Residues spanning the putative PAS domains, based on the results of BLAST, are also labeled.  
(Bsu – Bacillus subtilis, Bli – Bacillus licheniformis, Bpu – Bacillus pumilis, Gka – Geobacillus 
kaustophilus, Gst – Geobacillus stearothermophilus, Gth_465 – Geobacillus thermodenitrificans strain 
465, Gth_466 – Geobacillus thermodenitrificans strain 466).  The gel on the bottom right represents SDS-
PAGE analysis of Gth 466 KinE 282-CT under denaturing conditions, either with 200 mM βME (lane 1) 







Table 4.3)  Crystallization trials performed to date on Gth 466 KinE 282-CT/Sda.  Protein crystals have not 
yet been obtained. 
 
 
Sda Inhibits KinE Autophosphorylation 
Previous studies have shown that Sda inhibits CA-DHp domain cross talk of 
KinA and KinB, effectively shutting down the autophosphorylation reaction (Bick et al., 
2009; Rowland et al., 2004).  We identified three KinB residues within a sequence motif, 
GFXXL, that are crucial for recognizing Sda.  Introduction of these amino acids by 
mutagenesis to an HK normally unresponsive to Sda renders that HK sensitive to Sda 
inhibition.  We also showed that the GFXXL sequence motif is present in all five of the 
B. subtilis sporulation kinases, KinA-KinE (Bick et al., 2009).  It was therefore 
reasonable to assume that Sda would also inhibit KinE autophosphorylation. 
 To confirm our hypothesis, we carried out Sda inhibition assays on KinE.  From 
our studies on KinB, we knew that Sda in a 1:1 ratio with KinB is not sufficient to 
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abolish autophosphorylation.  So it was expected that KinE co-purified with Sda would 
still autophosphorylate.  Indeed, this is what we found.  KinE/Sda without additional Sda 
was labeled to significant levels in the presence of γ-[32P]ATP (Figure 4.8A).  However, 
with the addition of a 25 molar excess of Sda, KinE autophosphorylation was fully 




Figure 4.8)  Autoradiography images of autophosphorylation time course experiments performed on full-
length KinE/Sda in the presence of γ-[32P]ATP and Mg2+.  (A) Gst KinE/Sda without the addition of excess 








Conclusions and Future Directions 
  
We have established an expression system for a full-length cytoplasmic 
sporulation histidine kinase.  Removal of the two N-terminal PAS domains from the 
signaling region should not hinder the ultimate goal of the project, which is to investigate 
how signals are transduced to the catalytic core; the helix connecting the signaling and 
catalytic domains remains intact in our KinE construct.  We have also shown that, as for 
KinB, Sda remains associated with KinE through several chromatography steps.  In 
addition, Sda inhibits KinE autophosphorylation, a result that supports the hypothesis laid 
out in Chapter Two, which states that sporulation kinases containing the sequence motif 
GFXXL in their DHp domains are all affected by Sda.  Although we have not obtained 
KinE/Sda crystals, we have not exhausted all possibilities.  We will attempt 
crystallization with different nucleotides (ATP or non-hydrolyzable ATP analogs), as 











Materials and Methods 
 
Cloning of KinE and KinE/Sda Double Expression Constructs 
Geobacillus thermodenitrificans strain DSM 466 (ATCC 29493™) (Manachini et 
al., 2000) was grown on nutrient agar containing peptone and beef extract (ATCC 
Medium 3) at 60 ºC.  Isolated colonies were picked and stored in 20 µl ddH2O at -20 ºC 
until needed.  A single colony was boiled for 10 min, and the cellular debris was 
separated by centrifugation for 10 min at 14,000 RPM.  10 µl of supernatant was used as 
a source of Gth genomic DNA for PCR reactions.  Full-length KinE was PCR amplified 
(30 cycles of 30 s at 98 ºC, 30 s at 55 ºC, and 80 s at 68ºC, followed by a final extension 
step of 68 ºC for 6 min 40 s) using primers MB-97 (NheI) and MB-98 (BamHI).  MB-97 
introduces an NheI site at amino acid position 2 of KinE, and in the process changes 
residue 3 from a Gln to a Ser.  MB-98 introduces a BamHI site directly after the KinE 
stop codon.  Amplicons were purified with a PCR clean-up kit (Qiagen) and sequentially 
digested with NheI and BamHI (3 h each) at 37 ºC, with a PCR clean-up step in between 
enzymes.  KinE was ligated into NheI/BamHI doubly digested pSKB2.  Transformants 
were selected on LB agar supplemented with 50 µg/ml kanamycin, and colonies were 
screened for the presence of insert DNA by sequencing.  A similar strategy was used to 
clone Gth DSM 465 and Gst strain 10 KinE (primers MB-95 and MB-96). 
Gst, Gth 465, and Gth 466 KinE 282-CT (C-terminus) were PCR amplified (30 
cycles of 95 ºC for 30 s, 55 ºC for 30 s, and 68 ºC for 87 s, followed by a final extension 
of 7 min 15 s at 68 ºC) from pSKB2-KinE (full-length) using primers MB-119 (Gst, 
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NdeI) or MB-120 (Gth 465 and 466) and T7 terminator, doubly digested with NdeI and 
BamHI, and cloned into pSKB2. 
Gst Sda was subcloned from pET21a-Sda by PCR (30 cycles of 95 ºC for 30 s, 55 
ºC for 30 s, and 68 ºC for 20 s, followed by a final extension step of 68 ºC for 100 s) 
using primers Liz13 and MB-99.  Liz13 introduces a BamHI site into the lac operator of 
pET based vectors.  MB-99 changes the BamHI site in the multiple cloning site of 
pET21-Sda to an EagI site.  The Sda amplicon was digested with BamHI and EagI at 37 
ºC overnight, and purified by gel extraction (Qiagen) the following day.  Sda was ligated 
into BamHI/EagI doubly digested pSKB2-KinE (Gst, Gth 465, and Gth 466, either full-
length or 282-CT).  The presence of Sda insert DNA was confirmed by sequencing.    
 
Limited Proteolysis of Full-Length KinE         
 100 pmol of Gth 466 KinE/Sda was mixed with trypsin (Sigma, made up in 
protease buffer: 100 mM Tris, pH 8.0 and 20 mM CaCl2) in the following trypsin to KinE 
(mass:mass) ratios: 1:10 (10 pmol trypsin), 1:20 (5 pmol trypsin), 1:50 (2 pmol trypsin), 
and 1:100 (1 pmol trypsin), and 1:500 (0.2 pmol trypsin).  Reactions were brought up to 
10 µl with protease buffer and incubated at 26 ºC for 30 min.  1 µl of 100 mM PMSF was 
added to stop the reactions and the tubes were put in ice.  11 µl of 2X SDS loading buffer 
was added and the reactions were run out on 4-20% Tris-Glycine PAGE (Invitrogen). 
 For N-terminal sequencing of proteolytic fragments, following SDS-PAGE the 
protein was transferred to PVDF membrane (Bio-Rad) following the electroblotting 
procedure supplied by The University of Texas Medical Branch (UTMB) Protein 
Chemistry Laboratory (http://www.utmb.edu/proch/serv01.htm).  Proteolytic fragments 
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of interest were excised from the PVDF and sent to UTMB for N-terminal Edman 
sequencing. 
 
Protein Expression and Purification 
Gst, Gth 465, and Gth 466 full-length KinE/Sda double expression vectors (Sda is 
from Gst for all double expression vectors) were transformed into E. coli Rosetta2™ 
(DE3) for protein expression.  Transformed bacteria was used to inoculate a 5 ml LB 
culture supplemented with kanamycin at 50 µg/ml and chloramphenicol at 35µg/ml, and 
grown overnight at 37 ºC.  The 5 ml culture was used the following day to inoculate 2 L 
LB cultures (kan/cam).  Large-scale cultures were grown 37 ºC with shaking at 200 
RPM.  Protein expression was induced with 0.1 mM IPTG when the cultures reached an 
OD600 of between 0.6 and 1.0.  After the addition of IPTG, the temperature of the 
incubator was reduced to 16 ºC, and protein expression was carried out for approximately 
12 h with shaking at 200 RPM.  Cells were harvested by centrifugation at 4000 RPM for 
30 min at 4 ºC.  Pelleted bacterial from a 2 L cultures was resuspended in 35 ml nickel 
column buffer A (500 mM NaCl, 60 mM Tris, pH 8.0, 10 mM MgCl2, 5 mM imidazole, 
5% glycerol) and stored at -80 ºC.  
E. coli harboring full-length Gth 466 KinE/Sda was lysed between 12,000 and 
15,000 psi at 4 ºC using an EmulsiFlex-C5™(Avestin) high-pressure homogenizer, and 
the crude lysate was treated at 60 ºC for 25 min.  10 mM βME and 1 mM PMSF were 
added to the cells prior to lysis.  Heat-treated lysate was clarified by centrifugation at 
16,000 RPM for 30 min, 4 ºC.  The supernatant was passed over a 5 ml metal chelating 
column (GE life sciences), charged with NiSO4, at 1 ml/min, and the flow through was 
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collected.  KinE/Sda was eluted from the Ni2+ column using a step gradient over 60 ml to 
100% nickel column buffer B (same as buffer A with 200 mM imidazole) (10 ml at 20% 
B, 10 ml at 35%, 15 ml at 50%, and 25 ml at 100%).  Twelve 5 ml fractions were 
collected.  All fractions were analyzed by SDS-PAGE.  Peak elution fractions were 
pooled and PreScission™ Protease (GE life sciences) was added to an approximate 1:20 
mass:mass ratio with KinE/Sda in order to remove the N-terminal His6-tag from KinE.   
KinE harbors three (GPH) vector-derived residues at its N-terminus following 
PreScission™ Protease digestion.  Cleaved protein was dialyzed overnight at 4 ºC in 2 L 
of 100 mM NaCl, 20 mM Tris-Cl, pH 8.0, 10 mM MgCl2, 5% glycerol and 5 mM DTT, 
using 3,500 MWCO dialysis tubing (Spectracor).  The efficiency of the cleavage reaction 
was assessed by SDS-PAGE. 
 Following PreScission™ Protease digestion, the protein solution was centrifuged 
at 16,000 RPM, 4 ºC in order to remove a small amount of precipitated material.  Next, 
KinE/Sda was passed over a 5 ml GST column in series with a 5 ml Q anion exchange 
column (GE life sciences) at 0.5 ml/min.  The columns were equilibrated with 100 mM 
NaCl, 20 mM Tris-Cl, pH 8.0, 10 mM MgCl2, 5 mM DTT, and 5% glycerol (Q column 
buffer A).  After loading the protein onto the GST/Q series, the GST column was 
removed and KinE/Sda was eluted over 50 ml (10 column volumes) from the Q column 
at 1 ml/min using a linear gradient to the same buffer plus 600 mM NaCl (Q column 
buffer B).  Twenty-five 2 ml fractions were collected.  Finally, SpoIIE was passed over 
an SD200 (16/60) column, equilibrated with 150 mM NaCl, 20 mM Tris-Cl, pH 8.0, 10 
mM MgCl2, 10 mM DTT, and 10% glycerol at 0.3 ml/min.  After a 30 ml void volume, 
forty-five 2 ml fraction were collected.  Sda purified separately (see below) was used to 
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supplement KinE/Sda after each step of the purification, assuming 20% of KinE was not 
bound to Sda. 
 Gth 466 KinE 282-CT/Sda was purified following the same basic protocol as full-
length KinE/Sda, with the following exceptions.  After PreScission™ Protease digestion, 
a 2nd Ni2+ column step was frequently, though not always, added in order to remove any 
uncleaved KinE from the solution.  The PreScission™ Protease dialysis buffer was 100 
mM NaCl, 20 mM Tris-Cl, pH 8.0, 20 mM imidazole, 10 mM βME, 0.25 mM PMSF, 
and 5% glycerol.  A mono Q column (10/100 GE life sciences) was used in place of the 5 
ml HiTrap for anion exchange.  Q column buffers A and B were 20 mM Tris-Cl, pH 8.0, 
1 mM PMSF, 5% glycerol, 5 mM EDTA, 10 mM βME, and 100 mM NaCl for buffer A 
and 1 M for buffer B.  A Superdex™ 200 (26/60) column was used for size exclusion, 
equilibrated with 150 mM NaCl, 20 mM Tris-Cl, pH 8.0, and 5 mM DTT.  
Sda was expressed from a pET21a backbone at 37 ºC for 3 hr, using 1 mM IPTG.  
Bacteria from a 2 L culture was resuspended in 25 ml Sda buffer (150 mM NaCl, 50 mM 
Tris, pH 8.0, 5% glycerol) and divided into 10 aliquots, corresponding to approximately 
200 ml of culture.  Aliquots were stored at -80 ºC until needed.  Sda was prepared each 
time KinE was purified.  Bacteria from a 200 ml aliquot was lysed by sonication, and the 
crude lysate was clarified by centrifugation at 16,000 RPM for 30 min at 4 ºC.  The 
supernatant containing soluble Sda was heated to 60 ºC for 45 min in order to aggregate 
the majority of contaminating soluble E. coli proteins.  The sample was spun again at 
16,000 RPM for 30 min at 4 ºC.  A 5ml HiTrap Q (GE Lifesciences) anion exchange 
column (equilibrated with Sda buffer), loaded at 1 ml/min, was used to bind the majority 
of remaining contaminants; Sda did not bind the Q column.  Finally, Sda was passed over 
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a Superdex™ 200 (16/60, GE Lifesciences) size exclusion column (equilibrated with Sda 
buffer) at 0.3 ml/min.  Forty-five 2 ml fractions were collected following a 30 ml void 
volume.  Purified Sda was stored at 4 ºC and used to supplement KinE/Sda during its 
purification (see above). 
 
KinE Autophosphorylation and Sda Inhibition Assays 
For KinE kinase reactions, 100 pmol of KinE/Sda was mixed with 0.1 µl tris(2-
carboxyethyl)phosphine (TCEP) and 2 µl of a 1:1 mixture of 50 mM ATP and γ-
[32P]ATP.  Reactions were brought up to 20 µl with kinase buffer (50 mM EPPS, pH 8.5, 
50 mM KCl, 20 mM MgCl2, and 5% glycerol).  Reactions were incubated at 26 ºC.  5 µl 
samples (25 pmol) were removed at given time points, added to 1.25 µl 5X SDS loading 
buffer and flash cooled in liquid nitrogen until all time points had been taken.  For 
inhibition assays, 200 pmol of KinE/Sda was mixed with 8 µl of a 1:1 mixture of 50 mM 
ATP and γ-[32P]ATP, 0.4 µl of 100 mM DTT, and either 6 nmol of Sda or Sda storage 
buffer (9.2 µl).  Reactions were brought up to 40 µl with kinase buffer.  Reactions were 
incubated at 26 ºC.  10 µl samples were taken at given time points, added to 2.5 µl 5X 
SDS loading buffer and flash cooled in liquid nitrogen until all time points had been 
taken.  Samples were separated by SDS-PAGE (Tris-Tricine), and the radioactive bands 






Gth 466 KinE 282/Sda was concentrated using 15 ml 5000 MWCO Vivaspin 
concentrators (Vivascience).  Dilutions were made to various concentrations in SD200 
buffer (150 mM NaCl, 20 mM Tris-Cl, pH 8.0, 5 mM DTT).  Crystallization trials were 
set up with either KinE/Sda on its own or in the presence of 5 mM MgCl2 and a 5 molar 
excess of ADP (relative to the protein concentration).  KinE/Sda was subjected to a 
variety of 96-condition crystallization screens from Qiagen (Table 4.3).  All 
crystallization trials were carried out using the vapor diffusion method and 96-well sitting 
drop trays (Corning).  Crystallization drops consisted of a 1 µl to 1 µl ratio of protein to 
crystallization solution and were equilibrated over a 100 µl well volume.  A similar 
procedure was followed for full-length Gth 466 KinE/Sda, except that the protein was 
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CHAPTER 5 




Entry to sporulation is dictated by the level of Spo0A~P in the cell.  However, it 
is not until stage II of sporulation, after polar division has occurred that the bacterium is 
committed to sporulate (Parker et al., 1996); the cell cannot return to vegetative growth 
without first becoming a full-fledged spore.  Completion of the asymmetrical division 
septum at one pole of the cell defines stage II.  The switch from medial to asymmetric 
division is dependent upon the redeployment of the tubulin-like protein FtsZ from the 
middle to the poles of the cell (Ben-Yehuda and Losick, 2002).  The spore septum is 
composed of a much thinner layer of peptidoglycan than that of the vegetative cell, most 
likely because it is hydrolyzed during stage III of sporulation, when the mother cell 
engulfs the prespore (Perez et al., 2000).   
The alternative sigma factor σF is responsible for gene expression in the forespore 
(Losick and Stragier, 1992; Margolis et al., 1991).  A complex, forespore specific 
regulatory network comprised of the anti-σ factor SpoIIAB (AB), the anti-anti-σ factor 
SpoIIAA (AA), and the membrane bound serine phosphatase SpoIIE (E), controls the 
activity of σF (Figure 5.1).  σF is produced shortly after the initiation of sporulation and is 
present in the predivisional cell, where SpoIIAB-ATP maintains it in an inactive complex 
(Alper et al., 1994).  The inactive AB-ATP:σF complex persists in the mother cell 
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following asymmetrical septation (Duncan and Losick, 1993).  Structural analysis of an 
AB:σF complex revealed a 2:1 stoichiometry (Figure 5.2).  σF makes mainly superficial 
contacts with one of the molecules of AB in the complex, while interactions with the 
second AB are more extensive.  This has important implications for destabilization of the 
AB2-ATP:σF complex through the action of the SpoIIAA (see below).  Binding of 
SpoIIAB occludes a core RNA polymerase binding site on σF (Campbell et al., 2002).  
Like the sporulation histidine kinases, SpoIIAB is an ATP binding protein of the Bergerat 
fold variety.  In addition to its role as an anti-σF, AB also functions as a serine kinase that 
targets the anti-anti-σ factor SpoIIAA for phosphorylation (Min et al., 1993).  
 
Figure 5.1)  Schematic of the forespore specific stage II σF pathway from Bacillus subtilis. 
  
SpoIIAA functions as an anti-anti-σ by interacting with the weakly bound 
SpoIIAB of the AB2-ATP:σF complex, and promoting dissociation of σF from the second 
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AB-ATP by steric displacement (Ho et al., 2003).  Crystal structures of SpoIIAA in 
complex with the ATP and ADP bound forms of SpoIIAB have enhanced our 
understanding of the mechanism of SpoIIAA induced dissociation of the AB2:σF complex 
(Figure 5.3) (Masuda et al., 2004).  AB-ATP released from σF targets AA for 
phosphorylation, rendering SpoIIAA~P, which is incompetent for recognizing AB.  
However, after utilizing ATP, the ADP form of AB becomes the target for an additional 
molecule of unphosphorylated AA, with which it makes a stable complex. 
 
Figure 5.2)  2.9 Å crystal structure of the SpoIIAB2:σF complex from Geobacillus stearothermophilus 
(PDB code 1L0O) (Campbell et al., 2002).  Only region 3.1 of σF was observed in the structure 
(chartreuse).  Two molecules of SpoIIAB (wheat and cyan) bind to σF in an asymmetrical fashion.  (right)  
Close-up of key residues, identified from the structure and genetic screens (Decatur and Losick, 1996), 
important for SpoIIAB:σF complex formation.  ‘ labeled residues are from the second SpoIIAB (cyan). 
 
The concentration of unphosphorylated AA determines whether AB-ATP will completely 
lock up σF (if there is more AB-ATP than AA), or whether enough AB-ADP will be 
complexed with AA to free σF (if there is more unphosphorylated AA than AB) (Alper et 
al., 1994; Duncan et al., 1996).  Unphosphorylated SpoIIAA is present in the 
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predivisional cell, but not at levels sufficient to activate σF.  Only in the forespore does 
AA reach the necessary threshold concentration, enough to fully sequester AB-ADP in a 
“sink” away from σF to allow σF to form holoenzyme with core RNA polymerase and 
carry out forespore gene expression (Carniol et al., 2004). 
 
Figure 5.3)  2.7 Å structure of a SpoIIAB-ATP:SpoIIAA complex from Geobacillus stearothermophilus.  
SpoIIAB is poised for the kinase reaction, but is unable to phosphorylate SpoIIAA due to the Ser 58 to Ala 
AA mutant used for crystallization.  Comparison of the AB:AA complex with the AB2:σF complex (Figure 
5.2) reveals a mutually exclusive binding site on AB for AA and σF.  ATP bound to each molecule of AB is 
represented as sticks.  A portion (K100 - I121) of the AB model (left side) has been removed to show the 
close proximity of ATP to Ala 58.  Magnesium ions are shown as magenta spheres.  Adapted from 
(Masuda et al., 2004).   
 
B. subtilis SpoIIAA is a 119 amino acid, single domain cytoplasmic protein.  
Crystal structures of SpoIIAA in the unphosphorylated and phosphorylated state from the 
related species B. sphaericus have been solved (Seavers et al., 2001).  Few structural 
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differences between unphosphorylated and phosphorylated AA exist, suggesting that 
covalent modification of the active site Ser functions more as a temporary negative 
marker rather than to promote global structural rearrangements as in many eukaryotic 
signaling systems.  The overall fold of SpoIIAA consists of a four-stranded β-sheet with 
two α-helices above the sheet, one short α-helix at the side, and a short C-terminal α-
helix (Figure 5.4).  The conserved serine residue 58, which is the site of phosphorylation, 
is located at the beginning of the second α-helix. 
 
Figure 5.4)  The 1.61 Å and 1.16 Å resolution crystal structures of Bacillus sphaericus SpoIIAA (left, PDB 
code 1H4Y) and phosphorylated SpoIIAA (right, PDB code 1H4X), respectively.  Structures are colored N- 
to C-terminally from blue to red.  The side chain of Ser57, the site of phosphorylation, is shown as sticks. 
 
The phosphorylation state of SpoIIAA is not only contingent on the kinase 
activity of SpoIIAB, but also on the activity of the serine phosphatase SpoIIE.  
Expression of SpoIIE is directly controlled by Spo0A~P (Fawcett et al., 2000).  The 
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mechanism by which SpoIIE is able to dephosphorylate SpoIIAA in the forespore to 
levels sufficient for sporulation is a matter of some controversy.  It has been suggested by 
several studies that during asymmetric division SpoIIE is targeted to the forespore side of 
the septum.  Due to an increased surface to volume ratio, the ratio of SpoIIE to SpoIIAA 
within the forespore would be increased, allowing SpoIIAA to be sufficiently 
dephosphorylated (Duncan et al., 1995; Feucht et al., 2002; Wu et al., 1998).  In a 
separate set of experiments, however, unequal distribution of SpoIIE was not found to be 
a contributing factor of σF activation.  Instead, a predivisional inhibitor of SpoIIE was 
proposed, though its discovery has remained elusive (Arigoni et al., 1999).   
Genetic asymmetry, the phenomena where some genes become accessible to 
transcription in the forespore before others, may also contribute to elevated levels of 
unphosphorylated SpoIIAA in the forespore.  Only one-third of the chromosome has 
translocated into the forespore by the time the asymmetric division septum is complete 
(Errington et al., 2001).  The remaining two-thirds are slowly pumped in over the course 
of sporulation.  SpoIIAB is susceptible to proteolysis at 37 ºC and is degraded with a 
half-life of approximately 25 min in both the mother cell and forespore (Pan et al., 2001).  
Because the gene for SpoIIAB is located towards the terminal end of the segregating 
chromosome, it will only be available for transcription long after sporulation has 
commenced.  Thus, levels of SpoIIAB in the forespore would be temporarily reduced 
relative to the more stable proteins SpoIIAA and σF, allowing σF to gain a foothold on 
transcription (Dworkin, 2003). 
SpoIIE from B. subtilis is an 827 amino acid protein consisting of three domains 
(Figure 5.5) (Arigoni et al., 1999).  Residues 33-322 comprise the highly hydrophobic 
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domain I, consisting of 10 membrane spanning segments (residues 1-32 make up a short 
cytoplasmic N-terminal tail) which targets SpoIIE to the membrane.  Domain II (residues 
331-606) is involved in oligomerization of SpoIIE and in interactions with the tubulin-
like protein FtsZ, which is required for the formation of the asymmetric septum (Ben-
Yehuda and Losick, 2002; Lucet et al., 2000).  Localization of SpoIIE to the septum is 
dependent on this interaction with FtsZ (Levin et al., 1997).  Mutations within domain II 
result in a number of phenotypes, ranging from total sporulation deficiency to predivision 
activation of σF (Barak and Youngman, 1996; Feucht et al., 2002).  Domain III (residues 
607-827) contains a serine phosphatase that has structural homology to the eukaryotic 
PP2C serine/threonine phosphatases involved in stress responses in both prokaryotes (i.e. 
sporulation) and eukaryotes (Meyer et al., 1994; Shiozaki et al., 1994).  This domain has 
10% sequence identity with the catalytic domain of human PP2Cα (Adler et al., 1997). 
 
Figure 5.5)  Predicted domain organization of SpoIIE from Bacillus subtilis.  Transmembrane (TM) 
spanning regions are represented by grey rectangles.  The soluble domains II and III are shown as globules.  
Numbers correspond to residues in the protein.  The number of positively charged residues (Lys, Arg) in 
the loops between successive TM regions are indicated.  Boxes relate to biochemical assays performed in 
the publication (Arigoni et al., 1999).  
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The crystal structure of human PP2Cα has been solved to 2.0 Å resolution (Das et 
al., 1996).  The N-terminal catalytic domain contains six α-helices and 11 β-strands, a 
feature common to all members of the PP2C family.  A central buried β-sandwich formed 
by the association of two anti-parallel β-sheets makes up the architecture of the catalytic 
center.  A pair of anti-parallel α-helices flank both β-sheets of the β-sandwich.  The α-
helices are inserted between the two central β-sheets.  The central β-sandwich binds two 
Mn2+ ions, which coordinate the phosphate group of the substrate and provide a 
nucleophile for dephosphorylation.  10 invariant residues that PP2Cα shares with SpoIIE 
are situated at or close to the Mn2+ sites.  A recent study by Jackson et al. identified three 
PP2Cα active center aspartates (D60, D239, and D282) that when mutated to asparagine 
produced an enzyme with moderate to dramatic decreases in Kcat values and dramatic 
increases for KM values for metal or substrate (Table 5.1) (Jackson et al., 2003).  D60 
bridges metals M1 and M2 (PP2Cα utilizes either Mn2+ or Mg2+ for catalysis, though 
Mn2+ is present in the PP2Cα structure) in the active center, and D239 coordinates metal 
M2 (Figure 5.6).  The third residue of importance, D282, activates a water-bound 
nucleophile, and thus when mutated only showed a decrease in Kcat.  These active site 
aspartates are conserved in SpoIIE, and offer promising targets for mutagenesis and the 
stabilization of a SpoIIAA-E complex. 
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Figure 5.6)  (A) Schematic representation of the ligand environment in human PP2Cα.  Hydrogen bonding 
interactions coordinate the phosphate with metal centers M1 and M2 through water ligands.  Asp-60 
(corresponding to SpoIIE Asp-630) bridges the two metal ions.  Asp-239 and Asp-282 (SpoIIE 748 and 
797, respectively) make direct contacts with the metal centers.  (B) Proposed mechanism for PP2Cα 
induced dephosphorylation.  Asp-282 (SpoIIE 797) is proposed to activate the metal-associated water 
molecule for nucleophilic attack at the phosphorus atom by an SN2 mechanism.  Based on (Das et al., 1996; 




Table 5.1)  Steady-State kinetic parameters for wild-type PP2Cα and mutants E37Q, D38N, D60N (SpoIIE 






In order to gain insights into the mechanism of SpoIIE induced dephosphorylation 
of SpoIIAA, we sought to determine the crystal structures of both SpoIIE on its own, and 
a SpoIIE-AA complex.  To that end, we established preliminary expression constructs 
and purification protocols for both wild-type and mutant forms of SpoIIE, as well as a 
preliminary SpoIIAB-AA-E triple expression construct. 
 
Establishing a SpoIIE Expression System 
Based on secondary structural predictions (Rost et al., 2004), Gst SpoIIE residue 
Ser 324 was identified as the first cytoplasmic residue following the membrane spanning 
domain I.  Therefore, SpoIIE 324-CT (C-terminus) was cloned into plasmid pSKB2 and 
used as the basis from which subsequent SpoIIE constructs were derived.  SpoIIE 324-CT 
encompasses the cytoplasmic domains II, which is responsible for self-oligomerization, 
and III, which possesses a PP2C-like serine phosphatase activity. 
Due to the presence of several rare codons in the SpoIIE coding sequence, protein 
expression of SpoIIE 324-CT was carried out using E. coli Rosetta2™ (DE3) cells.  The 
Rosetta2™ strain carries a plasmid that supplies tRNAs for 7 codons rarely used in E. 
coli.  Rosetta2™ was developed primarily for the expression of eukaryotic proteins, but 
our experience has shown that expression levels for many non E. coli proteins can be 
greatly enhanced using this strain.  When expressed at 16 ºC with 0.1 mM ITPG, SpoIIE 
324-CT was estimated to be more than 50% soluble (Figure 5.7).  The protein was 
purified to greater than 90% homogeneity using nickel affinity, anion exchange, and size  
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Figure 5.7)  SDS-PAGE analysis of SpoIIE 324-CT after each stage of the purification process.  Numbers 
below the gels indicate fractions from the corresponding chromatography step.  WM - protein weight 
marker.  S - Soluble fraction after lysis.  I - Insoluble fraction after lysis.  FT - Unbound protein in the flow 
through.  For Nickel Affinity, lane numbers correspond to increasing percentage of elution buffer 
containing 200 mM imidazole: lanes 1 and 2 - 20% elution buffer; lanes 3 and 4 - 35%; lanes 5 through 7 - 
50%; lanes 8 through 12 - 100%.  
 
exclusion chromatography (Figure 5.7).  No crystallization trials were performed with 
this construct because of previous observations made with Bsu SpoIIE that suggested any 
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construct containing a complete domain II would suffer badly from aggregation, even in 
the presence of 10% glycerol and 0.1% Triton X-100.  Indeed, Gst SpoIIE 324-CT 
showed signs of aggregation in a concentrator beyond 1 mg/ml. 
 
Identification of Proteolytically Stable Domains of SpoIIE 
Because we suspected that SpoIIE 324-CT would not crystallize, we instead used 
protein from this construct to identify stable domains of SpoIIE through limited 
proteolysis that would not suffer from issues of aggregation.  SpoIIE 324-CT was 
subjected to trypsin, chymotrypsin, and subtilisin limited proteolysis (Severinov et al., 
1994), and N-terminal sequencing was used to identify proteolytic fragments.  Due to the 
non-specific activity of subtilisin, N-terminal sequencing could not conclusively 
determine where this enzyme had cut SpoIIE.  Digestion with trypsin and chymotrypsin, 
on the other hand, produced specific and somewhat overlapping fragments (Figure 5.8 
and Table 5.2). 
 
Figure 5.8)  SDS-PAGE analysis of trypsin and chymotrypsin limited proteolysis experiments on SpoIIE 
324-CT.  Lane 1 - uncut control sample; Lane 2 - Trypsin:IIE 1:5; Lane 3 - Trypsin:IIE 1:10; Lane 4 - 





Table 5.2)  N-terminal Edman sequencing results on the proteolytic fragments from Figure 5.8. 
  
Based on the proteolysis experiments, we constructed SpoIIE 334-CT and SpoIIE 
479-CT.  SpoIIE 479-CT contains the C-terminal half of domain II and all of domain III.  
This construct was expressed in the same manner as 324-CT, and purified using the same 
chromatography steps of nickel affinity, anion exchange, and size exclusion (Figure 5.9).  
The protein expressed to very high levels (185 mg was recovered after the first nickel 
column step), and proved to be very soluble to at least 62 mg/ml without the need for 
glycerol or detergent.  This finding suggests that a crucial determinant(s) for SpoIIE 
oligomerization resides in the N-terminal half of domain II. 
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Figure 5.9)  SDS-PAGE analysis of SpoIIE 479-CT after each stage of the purification process.  Numbers 
below the gels indicate fractions from the corresponding chromatography step.  WM - protein weight 
marker.  S - Soluble fraction after lysis.  I - Insoluble fraction after lysis.  FT - Unbound protein in the flow 
through.  Ni - pooled nickel fractions prior to PreScission™ Protease cleavage.  PPX - Protein after 
digestion with PreScission™ Protease.  For Nickel Affinity, lane numbers correspond to increasing 
percentage of elution buffer containing 200 mM imidazole: lane 1 - soluble fraction prior to nickel affinity; 
lane 2 - insoluble fraction prior to nickel affinity; lane 3 - unbound protein in the flow through; lanes 4 and 






Crystallization of SpoIIE 
The purity of SpoIIE 479-CT was estimated by SDS-PAGE to be only about 90% 
(Figure 5.9, size exclusion).  Nevertheless, we used this protein to screen for preliminary 
crystallization conditions (Table 5.3).  To date, we have not observed protein crystals in 
any condition (trials were performed in the fall of 2007).  For future crystallization 
studies it may be fruitful to further optimize the purification scheme and/or add an 
additional chromatography step. 
Table 5.3 
 
Table 5.3)  Crystallization trials performed to date on SpoIIE 479-CT. 
 
Active Site Mutations of SpoIIE 
 Domain III, which begins approximately at residue 607, is a PP2C-like serine 
phosphatase (Adler et al., 1997).  Jackson et al. identified key active site Asp residues in 
PP2Cα that when mutated to Asn dramatically decreased values for Kcat, but either 
maintained or increased the values of Km for metal (Mn2+) or substrate (Jackson et al., 
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2003).  Because these residues are conserved, using similar logic we sought to introduce 
the corresponding Asp to Asn mutations into SpoIIE.  SpoIIE harboring these mutations 
would presumably still bind phosphorylated SpoIIAA (no decrease in Km), but 
dephosphorylation of AA would be abolished (decreased Kcat), and in turn the E-AA 
complex would be stabilized. 
 Each mutation, D630N, D748N, and D797N, was first introduced into the SpoIIE 
334-CT construct.  A construct encompassing the complete domains II and III of SpoIIE 
was chosen because SpoIIE might be prevented from multimerizing in the context of a 
stable E-AA complex.  After the Asp to Asn mutants were generated, each was 
incorporated into an AB-AA-E triple expression vector.  The triple expression construct 
was designed under the assumption that when expressed together in the cell, the kinase 
activity of SpoIIAB would produce sufficient levels of phosphorylated SpoIIAA, which 
would in turn promote complex formation between mutant SpoIIE and AA.  SDS-PAGE 
analysis showed that when co-expressed, AB, AA, and E all expressed to high levels 
(Figure 5.10).  However, while AB and AA partitioned to the soluble fraction, E was 
100% insoluble, even in the presence of 1% Triton (Figure 5.10).  This could be 
explained in one of two ways.  Either the mutant SpoIIE proteins are unable to recognize 
AA, or the E-AA interaction is unchanged by single Asp to Asn substitutions and remains 
a transient event.  Clearly the E-AA interaction is not strong enough to either pull E into 
the soluble fraction, or AA into the insoluble fraction. 
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Figure 5.10)  SpoIIE Asp to Asn mutants express to high levels, but are insoluble, even when expressed in 
the context of SpoIIAB and SpoIIAA.  WM - Protein weight marker, U - pre expression, I (left gel) - post 
IPTG induction, T - total protein from bacterial lysate, S - soluble fraction following lysis, I (right gel) - 
insoluble fraction following lysis.   
 
SpoIIE 334-CT is also 100% insoluble when expressed on its own (data not 
shown).  It is interesting to note that inclusion of merely an extra 10 residues (SpoIIE 
324-CT vs. 334-CT) to the construct renders the protein more than 50% soluble.  We 
therefore sought to introduce the catalytic site Asp to Asn mutations into SpoIIE 324-CT.  
The decision was made to bypass the single mutants, and instead focus on generating a 
D630N, D748N, D797N triple mutant.  Due to changing thesis priorities, to date only the 
pSKB2-SpoIIE 324-CT D748N D797N double mutant has been made.  The SpoIIE triple 
mutant has not yet been constructed, and the double mutant has not yet had its expression 




Materials and Methods 
 
All oligonucleotide primers for PCR were resuspended to 100 pmol/µl in TE 
buffer, pH 8.0, unless otherwise noted.  All PCR reactions were carried out with 
Accuprime™ pfx Taq DNA polymerase (2.5 units/µl), and the corresponding 10 X buffer 
containing dNTPs and Mg2+ (Invitrogen).  All PCR reactions were carried out in 100 µl 
reactions consisting of 0.5 µl of forward and reverse primers, 10 µl of 10 X pfx buffer, 
0.5 µl DNA template, 0.5 µl of pfx polymerase, and 88.5 µl of ddH2O, unless otherwise 
noted.  All PCR reactions had an initial DNA melting step of 120 s at 95 ºC.  All vector 
DNA was treated with calf intestinal phosphatase (CIP) for 1 h at 37 ºC prior to ligation.  
All ligation reactions were carried out at 15 ºC for approximately 16 h using T4 DNA 
ligase (NEB).  All transformations for cloning steps were carried out with freshly 
prepared CaCl2 competent E. coli, strain CC118. 
 
Cloning SpoIIE from Genomic Geobacillus stearothermophilus DNA. 
Gst strain DSM 13240 (German Collection of Microorganisms and Cell Culture), 
also known as strain 10 (University of Oklahoma), was grown on trypticase soy agar 
overnight (~16 h) at 65 °C.  Isolated colonies were picked and resuspended in 20 µl of 
ddH2O, and frozen at -20 °C until needed.  For full-length SpoIIE amplification, a single 
colony in 20 µl of ddH2O was boiled in a water bath for 10 min and spun at 14,000 RPM 
in a microfuge to pellet out the cellular debris.  SpoIIE was amplified using primers MB-
13 (NheI) and MB-14 (BamHI) and the following PCR parameters: 30 cycles of 15 s at 
 194 
95 °C, 30 s at 54 °C, and 150 s at 68 °C, followed by a final extension step of 68 °C for 
12.5 min.  Amplicons were analyzed by agarose gel electrophoresis. 
 Full-length SpoIIE was separated on a 1% agarose gel and extracted using a gel 
extraction kit (Qiagen) following the manufacturer’s protocol.  Gel purified SpoIIE was 
sequentially digested with NheI and BamHI in 50 µl reactions at 37 °C, with a PCR clean 
up kit (Qiagen) step in between the NheI and BamHI digestions.  SpoIIE was ligated into 
NheI/BamHI digested pSKB2 (Kanr).  pSKB2 is a derivative of pET28a with a 
PreScission™ Protease site in place of the thrombin cleavage site.  Ligation reactions 
were transformed and selected by overnight growth at 37 °C on LB agar supplemented 
with 50 µg/ml kanamycin.  Colonies were picked into 5 ml of LB supplemented with 
kanamycin and grown overnight at 37 °C, with shaking at 200 RPM.  Plasmid DNA from 
1.5 ml of overnight cultures was prepared using a miniprep kit (Qiagen) following the 
manufacturer’s protocol.  Plasmids containing SpoIIE insert DNA were confirmed by 
analytical NheI/BamHI digestion and agarose gel electrophoresis.  Maxipreped (Qiagen) 
DNA of the pSKB2-SpoIIE construct was used for all subsequent cloning.  (It was later 
discovered through sequencing of the pSKB2-SpoIIE plasmid that primer MB-13 had in 
fact introduced a frame shift at the beginning of the coding sequence.  Therefore, pSKB2-
SpoIIE is not suitable for protein expression, but is perfectly usable for subcloning). 
 
Subcloning of SpoIIE 324-CT, SpoIIE 334-CT, and SpoIIE 479-CT 
SpoIIE 324-CT (C-terminus), 334-CT, and 479-CT were all PCR amplified from 
pSKB2-SpoIIE full-length using primers MB-69 (NdeI), and MB-33 (NdeI), and MB-77 
(NdeI), respectively, and the T7 terminator.  MB-69, MB-33, and MB-77, all introduce 
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an NdeI site immediately 5’ to the first codon of their respective amplicons.  The PCR 
parameters for each insert were as follows: SpoIIE 324-CT: 30 cycles of 30 s at 95 °C, 30 
s at 55 °C, and 120 s at 68 °C, followed by a final extension step of 10 min at 68 ºC.  
SpoIIE 334-CT: 30 cycles of 30 s at 95 ºC, 30 s at 60 ºC, 100 s at 68 ºC, followed by a 
final extension of 7 min at 68 ºC.  SpoIIE 479-CT: 30 cycles of 30 s at 95 ºC, 30 s at 55 
ºC, and 90 s at 68 ºC, followed by a final extension of 5 min, 50 s at 68 ºC.  All 
amplicons were purified using a PCR clean up kit and doubly digested with NdeI and 
BamHI overnight at 37 °C.  Digested products were gel purified and ligated into 
NdeI/BamHI digested pSKB2.  Ligation reactions were transformed and selected as for 
full-length pSKB2-SpoIIE.  Candidate constructs were confirmed by sequencing with the 
T7 promoter and terminator primers. 
 
SpoIIE Asp to Asn Mutagenesis 
All mutations were introduced using the megaprimer method, with slight 
modifications (Sarkar and Sommer, 1990).  Primers for each Asp to Asn mutant (MB-46 
for D630N, MB-48 for D748N, and MB-50 for D797N) were first used with the T7 
terminator primer to generate a megaprimer by PCR.  All megaprimers were gel purified 
and resuspended in ddH2O.  SpoIIE 334-CT was amplified from pSKB2-SpoIIE full-
length using the megaprimer (final concentration of 0.5 µM) containing the bases coding 
for the each specific mutation, and MB-33 as the second primer (30 rounds of PCR 
amplification: 95 °C for 30 s, 55 °C for 60 s, 68 °C for 120 s, followed by a final 
extension step of 10 min at 68 ºC).  SpoIIE 334-CT mutant amplicons were then doubly 
digested with NdeI and BamHI, and subsequently ligated back into NdeI/BamHI pSKB2. 
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SpoIIAB-AA Double Expression Construct 
 Both Gst SpoIIAB C145S and SpoIIAA were NdeI/BamHI digested from 
plasmids pLC6 and pLC5a, respectively (pLC6 and pLC5a were provided by Elizabeth 
Campbell).  SpoIIAB with a C145S mutation has previously been used for structural 
studies (Campbell et al., 2002).  Insert DNA was gel purified and ligated into 
NdeI/BamHI digested pET21a.  For construction of the pET21a-AB-AA double 
expression vector, SpoIIAA was subcloned from pET21a using primers Liz13 and MB-
27 with the following PCR conditions:  95 ºC for 120 s, 30 cycles of 30 s at 95 ºC, 30 s at 
56 ºC, and 35 s at 68 ºC, followed by a final extension step of 68 ºC for 175 s.  Liz 13 
introduces a BamHI site into the lac operon of pET based vectors.  MB-27 abolishes the 
BamHI site from the multiple cloning site of pET21a.  BamHI/EcoRI digested SpoIIAA 
was ligated into BamHI/EcoRI digested pET21a-SpoIIAB to afford the pET21a-AB-AA 
double expression construct. 
 
SpoIIAB-AA-E Triple Expression Construct 
SpoIIE 334-CT Asp to Asn mutants were amplified from their respective 
plasmids with primers Liz13 Eco and MB-29 with the following PCR conditions: 30 
cycles of 30 s at 95 ºC, 30 s at 55 ºC, and 120 s at 68 ºC, followed by a final extension 
step of 68 ºC for 10 min.  Liz13 Eco introduces an EcoRI site into the Lac operon of pET 
based vectors.  MB-29 changes the SalI site in the multiple cloning site of pET based 
vectors to a NotI site.  Amplicons were purified with a PCR clean up kit (Qiagen) and 
doubly digested with EcoRI and NotI overnight at 37 ºC.  Digested insert DNA was gel 
purified and ligated into EcoRI/NotI digested pET21a-SpoIIAB-AA to afford the 
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pET21a-SpoIIAB-AA-E triple expression constructs.  Transformants were selected on 
LB agar supplemented with 150 µg/ml ampicillin and clones were confirmed by DNA 
sequencing. 
 
SpoIIE 324-CT and 479-CT Protein Expression 
 pSKB2-SpoIIE 324-CT was transformed into freshly made chemically competent 
E. coli Rosetta2 (DE3) cells (Novagen).  Transformed cells were used to inoculate a 5 ml 
LB culture supplemented with 50 µg/ml kanamycin and 35 µg/ml chloramphenicol.  The 
culture was grown overnight at 37 ºC with shaking at 200 RPM.  The 5 ml culture was 
used to inoculate a 300 ml LB (Kan/Cam) culture, which was grown overnight at 37 ºC, 
again at 200 RPM.  For large-scale protein expression, 50 ml of the 300 ml culture was 
used to inoculate four 2 L LB (Kan/Cam) cultures.  2 L cultures were grown at 37 ºC, 200 
RPM until an OD600 of 1.0.  Protein expression was induced by the addition of IPTG to a 
final concentration of 0.1 mM.  The temperature was then reduced to 16 ºC, and the 
cultures were incubated overnight at 200 RPM.  Cells were pelleted at 4000 RPM, 4 ºC 
for 30 min and the supernatant was discarded.  2 L of cells were resuspended in 30 ml of 
nickel column buffer A (20 mM Tris-Cl, pH 7.4, 0.5 M NaCl, 10 mM MgCl2 5 mM 
imidazole, 1% Triton X-100, 5% glycerol) and frozen at -80 ºC. 
 All chromatography steps for protein purification were carried out on an ÄKTA 
fast performance liquid chromatography (FPLC) system (GE life sciences).  1 mM each 
of PMSF and β-ME was added to 2 L of cells prior to lysis.  Cells were lysed between 
12,000 and 15,000 psi at 4 ºC using an EmulsiFlex-C5™(Avestin) high-pressure 
homogenizer, and the crude lysate was clarified by centrifugation at 16,000 RPM for 30 
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min at 4 ºC.  The supernatant was passed over a 5 ml metal chelating column (GE life 
sciences), charged with NiSO4, at 1 ml/min, and the flow through was collected.  Protein 
was eluted from the Ni2+ column using a step gradient over 60 ml to 100% nickel column 
buffer B (same as buffer A with 200 mM imidazole) (10 ml at 20% B, 10 ml at 35%, 15 
ml at 50%, and 25 ml at 100%).  Twelve 5 ml fractions were collected.  All fractions 
were analyzed by SDS-PAGE. 
 Peak elution fractions were pooled and PreScission™ Protease (GE life sciences) 
was added to an approximate 1:150 mass:mass ratio with SpoIIE 324-CT in order to 
remove the N-terminal His6-tag.  SpoIIE324-CT harbors four vector-derived residues at 
its N-terminus following PreScission™ Protease digestion.  Cleaved protein was dialyzed 
overnight at 4 ºC in 2 L of 100 mM NaCl, 20 mM Tris-Cl, pH 7.9, 10 mM MgCl2, 10% 
glycerol, 1% Triton X-100, and 1 mM DTT, using 12,000 - 14,000 MWCO dialysis 
tubing (Spectracor).  The efficiency of the cleavage reaction was assessed by SDS-
PAGE. 
 Next, SpoIIE 324-CT was passed over a 5 ml GST column in series with a 5 ml Q 
anion exchange column (GE life sciences) at 0.5 ml/min.  The columns were equilibrated 
with 100 mM NaCl, 20 mM Tris-Cl, pH 7.9, 10 mM MgCl2, 1 mM DTT, and 10% 
glycerol (Q column buffer A) in an attempt to remove Triton from the protein.  After 
loading the protein onto the GST/Q series, the GST column was removed and SpoIIE 
324-CT was eluted over 50 ml (10 column volumes) from the Q column at 1 ml/min 
using a linear gradient to the same buffer plus 700 mM NaCl (Q column buffer B).  
Twenty-five 2 ml fractions were collected.  Two peaks were observed, the first at fraction 
3 (~10% high salt buffer), and the second around fraction 1 (~300 mM NaCl).  It was 
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assumed that the first peak was aggregated SpoIIE, and hence was not used for further 
chromatography steps. 
 Finally, SpoIIE was passed over an SD200 (16/60) column, equilibrated with the 
Q column buffer A, at 0.3 ml/min.  After a 30 ml void volume, forty-five 2 ml fraction 
were collected.  Two partially overlapping peaks were observed, one corresponding to 
presumably multimeric species of SpoIIE, the other to monomeric SpoIIE.  All fractions 
were analyzed by SDS-PAGE.  Aliquots of monomeric SpoIIE 324-CT were snap frozen 
in liquid nitrogen and stored at -80 ºC. 
 SpoIIE 479-CT was expressed essentially the same as SpoIIE 324-CT, and 
followed the same sequence of chromatography steps, but with the following exceptions.  
Nickel column buffers A and B were 150 mM NaCl, 20 mM Tris-Cl, pH 7.0, 10 mM 
MgCl2, 5 mM imidazole (or 200 mM imidazole for buffer B), and 5% glycerol. 
PreScission™ Protease dialysis buffer was 100 mM NaCl, 20 mM Tris-Cl, pH 7.0, 10 
mM MgCl2, 1 mM DTT.  The GST/Q column buffers A and B and gel filtration buffer 
were the same as the PreScission™ Protease dialysis buffer (except 700 mM NaCl for Q 
column buffer B, and 2 mM DTT for the gel filtration buffer). 
 
Limited Proteolysis of SpoIIE 324-CT 
 58 pmol of SpoIIE 324-CT was mixed with either trypsin or α-chymotrypsin 
(Sigma, made up in protease buffer: 20mM Tris, pH 7.9, 50 mM NaCl, 5% glycerol, 0.1 
mM EDTA, 1mM DTT, 10 mM CaCl2) in the following protease to SpoIIE (mass:mass) 
ratios: 1:5.8 (10 pmol protease), 1:11.6 (5 pmol protease), 1:36 (1.6 pmol protease), and 
1:53 (1.1 pmol protease).  Reactions were brought up to 15 µl with protease buffer and 
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incubated at 26 ºC for 30 min.  0.5 µl of 100 mM PMSF was added to stop the reactions 
and the tubes were put in ice.  10 µl of each reaction plus 2.5 µl of 5X SDS loading 
buffer was run out on 4-20% Tris-Glycine PAGE (Invitrogen). 
 For N-terminal sequencing of proteolytic fragments, following SDS-PAGE the 
protein was transferred to PVDF membrane (Bio-Rad) following the electroblotting 
procedure supplied by The University of Texas Medical Branch (UTMB) Protein 
Chemistry Laboratory (http://www.utmb.edu/proch/serv01.htm).  Proteolytic fragments 
of interest were excised from the PVDF and sent to UTMB for N-terminal Edman 
sequencing. 
 
SpoIIE 479-CT Crystallization 
 Gel filtration purified SpoIIE 479-CT (in 100 mM NaCl, 20 mM Tris-Cl, pH 7.0, 
10 mM MgCl2, 2 mM DTT) was concentrated using 10,000 MWCO Vivaspin 
concentrators (Vivascience).  Dilutions were made using the same buffer and the protein 
was subjected to a variety of 96-condition crystallization screens from Qiagen (Table 
5.2).  All crystallization trials were carried out using the vapor diffusion method and 96-
well sitting drop trays (Corning).  Crystallization drops consisted of a 1 µl to 1 µl ratio of 
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CHAPTER 6 
Crystal Structures of the Sulfotransferase Teg12 in a 




During the 20th century, widespread use of antibiotics significantly reduced the 
threat of many once lethal infectious diseases.  However, the success of these wonder 
drugs may soon become their Achilles’ heel.  Bacterial pathogens that have developed 
resistance to most widely used antibiotics are now regularly seen in clinical settings.  
Vancomycin and teicoplanin are glycopeptide antibiotics used in the treatment of many 
gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus 
(MRSA).  With the appearance of vancomycin resistant Enterococci in the late 1980s and 
resistant Staphylococci in the early 1990s, these traditional antibiotics of last resort are in 
danger of becoming clinically compromised (Hiramatsu et al., 1997; Linden, 2008; Uttley 
et al., 1988).  As with many bacterial natural products, the discovery of additional 
glycopeptide congeners that might combat the growing problem of antibiotic resistance 
has slowed as it has become increasingly difficult to identify new biodiversity from 
which novel molecules might be characterized. 
The vast majority of bacteria present in the environment remain recalcitrant to 
culturing (Rappe and Giovannoni, 2003).  This uncultured majority no doubt contains 
previously inaccessible glycopeptide biosynthetic gene clusters, many of which could 
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encode the biosynthesis of novel glycopeptide congeners.  Although metabolites 
produced by bacteria that are difficult to culture in the laboratory cannot be characterized 
using standard microbiological methods, it is possible to extract DNA directly from 
environmental samples and then analyze this DNA for sequences that might encode the 
biosynthesis of new natural products.  In a recent analysis of DNA extracted directly 
from desert soil, we uncovered a new glycopeptide biosynthetic gene cluster (the TEG 
gene cluster) that is predicted to encode the biosynthesis of the first polysulfated 
glycopeptide congeners (Banik and Brady, 2008).  The TEG gene cluster contains three 
closely related 3'-phosphoadenosine 5'-phosphosulfate (PAPS) dependent 
sulfotransferases (Teg12, 13 and 14).  In vitro, these three sulfotransferase finishing 
enzymes sulfate teicoplanin-like glycopeptides at three unique sites and, in combination, 
can be used to produce seven different glycopeptide sulfation patterns (Figure 6.1).  
 
Figure 6.1)  Predicted structures for the glycopeptide congeners produced by the TEG gene cluster.  Seven 
nonribosomal peptide synthetase modules encoded by the TEG cluster are predicted to biosynthesize a 
heptapeptide that is oxidatively cross-linked by OxyA-D homologs and then sulfated by Teg12, 13, and 14. 
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Vancomycin- and teicoplanin-like glycopeptides are structurally defined by the 
presence of an oxidatively cross-linked heptapeptide core (Hubbard and Walsh, 2003; 
Kahne et al., 2005).  The peptide core is initially produced as a linear polymer by 
nonribosomal peptide synthetases, which is then oxidatively cross-linked into either three 
or four large macrocycles by conserved cytochrome P450 oxidases.  During their 
biosynthesis, each member of this family of antibiotics is functionalized by a unique 
collection of finishing enzymes that includes glycosyl transferases, halogenases, acyl 
transferases and sulfotransferases.  Although glycopeptides show some variation in the 
sequence of the heptapeptide core, the bulk of the structural diversity seen within this 
class of antibiotics arises from the functionality added by finishing enzymes.  Over 150 
different glycosylated, halogenated, and alkylated glycopeptide congeners have been 
characterized from cultured bacteria (Nicolaou et al., 1999).  Only three naturally 
occurring sulfated congeners have been identified to date from studying this same pool of 
bacteria (Boeck and Mertz, 1986; Nicolaou et al., 1999).  While anionic glycopeptides 
have rarely been reported as natural products, telavancin, a semisynthetic phosphono 
congener that proved to be a very effective antibiotic in clinical trials, was recently 
approved for use in humans by the FDA (Higgins et al., 2005; Stryjewski et al., 2005).  
Increasing the hydrophilicity with the addition of the negatively charged phosphono 
group was found to significantly improve the adsorption, distribution, metabolism, and 
excretion profile of this class of antibiotics (Leadbetter et al., 2004).  The enzymatic 
synthesis of anionic glycopeptides may provide a facile means to access additional 
anionic congeners with improved pharmacological properties.  
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In this chapter we report a series of Teg12 sulfotransferase structures, including 
an apo structure, a binary structure complexed with the teicoplanin aglycone substrate, as 
well as a ternary structure containing both PAP and the teicoplanin aglycone.  In the 
binary and ternary structures, the glycopeptide substrate is observed bound at two 
different locations.  Teg12 appears to undergo a series of conformational rearrangements 
during glycopeptide recruitment, binding and catalysis.  These studies provide insight 
into the sulfotransferase mechanism, as well as insights into how this rarely seen class of 




Teg12 Apo Structure 
N-terminally His6-tagged Teg12 was affinity purified using nickel NTA resin and 
crystallized without the need for further purification.  The apo structure was solved to 
2.91 Å resolution by molecular replacement using StaL (PDB code 2OV8) as a search 
model (Shi et al., 2007).  StaL is a related sulfotransferase involved in the biosynthesis of 
the monosulfated glycopeptide congener A47934 (Boeck and Mertz, 1986; Lamb et al., 
2006).  StaL has 52.9% sequence identity with Teg12.  The Teg12 structure superimposes 
well on StaL (rmsd of 1.05 Å over 210 Cα atoms).  Teg12 crystallizes as a dimer and the 
overall structure resembles that of StaL.  Running Teg12 through the DALI server shows 
that its closest eukaryotic sulfotransferase relative is the human cytosolic sulfotransferase 






Figure 6.2 (adjacent page)  The Three Teg12 structures are presented.  Only a single monomer from the 
dimer is shown for clarity.  (A) Teg12-Apo is colored using a rainbow scheme, from blue (N-term) to red 
(C-term).  Regions of disorder are connected with grey dots, with the number of disordered residues 
indicated.  The flexible GHL Helix is shown in orange.  Side chains for the proposed active site residues 
His67 and Ser9 are also shown.  (B) Teg12-ternary complex containing PAP and the teicoplanin aglycone.  
The protein has been colored grey in order to accentuate regions of the structure that differ from Teg12-
Apo.  Specifically, these regions are the variable loops V1-V3, colored blue, red, and green, respectively.  
Also shown is a molecule of PAP in the active site, a molecule of teicoplanin aglycone that interacts with 
the V3 loop (colored sky blue), and an additional molecule of teicoplanin aglycone involved in crystal 
packing interactions (colored hot pink).  (C) Teg12-binary structure complexed with teicoplanin aglycone 
in the active site cavity.  Again, the protein has been colored grey with V1-V3 colored as in the ternary 
structure.  The active site is shown as a stereo close-up image in Figure 6.6.  Teg12 sulfates the hydroxyl of 
residue 3 of the teicoplanin aglycone, which has been indicated in the figure with a red arrow.  Omitted 
from the binary structure is a second molecule of teicoplanin aglycone bound to the outside of the protein 
on the opposite side of the GHL helix.  (bottom panel) Stereo view of a Cα trace of the Teg12-ternary 




(Dombrovski et al., 2006).  As with other sulfotransferases in this family, Teg12 consists 
of a single globular α/β domain composed of a parallel beta sheet core surrounded by 
alpha helices (Figure 6.2A).  The beta sheet core of both StaL and Teg12 contains four 
strands.  The dimer interface, which resembles that seen in StaL, consists of a 
symmetrical interaction between a short helix-loop motif from one monomer and the 
same helix-loop motif from the other monomer.  In addition to the hydrophobic contacts 
that exist between the two helices there is a hydrogen bond between the carbonyl oxygen 
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of Gly51 at the end of the helix from one monomer and the backbone nitrogen of Val74 
of the other monomer.  The active site cavity of each monomer faces the dimer interface. 
Minor differences exist between the two monomers of the apo structure.  The 
pET28a vector derived N-terminal tail, including the His6, thrombin cleavage site and T7 
tags, from monomer A is ordered and involved in crystal packing interactions.  The 
arrangement of these residues within the crystal causes distortions in the region Gly28 
through Ser41 when compared with StaL, and subsequent Teg12 complex structures.  In 
monomer B, residues Gly28 through Ser41 could not be modeled in the electron density 
map, further underscoring the conformational flexibility of this region.  From our co-
crystal structures and that of StaL, it is known that residues Glu216 through Asp250 
constitute a largely disordered loop.  In the Teg12 apo structure, this disorder extends 
even further N-terminally into what is observed as a helix in the Teg12 binary and ternary 
structures and StaL.  Electron density falls off in monomer A after Ser203, but extends 
through Glu210 in monomer B.  Ser203 corresponds to Cys196 in StaL.  In StaL Cys196 
makes a disulfide bond with Cys20 (residue 20 is also a cysteine in Teg12).  The absence 
of a disulfide in Teg12 could impart a greater flexibility in this region and explain the 
additional observed disorder.  In subsequent Teg12 co-crystal structures, portions of this 
helix-loop region (Thr204-Asp250) play key roles in binding the glycopeptide substrate.  
Because of its role in binding the glycopeptide, we have termed this entire 
conformationally flexible region the GHL (glycopeptide-helix-loop).   
ClustalW alignment of the three TEG sulfotransferases shows that most of the 
sequence variability seen within this family of sulfotransferases is concentrated on three 
short loops (variable regions V1, V2, V3) that surround the predicted active site (Figure 
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6.3).  The large disordered loop from the GHL corresponds to the longest of these three 
variable regions, V3.  V2 encompasses residues Gly127 through Gly137.  Much of V2 
(Ala130 to Gly135 in monomer A and Asn129 through Gly136 in monomer B) is 
disordered in the Teg12 apo structure.  V1, the shortest of the three variable sequences, 
corresponds to an ordered region (though disordered in monomer B) that spans Ile37 
through Thr43. 
 
Figure 6.3)  ClustalW alignment of glycopeptide sulfotransferases.  Highly variable sequences (V1, V2 and 
V3) and the flexible part of the GHL helix appear in colored boxes that match the coloration seen in 
Figures 6.2B and 6.2C.  Results from alanine exchange mutagenesis experiments are color coded by 
percent activity.  Results for catalytic and PAPS associated residues are shown in solid or dashed boxes, 
respectively.  All other mutated residues are thought to interact with the glycopeptides.  The H67A mutant 
was insoluble and therefore H67Q data is reported. 
 
Electron density was observed in the PAPS binding site of monomer A (this 
binding site was empty in monomer B).  However, neither PAP nor PAPS could be 
modeled into the density.  We were able to model the dipeptide aspartame (N-(L-a-
aspartyl)-L-phenylalanine,1-methyl ester) into this density (Figure 6.4).  Aspartame is a 
component of the Silver Bullets™ screen (Hampton) used during crystallization.  The 
orientation of aspartame in the structure mimics that of PAP.  Its phenylalanine ring 
stacks with Trp17, as does the adenine ring of PAP, and its N-terminal nitrogen hydrogen 
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bonds with the hydroxyl of Ser98.  Eukaryotic sulfotransferases are known to tightly bind 




 Figure 6.4)  Comparison of the ligands bound in the PAPS binding sites from Teg12-Apo and Teg12-
ternary. Electron density from the 2|Fo| - |Fc| map surrounding each ligand and contoured at 1σ is shown.  
(A) The PAPS binding site of monomer A from Teg12-Apo contained a molecule of the dipeptide 
aspartame (N-(L-a-aspartyl)-L-phenylalanine,1-methyl ester).  Several Teg12 residues important for 
coordinating PAP also make contacts with aspartame.  Their side chains are shown.  (B) PAP bound in the 
Teg12-ternary complex.  Leu205 and Met208 from the GHL helix and Phe243 and Val244 from the V3 
loop make significant Van der Waals contacts with PAP.  (C) Electron density in the PAPS binding site of 
the Teg12-apo monomer A, before the addition of aspartame to the model is shown.  Both the 2|Fo| - |Fc| 
(contoured at 1σ) (blue) and the |Fo| - |Fc| (contoured at 3σ) (green) maps are shown.  Aspartame was added 
to the model only after the protein had been fully built, at the second to last refinement step (before the 






Teg12 Co-crystal Structures 
The TEG gene cluster is predicted to encode the biosynthesis of a heptapeptide 
(hydroxyphenylglycine (Hpg)-betahydroxytyrosine (Bht)-dihydroxyphenylglycine (Dpg)-
Hpg-Hpg-Bht-Dpg) that is oxidatively cross-linked into the four macrocycles seen in 
teicoplanin-like glycopeptides (Figure 6.1).  This TEG derived, oxidatively cross-linked 
heptapeptide skeleton only differs from the teicoplanin aglycone by the substitution of 
Bht for Tyr at the 2nd position in the peptide core.  All three TEG sulfotransferases can 
use the teicoplanin aglycone as a substrate.  We therefore used this molecule in Teg12 co-
crystallization experiments.  The Vmax and Km values for the teicoplanin aglycone were 
determined to be 215.3 ± 25.2 nmol/min/mg and 59.6 ± 1.1 µM, respectively.  Attempts 
to obtain co-crystals by soaking Teg12 apo crystals with either the teicoplanin aglycone 
or the co-substrate PAP were unsuccessful.  The addition of PAP to drops containing apo 
crystals caused the crystals to rapidly dissolve into the mother liquor.  Therefore, we co-
crystallized Teg12 and the teicoplanin aglycone with and without PAP.  PAP is the 
desulfated byproduct of PAPS from the sulfonation reaction.  Our co-crystallization 
experiments led to a Teg12 binary structure bound to teicoplanin, and a ternary structure 
bound to PAP and teicoplanin.  These structures represent the first examples of 
sulfotransferase structures containing glycopeptide substrates. 
 
Teg12 Ternary Structure 
We obtained a 2.05 Å structure of a Teg12-PAP-teicoplanin aglycone ternary 
complex by co-crystallization (Figure 6.2B and 6.2 bottom panel).  Several regions of the 
Teg12 sequence not seen in the other Teg12 structures could be modeled into the electron 
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density.  Loop region Gly127 to Val137, which is primarily disordered in the other Teg12 
structures, is fully ordered in one of the monomers of the ternary complex.  This short 
loop contains the V2 region, one of the three regions that are highly variable within the 
three TEG sulfotransferase sequences.  The V2 loop in Teg12 is extended by four amino 
acids compared with StaL, and by two amino acids when compared with Teg13 and 
Teg14.  A much larger portion of the GHL helix and loop could be modeled in the ternary 
structure.  The GHL helix extends through Ser15 in one monomer.  In the opposite 
monomer the helix extends to Gln218 and transitions uninterrupted to the GHL loop.  
Both monomers of the ternary structure contain a single molecule of PAP bound 
in the predicted active site location.  Three highly conserved structural motifs in 
sulfotransferases are known to play a role in binding PAPS, all of which are seen in 
Teg12.  Lys12 from the 5’-phosphate binding loop (PSB) (Pro11-Thr16) hydrogen bonds 
with the 5’-phosphate of PAP, Ser98 from the 3’-phosphate binding loop (PB) (Val89-
Ser99) hydrogen bonds with the 3’-phosphate of PAP, and Trp17 parallel stacks with the 
adenine base.  A number of additional residues from the PSB loop region, the PB loop 
region and the conformationally flexible GHL region are within hydrogen bonding 
distance of PAP (Figure 6.4B).  Thr16 is only ~2.6 Å from the 5’ phosphate, to which it 
hydrogen bonds.  This residue corresponds to a histidine in StaL, although threonine is 
the more common side chain at this position in eukaryotic sulfotransferases (Shi et al., 
2007).  A general hydrogen bond donor at position 16 is likely to be important for 
properly coordinating PAPS in the active site.  Indeed, an alanine replacement mutant of 
Thr16 was inactive for the sulfation reaction.  A K12A mutant was also inactive, while 
S98A was partially active (27% compared with wild-type).  A W17A mutant did not 
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express as soluble protein, indicating a role not only in binding PAP, but also in protein 
folding and stability. 
PAPS dependent sulfotransferases are believed to use a histidine as a general base 
to activate the hydroxyl or amine used in the sulfate exchange reaction.  Teg12 contains 
three histidine residues, His67, His226 and His269.  Of these, only His67 is located near 
the co-substrate binding site.  The 5’-phosphate of PAP is ~5 Å from the imidazole of 
His67, and when PAPS is modeled in its place, the sulfate is positioned directly adjacent 
to His67 (Figure 6.7).  In this model, both Lys12 and Lys65 are close enough to 
coordinate with the sulfate.  In place of the sulfate from PAPS, a water molecule occupies 
this space in the ternary structure.  Ser9, which is within hydrogen bonding distance of 
the imidazole ring, was proposed to help activate the catalytic histidine in StaL.  Attempts 
to mutate the predicted catalytic histidine in StaL resulted in an insoluble protein and 
therefore its role in catalysis had not been previously confirmed (Shi et al., 2007).  
Alanine exchange mutants were generated for His67, Ser9, and Lys65.  H67A and S9A 
did not express as soluble proteins, while K65A was partially active (65%). Additional 
glutamate and glutamine mutants of His67 were generated to potentially provide better 
expression.  H67E also expressed as an insoluble protein.  However, H67Q, which was 
soluble, produced a completely inactive sulfotransferase. 
 
Teicoplanin Aglycone Bound in the Ternary Structure 
One of the monomers in the ternary structure, in addition to PAP, contains two 
molecules of teicoplanin aglycone.  Both molecules of the aglycone are located outside of 
the predicted active site pocket, and appear to be organized primarily by crystallographic 
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forces (Figure 6.5A).  One of the 
molecules of aglycone makes 
numerous contacts with the GHL 
loop (Figure 6.5B).  Beginning 
with the N-terminal section of the 
GHL loop, residues Gly220 
through Ile224 fold back towards 
the dimer interface.  Pro223 stacks 
with Trp134 and helps to stabilize 
this region.  The subsequent six 
amino acids (Arg 225-Arg230) are 
disordered, before density picks up 
again at Met231.  However, these 
residues occupy a region of space 
where they could easily make  
Figure 6.5) (A) Two molecules of teicoplanin aglycone were modeled in the Teg12-ternary complex, 
colored sky blue and hot pink.  Their location within the crystal appears to mediate the packing of several 
Teg12 monomers, as shown in purple, cyan, dark green, and grey.  The two teicoplanins belong to the grey 
Teg12 in the crystal.  Also shown in yellow is the His6 portion of the N-terminal derived tag from the 
pET28a expression vector.  The tag-aglycone interaction is proposed to mimic the binding of the aglycone 
to its cellular target, D-Ala-D-Ala of the bacterial cell wall.  (B) A close-up of the GHL loop-aglycone 
complex from the Teg12-ternary structure.  Side chains for all alanine mutants are shown.  Lys233 
intercalates into the glycopeptide and makes hydrogen bond contacts with residues 1 and 7 of the aglycone.  
For orientation purposes, the molecule of PAP is shown in purple.  Also shown in orange is the GHL helix. 
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additional contacts with the glycopeptides.  Lys233 through Gln242 closely trace the 
outer surface of the N-terminal three amino acids of the aglycone.  These ten amino acids 
immediately precede the five residues (Phe243-Gly247) that interact with PAP.  Lys233 
intercalates between the Dpg at position 3 and the Hpg at position 5, and it hydrogen 
bonds with hydroxyls from the Hpg at position 1 and the Dpg at position 7.  The 
carboxylate from Asp271 of a symmetry mate makes several contacts with backbone 
nitrogens in the concave cleft of the glycopeptides. 
The carboxylate from Asp271 of a symmetry mate makes several contacts with 
backbone nitrogens in the concave cleft of the glycopeptides.  The C-terminal end of the 
teicoplanin aglycone extends out from the surface of the protein and interacts with a 
second glycopeptide molecule that is bound to the His6-tag from an adjacent monomer.  
Despite the assumption that these aglycone-GHL interactions are mediated primarily by 
crystal packing, we generated a series of mutants in GHL loop residues that contact the 
glycopeptides.  All mutants in this loop region, with the exception of G235A, had 
deleterious effects on the rate of substrate conversion, supporting the notion that the V3 
loop interacts with the substrate and is involved in recruitment.  The P241A mutation 
abolished Teg12’s activity completely.  While the observed glycopeptide-GHL 
interactions observed in the ternary structure are clearly stabilized by crystal packing 
interactions, our mutagenesis experiments make it so we cannot rule out the possibility 
that this represents a snapshot of the substrate recruitment path.  A summary of all 
mutations made in Teg12 and their corresponding activities is given in Table 6.3. 
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Teg12 Binary Structure and the Teg12 Active Site 
We solved a Teg12-teicoplanin aglycone structure to 2.27 Å resolution (Figure 
6.2C).  A single monomer constitutes the asymmetric unit and the dimer is generated by 
crystallographic symmetry.  The active site contains a single molecule of teicoplanin 
aglycone.  Two sets of side chain hydrogen bonds play key roles in creating the 
glycopeptide binding cavity.  The base of the binding pocket is largely defined by the 
outstretched side chain of Arg107 coordinating with the side chain of Gln251.  The back 
of the cavity is largely defined by two outstretched arginine side chains (Arg214 and 
Arg248) that interact with each other via a mediating water molecule.  Numerous 
hydrogen bonds exist between amino acid side chains from residues found in the GHL 
helix (Glu206, Arg207, Glu210 and Lys213) and the glycopeptide (Figure 6.6).  Several 
of the residues that make contacts with PAP also interact with the aglycone (Lys12, 
Arg90, Arg101, and Tyr167).  Side chains from Tyr167 and Lys12 coordinate the C-
terminal carboxylate, while a backbone carbonyl oxygen from Lys213 and water 
hydrogen bonded to Glu216 coordinate the N-terminal amine. 
The GHL helix and the helix immediately N-terminal (residues Ile193 to Ser203) 
form a single contiguous helix that runs along the top surface of the aglycone (Figure 
6.2C).  In the ternary structure with an empty active site pocket, these two helices adopt a 
bent conformation that results from unwinding of the long helix at Thr204 (compare 
orange GHL helix, Figures 6.2B and 6.2C).  This bent conformation is also observed in 
StaL.  In the bent conformation, the helices are at a nearly perpendicular angle to one 
another.  The long, largely disordered loop region of the GHL that interacts with PAP in 
the ternary structure is completely displaced by the bound glycopeptide in the binary 
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structure.  This disordered loop is now positioned at the back of Teg12, behind the bound 
glycopeptide.  The front surface of the glycopeptide, where the sulfotransferase reaction 
is predicted to occur on residue 3 (see red arrow in Figure 6.2C), is largely exposed to 
solvent.  With the exception of an additional small compensatory movement of a short 
loop (Gln31 through Ile37) into the void left by the straightening of the flexible helix 
from the GHL, the remainder of this Teg12 binary structure is essentially identical to that 
seen in the other Teg12 structures. 
 
 
Figure 6.6) Stereo views of the front and back sides of the active site of the Teg12-binary structure.  
Protein residues are colored green, and the aglycone is colored yellow.  Hydrogen bonds are indicated with 
dashed lines.  Water molecules that make important hydrogen bonds are shown as pink spheres. 
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The C-terminus of the glycopeptide is buried in the PSB loop from the strand-
loop-helix motif and the helix from the PB loop containing the strand-turn-helix motif 
runs along the under side of the glycopeptide.  While most residues only contact the outer 
surface of the glycopeptide, one residue, Arg101, extends into the core of the molecule.  
The side chain of Arg101 intercalates between the Dpg at position 3 and the Hpg at 
position 5.  The guanidinium from Arg101 hydrogen bonds with the backbone carbonyl 
from the Hpg at position 4 as well as with hydroxyls from the Dpg at position 3 and the 
Dpg at position 7.  In this respect, Arg101 behaves in much the same way as Lys233 in 
the ternary structure.  We generated a series of alanine replacement mutants for residues 
contacting the aglycone to determine which are important for substrate conversion.  The 
results are summarized in Table 6.3.  R101A showed a reduction of activity to 27% 
compared with wild-type.  Interestingly, an E212A mutation also showed a reduction of 
activity to 26%.  Glu212 is part of the GHL helix, but does not make contacts with the 
aglycone in the binary structure.  Instead, this residue is found on the upper, solvent 
exposed face of the helix.  Arg248, along with Arg214 forms the back of the active site 
cavity.  An alanine placed at position 248 resulted in a two-fold increase in sulfation.  
Removing the bulky side chain at this position may impart more flexibility on the active 
site, allowing the glycopeptide to shift more easily towards His67 (see discussion). 
Although the glycopeptide substrate interacts with different sets of GHL residues in the 
binary and ternary structures, the general glycopeptide binding motif seen in these 
structures is very similar.  In both cases, a long positively charged amino acid side chain 
(Lys233 in the ternary, Arg101 in the binary) extends into the core of the glycopeptide, 
where it coordinates with the same set of side chain hydroxyls.  All other glycopeptide-
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protein contacts observed in these structures involve the outer surface of the 
glycopeptide.  
In addition to the glycopeptide bound in the active site cavity, there is a second 
glycopeptide molecule bound on the surface of the protein (not shown in Figure 6.2C).  
The location of the second teicoplanin aglycone in the crystal is likely not biologically 
relevant.  Instead, it appears to mediate crystal contacts between symmetry partners.  A 
stretch of electron density, large enough to contain four residues, is located in the D-ala-
D-ala binding cleft of the second aglycone.  Although it is presumed that this stretch of 
residues comes from the N-terminal vector derived His6-tag of an adjacent symmetry 





Teg12 sulfates the hydroxyl on the dihydroxyphenyl glycine at position 3 of the 
teicoplanin aglycone (Figure 6.2C, red arrow).  In an alignment of the binary and ternary 
structures, this hydroxyl is 16.4 Å from where the sulfate of PAPS would be and there is 
significant overlap between the C-terminus of the glycopeptide and PAP (Figure 6.7).  
Before the sulfonation reaction can proceed, there must be a substantial conformational 
rearrangement in the active site.  In the binary structure, the interaction of the 
glycopeptide with Arg 101 appears to preclude the substrate from shifting to 
accommodate PAPS or from its shifting into the vicinity of His67.  Arg101 makes  
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Figure 6.7)  A composite of the active site from the Teg12 binary and ternary structures.  PAPS was 
modeled into the ternary structure in place of PAP.  In this aligned view, PAPS and teicoplanin aglycone 
would not be able to occupy their respective positions simultaneously, as there would be strong clashes 
between the two substrates.  Residue 3 of the teicoplanin aglycone, the site of sulfation, is more than 16 
angstroms from the sulfate of PAPS when the ternary and binary structures are overlapped.  A substantial 
rearrangement of teicoplanin aglycone within the active site would have to occur in order for sulfation to 
proceed by the proposed in-line attack mechanism.  The positions of Arg101 in the binary (green) and 
ternary (tan) structures appear to preclude the movement of teicoplanin aglycone towards His67.  Arg101’s 
position in the context of the apo structure (grey) creates a more open active site, where the aglycone could 
pivot towards His67 more easily. 
 
mutually exclusive contacts with the substrates present in the binary and ternary 
structures.  In the binary structure it is inserted into the peptide core and hydrogen bonds 
with residues 1 and 7, while in the ternary structure it forms a key salt bridge with the 3-
phosphate of PAP.  If, when both substrates are present in the active site, Arg101 were to 
adopt the conformation seen in the apo structure, the glycopeptide would largely be free 
 225 
to move out of the PAPS binding pocket and towards His67.  By pivoting towards His67, 
the glycopeptide would occupy the same general location that substrates bind in 
eukaryotic sulfotransferases (Allali-Hassani et al., 2007), and it would also be positioned 
so that it could interact with all three variable loops. 
The movement the glycopeptide must undergo to reach the PAPS sulfate traces a 
path similar to that which the GHL helix undergoes when it bends.  This conformational 
rearrangement may serve not only as a mechanism to allow large glycopeptide substrates 
into the active site, but it could also play a role in positioning a glycopeptide for catalysis 
once it enters the active site.  Alanine exchange mutagenesis of residues found on both 
the lower glycopeptide associated face (E206A, R207A, and R214A) and the upper 
solvent exposed face of the helix (E212A) led to decreases in substrate conversion.  
Residues around the entire helix likely make key contacts with the glycopeptide at 
different points in time as a result of the rotation in the helix as it bends.  In fact, all 
residues that contact the glycopeptide in the binary structure face out from the active site 
cavity in the ternary structure.  One alanine exchange mutant, R248A, resulted in a two-
fold increase in activity.  R248, along with R214 of the GHL helix, and a mediating water 
molecule, forms a cage-like enclosure over the top of the glycopeptide (Figure 6.6).  
Introduction of an alanine side chain at this position would open up the back side of the 
active site to the solvent, and could provide substrates in the active site more room for 
positional rearrangement.  The sequence of the GHL helix is conserved throughout the 
TEG sulfotransferases and a large portion of it is also conserved in StaL.  The mechanics 
of the conformational change from the straight to bent structures may therefore be 
conserved throughout this family of finishing enzymes. 
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Sequence and structural similarities between eukaryotic and prokaryotic 
sulfotransferases indicate that all members have likely arisen from one common ancestor.  
In eukaryotic structures the loop that would correspond to the V3 loop of the GHL 
behaves in much the same way as it does in Teg12; it is disordered in apo structures and 
associated with PAP and the substrate in co-crystal structures (Allali-Hassani et al., 
2007).  The open active site conformation that results from the straightening of the GHL 
helix was not observed in previous StaL structures.  While a GHL-like helix-loop region 
is present in eukaryotic sulfotransferases, the helix from these structures does not appear 
to exhibit the same conformational rearrangements from a single straight helix to two 
helices with a bent conformation during substrate binding as it does in Teg12.  At over 
1000 Daltons, glycopeptides are significantly larger than the substrates used by most 
eukaryotic sulfotransferases.  The increased conformational plasticity that results from 
the ability of the GHL helix to easily flex may help TEG-like sulfotransferases 
accommodate larger substrates.  
In addition to the conformational flexibility seen in the V3 loop, both the V1 and 
V2 loops adopt different conformations in this series of structures, suggesting they could 
easily reorganize to accommodate an incoming glycopeptide substrate.  The sequence 
differences seen between Teg12, 13, and 14 suggest that these three short variable 
regions likely control the selection and orientation of the glycopeptide substrate bound in 
the active site.  Systematically altering the residues found in the three TEG variable 
regions may provide a means to generate new glycopeptide finishing enzymes that sulfate 
a broader collection of glycopeptide congeners than is currently possible with the small 
number of sulfotransferases that have been identified naturally.  The sulfated teicoplanin 
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aglycone derivatives produced by the native TEG sulfotransferase retain potent in vitro 
antibacterial activity (Banik and Brady, 2008).   
The cloning and characterization of biosynthetic gene clusters derived from 
uncultured bacteria provides a means to access both novel small molecules and new 
biosynthetic enzymes.  Teg12 is one of the first enzymes discovered using culture 
independent methodologies to be characterized structurally, and the Teg12-teicoplanin 
aglycone co-crystal structures are the first examples of a substrate complexed with a 
member of this family of glycopeptide finishing enzymes.  This series of Teg12 
structures provides key insights into how sulfotransferases might be engineered to 
generate additional anionic glycopeptides that could be evaluated against clinically 










Materials and Methods 
 
Teg12 Expression and Purification 
Teg12 was cloned and expressed as previously described (Banik and Brady, 
2008).   Briefly, teg12 was amplified (30 cycles of 95 °C for 30 s, 60 °C for 30 s, and 72 
°C for 90 s; FailSafe system from Epicentre) from eDNA cosmid clone D30 using the 
following primers: Teg12FWD(BclI):GCGCTGATCAATGAACGGAATTCGATGG, 
Teg12REV(HindIII):GCGCAAGCTTTCCTTAACCGGCATACCCGTA.  Restriction 
enzyme sites used for cloning are shown in bold.  The resulting product was doubly 
digested with BclI and HindIII and subsequently ligated into pET28a, which had been 
BamHI/HindIII doubly digested.  The resulting construct was then transformed into E. 
coli BL21(DE3) for protein expression.  Expression cultures were grown to OD600=0.6, 
followed by IPTG induction, and overnight growth at 20 °C.  The culture was pelleted by 
centrifugation (3,200 x g for 30 min), the supernatant was discarded, and the cell pellet 
was resuspended in 40 mL lysis buffer (50 mM HEPES, pH 7.5, 0.5 M NaCl, 5% 
(vol/vol) glycerol, 20 mM imidazole, pH 8, 10 mM β-mercaptoethanol and 0.5% 
(vol/vol) Triton X-100).  The resuspended cell pellet was lysed by sonication, and the 
insoluble portion was removed by centrifugation (15,000 x g for 30 min).  The cleared 
cell lysate was incubated with 1 mL Ni-NTA resin for 15 min.  The slurry was loaded 
onto a column, allowed to empty by gravity flow, washed with 40 mL lysis buffer, and 
finally washed with 40 mL wash buffer (50 mM HEPES, pH 7.5, 0.5 M NaCl, 5% 
(vol/vol) glycerol, 20 mM imidazole, pH 8.0, and 10 mM β-mercaptoethanol).  The 
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protein was eluted by the addition of 15 mL of elution buffer (50 mM HEPES, pH 7.5, 
0.5 M NaCl, 5% (vol/vol) glycerol, 125 mM imidazole, pH 8, and 10 mM β-
mercaptoethanol).  No attempt was made to remove the vector derived His6-tag, resulting 
in a Teg12 protein plus 34 additional residues N-terminal to the start methionine.  Protein 
was concentrated using Vivascience Vivaspin 30,000 MWCO ultrafiltration 
concentrators, and was buffer exchanged 3 times into protein buffer (200 mM NaCl, 20 
mM HEPES, pH 7.5, 5% glycerol, and 1 mM DTT).  
 
Teg12 Crystallization 
Concentrated protein was centrifuged at 14,000 rpm (4 °C, 30 min) in a 
microcentrifuge to remove any insoluble material prior to crystallization.  All crystals 
were grown using the hanging drop vapor diffusion method.  Initial Teg12-apo crystals 
were obtained by mixing 1 µl of protein (7.5 mg/ml in protein buffer) with 1 µl of 
reservoir solution (1.0 M sodium citrate, 0.1 M sodium cacodylate, pH 6.5, JCSG core 
III-48, Qiagen) over a 500 µl reservoir.  Blade-like crystals grew overnight at 22 °C and 
reached a maximal size of 400 µm X 50 µm X 20 µm in approximately one week.  To 
improve crystal thickness, Teg12-apo crystals were optimized by microseeding, in 
addition to mixing 1 µl of protein at 7.5 mg/ml with 0.5 µl of reservoir and 0.5 µl of 
Silver Bullets™ reagent 29 (Hampton Research).  A component of the Silver Bullets™ 
screen, aspartame, was modeled into the PAPS binding site of one of the monomers of 
the Teg12 dimer.  Crystals were soaked in a 20 µl drop containing reservoir solution plus 
10% ethylene glycol.  The drop was allowed to dehydrate by exposure to open air at 
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room temperature for approximately 5 hours before flash cooling the crystals in liquid 
ethane.   
Teg12-ternary crystals were co-crystallized at 4 °C in the presence of 2 mM PAP 
and 1 mM teicoplanin aglycone.  Teg12 was first concentrated to 20 mg/ml in protein 
buffer.  The protein was then diluted 1:1 with 50 mM CHES, pH 9.1, 2 mM teicoplanin 
aglycone, 4 mM PAP, achieving a final concentration of 10 mg/ml Teg12 in 0.5X protein 
buffer, 25 mM CHES, pH 9.1, 1 mM teicoplanin aglycone, 2 mM PAP.  1 µl of protein 
was mixed 1:1 with reservoir solution (0.2 M ammonium acetate and 20% w/v PEG 
3350, JCSG, core I-25, Qiagen).  Crystals appeared in 2-3 days and grew to a maximal 
size of 100 µm X 50 µm X 50 µm in approximately 1 week.  These crystals were of an 
irregular chunk-like morphology and had cracks throughout.  Crystals were cryo-
protected by quickly dunking in reservoir solution plus 15% ethylene glycol and were 
flash cooled in liquid nitrogen. 
Teg12-binary crystals were co-crystallized at 4 °C in the presence of 1 mM 
teicoplanin aglycone.  Similar to Teg12-ternary crystallization, the protein was first 
concentrated to 20 mg/ml in protein buffer, then diluted to 10 mg/ml with 50 mM CHES, 
pH 9.1, 2 mM aglycone  (final 0.5X protein buffer, 25 mM CHES, 1 mM teicoplanin 
aglycone).  1 µl of protein solution was mixed with 1 µl of reservoir solution (2.0 M 
sodium formate, 0.1 M sodium acetate, pH 4.6, JCSG core III-85, Qiagen).  Cubic 
crystals grew between 2 and 3 weeks, and were approximately 50 µm X 50 µm X 50 µm.  
Crystals were soaked in 6.0 M sodium formate, 0.1 M sodium acetate, pH 4.6, 1 mM 
teicoplanin aglycone overnight, prior to flash cooling in liquid nitrogen. 
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Data Collection and Structure Solving   
All data sets were reduced and scaled using the HKL2000 package (Otwinowski 
and Minor, 1997).  Data for Teg12-apo crystals were collected at the NSLS, beamline 
X29A.  All but one of the crystals screened diffracted poorly to approximately 4 Å 
resolution.  The crystal from which the 2.91 Å dataset was collected rotated briefly out of 
the cryostream, and thereby had gone through a room temperature annealing cycle of 
several seconds.  Diffraction from this crystal was dramatically improved compared with 
other crystals taken from the same drop.  Data for Teg12-apo was reduced and scaled in 
space group C2221.  Phase information was obtained by molecular replacement using the 
program Phaser and StaL (GenBank accession number AAM80529, PDB code 2OV8), 
devoid of all flexible loops, as the search model (McCoy et al., 2007).  The initial 
molecular replacement model was refined against the Teg12-apo dataset using rigid body 
refinement in Refmac (Murshudov et al., 1997).  Additional features of the map were 
enhanced through density modification, and 2-fold ncs averaging in CNS (Brunger, 2007; 
Brunger et al., 1998).  The model was rebuilt manually using the program Coot (Emsley 
and Cowtan, 2004).  Full restrained refinement was carried out using the 
translation/libration/screw model in Refmac, with the addition of hydrogen atoms, 
converging to a final Rwork and Rfree of 21.96 and 27.19, respectively (Winn et al., 2001).  
NCS restraints were not used during refinement.  The final model comprises residues 1-
129, 136-203, and 251-285 for monomer A, and 1-27, 42-128, 137-210, 247-285 for 
monomer B.  The Teg12-apo model was used as a molecular replacement model for all 
subsequent structures. 
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Teg12-ternary and Teg12-binary data sets were collected at the APS, microfocus 
beamline 24-IDE.  Teg12-ternary data was reduced and scaled in space group P212121.  
Teg12-binary was scaled in space group I212121.  The crystal structure of glycopeptide 
aglycone A-40926 was used as a starting point to generate a restraint definition file for 
teicoplanin aglycone using the program Phenix Elbow (Schafer et al., 1996).  Geometry 
optimization was achieved using the semi-empirical quantum mechanical AM1 method.  
Teg12-binary and Teg12-ternary models were refined using the translation/ 
libration/screw model in Phenix Refine to a final Rwork and Rfree of 17.30 and 22.61, and 
17.12 and 22.47, respectively (Adams et al., 2002).  The final Teg12-binary model 
comprises residues 1-129, 135-216, and 247-285.  The final Teg12-ternary model 
comprises residues 1-215, 220-224, and 231-285 for monomer A, and residues 1-129, 
136-224, and 240-285.  All structures were validated using the Molprobity server from 
the Richardson laboratory at Duke University (Davis et al., 2007). 
 
Site-Directed Mutagenesis   
Teg12 point mutants were generated using the “megaprimer” method, with slight 
modifications (Sarkar and Sommer, 1990).  Oligonucleotide primers were designed for 
each mutant (Table 6.2), and a megaprimer was generated by PCR amplification from the 
Teg12/pET28a construct using the Pfx Accuprime System (Invitrogen), the relevant 
mutant oligonucleotide primer, and either the T7 promoter (for mutations at residues 9-
108) or the T7 terminator (for mutations at residues 167-251) as the second 
oligonucleotide primer, (30 rounds of amplification: 95 °C for 30 s, 55°C for 30 s, 68 °C 
for 30 s).  The full length mutant Teg12 gene was amplified from the Teg12/pET28a 
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construct, using the megaprimer, which then contained the bases that code for the specific 
mutant residue, and either the T7 terminator (for mutations at residues 9-108) or the T7 
promoter (for mutations at residues 167-251) as the second oligonucleotide primer (30 
rounds of amplification: 95 °C for 30 s, 55 °C for 30 s, 68 °C for 80 s).  Full-length 
mutant amplicons were then sequentially digested with BamHI and HindIII, and 
subsequently ligated into BamHI/HindIII doubly digested pET28a.  Ligated constructs 
were transformed into E. coli EC100 (Epicentre), and sequenced to identify successfully 
mutated constructs.  Mutant constructs containing the desired point mutation were then 
transformed into E. coli BL21 (DE3) for protein expression.  
 
Mutant Teg12 Expression and Purification   
Mutant proteins were expressed and purified in a manner similar to the native 
Teg12, except on a reduced scale.  100 mL overnight expression cultures were pelleted 
and resuspended in 4 mL lysis buffer.  After sonication to lyse the cells, the crude lysates 
were centrifuged to remove insoluble material (10 min at 15,000 x g).  The cleared 
lysates were incubated with 100 µl Ni-NTA resin for 15 min.  The slurry was then loaded 
onto a column, allowed to empty by gravity flow, washed with 4 mL lysis buffer, 
followed by a second wash with 4 mL wash buffer.  The protein was eluted by the 
addition of 1.5 mL elution buffer.  All Teg12 mutants used in activity assays appeared to 





Teg12 Activity Assays  
All soluble Teg12 mutants were assayed for activity using the teicoplanin 
aglycone as a substrate.  50 µL reactions were run in duplicate, as follows: 15 mM 
HEPES, pH 7.5, 1 mM 3’-phosphoadenosine-5’-phosphosulfate (PAPS), 0.1 mM DTT, 
1.2 mM teicoplanin aglycone (in DMSO), and 500 ng purified protein in elution buffer.  
Reactions were carried out at 30 °C for each of the four time points (10, 15, 20, 25 min), 
followed by heat inactivation at 99 °C for 10 min, and a further 10 min in an ice water 
bath.  Vmax and Km values were determined under the same reaction conditions using the 
teicoplanin aglycone as substrate (5 mM to 100 mM).  25 µL of each reaction was run on 
a Waters analytical HPLC system (C18 (4.6 x 150 mm)).  A linear gradient (1.5 ml/min) 
was run from an initial condition of 95:5 20 mM ammonium acetate:acetonitrile to 70:30 
20 mM ammonium acetate:acetonitrile over twenty minutes.  The area under the UV peak 
(Diode Array, 240 nm-400 nm) was determined for both the monosulfated product and 
the teicoplanin aglycone substrate at each time point. The percent substrate conversion 
for duplicate time points was averaged.  The slope of the graph derived from the four 
time points for Teg12 and each mutant was then determined.  Relative activity of each 









 Teg12 apo Teg12 ternary Teg12 binary 
Data collection    
Space group C2221 P212121 I212121 
Cell dimensions    
a, b, c (Å) 79.39, 126.09, 
145.13 
77.12, 78.56, 100.54 66.12, 80.15, 132.94 
α, β, γ (º) 90, 90, 90 90, 90, 90 90, 90, 90 
No. reflections 
(observed/unique) 
55,339/15,372 177,647/38,619 66,588/16,647 
Resolution (Å) 50.00 – 2.93 
(3.03 – 2.93) 
50.00 – 2.05 
(2.12 – 2.05) 
50.00 – 2.28 
(2.36 – 2.28) 
Rmerge/Rsym 0.063 (0.396) 0.084 (0.464) 0.079 (0.542) 
I/σI 19.10 (2.04) 16.43 (2.62) 15.50 (2.17) 
Completeness (%) 95.5 (98.0) 97.7 (96.6) 99.9 (100.0) 
Redundancy 3.6 (3.6) 4.6 (4.6) 4.0 (4.1) 
Refinement    
Resolution (Å) 72.57 – 2.91 32.95 – 2.04 34.32 – 2.27 
No. reflections 14,562 36,951 15,761 
Rwork / Rfree 21.96 / 27.19 17.12 / 22.47 17.30 / 22.61 
No. atoms 3,628 4,820 2,222 
  Protein atoms 3,550 4,247 1,945 
  Ligand/ion 44 233 170 
  Waters 34 340 95 
B factors 36.2 35.7 43.0 
  Protein 35.9 35.6 40.3 
  Ligand/ion 61.7 30.1 69.5 
  Water 39.1 40.5 47.4 
Solvent Content 52.4 40.9 46.5 
Rms bond (Å) 0.014 0.007 0.006 
Rms angle (°) 1.495 1.183 1.038 
Rotamer Outlier 
(%) 




94.6 / 0.6 98.7 / 0.0 100.0 / 0.0 
PDB code 3MGC 3MGB 3MG9 
 



































































S9A N/A M232A 74 R101A 29 
K12A 0 K233A 79 S106A 92 
T16A 0 G234A 82 R107A 82 
W17A N/A G235A 100 D108A 82 
K65A 61 P236A 73 Y167A N/A 
H67A N/A G238A 56 K171A 69 
H67E N/A A239R 37 E206A 0 
H67Q 0 R240A 48 R207A 79 
R90A N/A P241A 0 E210A 97 
S98A 27 Q242A 64 E212A 26 
    K213A 99 
    R214A 67 
    R248A 196 
    Q251A 41 
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CHAPTER 7 




Vancomycin and teicoplanin are glycopeptide antibiotics used clinically to treat 
many gram-positive bacterial infections, including methicillin resistant Staphylococcus 
aureus (MRSA) (Nicolaou et al., 1999; Wolter et al., 2007).  During their biosynthesis 
each member of this family of antibiotics is functionalized by a unique set of finishing 
enzymes that includes glycosyl, acyl, methyl and sulfotransferases (Nicolaou et al., 1999; 
Wolter et al., 2007).  The discovery of new glycopeptide congeners has slowed in recent 
years as it has become increasingly difficult to identify new biodiversity from which 
novel molecules might be characterized.  The vast majority of bacteria present in nature 
remain recalcitrant to culturing and therefore they represent a potentially novel source of 
small molecules (Rappe and Giovannoni, 2003).  Although metabolites produced by 
these bacteria cannot be characterized using standard microbiological methods, it is 
possible to extract DNA directly from environmental samples and analyze this DNA for 
sequences that encode the biosynthesis of novel natural products (Brady et al., 2009).  In 
a survey of DNA extracted from desert soil, we uncovered a biosynthetic gene cluster 
(the TEG gene cluster) that is predicted to encode the biosynthesis of the first 
polysulfated glycopeptide congeners (Banik and Brady, 2008). 
The TEG gene cluster contains three closely related sulfotransferases (Teg12, 13, 
and 14) that sulfate teicoplanin like glycopeptides at three unique sites.  Over 150 
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different glycosylated, halogenated, and alkylated glycopeptide congeners have been 
characterized from cultured bacteria, yet only three sulfated congeners have been 
identified from studying these same microbes (Nicolaou et al., 1999).  Although anionic 
glycopeptides have rarely been reported as natural products, the semisynthetic phosphono 
congener, telavancin, recently received FDA approval (Higgins et al., 2005; Stryjewski et 
al., 2005).  The enzymatic synthesis of anionic glycopeptides could provide a facile 
means to access additional anionic congeners.   
In the previous chapter we presented three crystal structures of the 
sulfotransferase Teg12 in its apo form, in a binary complex bound to the teicoplanin 
aglycone, and in a ternary complex bound to teicoplanin aglycone and the co-substrate 
byproduct, 3'-phosphoadenosine 5'-phosphate (PAP).  These studies provided insight into 
the sulfotransferase mechanism employed by this class of finishing enzymes.  In the 
current chapter we present an apo structure of the third sulfotransferase from the TEG 
pathway, Teg14.  Teg14 displays many of the structural characteristics found in other 
members of this class of enzymes.  We discuss the Teg14 structure itself and make 










Overall Structure and Comparison with Teg12 and StaL 
N-terminally His6-tagged Teg14 was affinity purified using nickel NTA resin and 
crystallized without the need for further purification.  The structure was solved to 2.7 Å 
resolution by molecular replacement using the Teg12 ternary structure as a search model.  
The overall structure closely resembles that of Teg12 (82.9 % sequence identity) and of 
StaL (52.2% sequence identity) (for a sequence alignment, see Chapter 6, Figure 6.2).  
StaL is a related sulfotransferase involved in the biosynthesis of the monosulfated 
glycopeptide congener A47934 (Shi et al., 2007).  Sulfotransferases from this family are 
biologically active as dimers.  Teg14 dimerizes in the same manner as Teg12 and StaL.  
The Teg14 crystallographic asymmetric unit is comprised of a single monomer; the dimer 
is reconstituted by crystallographic symmetry.  The dimer interface consists of a 
symmetrical interaction between a short helix-loop motif from one monomer and the 
same helix-loop motif from the other monomer.  As seen in Teg12, there is a key 
hydrogen bond between the carbonyl oxygen of Gly51 at the end of the helix from one 
monomer and the backbone nitrogen of Val74 of the other monomer.  The side chain of 
Glu65 from one monomer is also within hydrogen bonding distance of the side chains of 
Thr66 and Lys65 of the opposite monomer.  Additional hydrophobic contacts exist 
between the two interface helices and help to stabilize the Teg14 dimer.  In the Teg14 











Figure 7.1 (adjacent page)  (A) Overview of the 2.7 Å crystal structure of Teg14.  The model is colored N- 
to C-terminally from blue to red.  Regions of disorder are represented with grey dots, with the number of 
disordered residues indicated.  (B) The same view as A, but with the protein colored grey in order to 
accentuate the regions of sequence variability, V1 (blue) and V2 (red).  V3, which is encompassed by the 
29 amino acid disordered region, was not visible in the structure.  Also shown in orange is the GHL helix, 
which adopts the bent conformation as in the Teg12 ternary and StaL structures.  (C) An alternate view of 
(A).  The molecules of CHES and glycerol in the active center are shown as sticks. 
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As with other sulfotransferases in this family, Teg14 consists of a single α/β 
globular domain composed of a parallel 
beta sheet core surrounded by alpha 
helices (Figure 7.1).  The beta sheet core 
contains four strands.  Teg14 contains the 
three sequence variable loop regions V1 
(Met37-Glu43), V2 (Arg127-Gly134), 
and V3 (Gln215-Pro233) we identified in 
Teg12.  V1, along with V2 and V3, has 
been hypothesized to play a role in 
substrate recruitment and orientation of 
the substrate within the active site cavity.  
The region Gly28-Glu43, which 
encompasses V1, adopts three highly 
divergent conformations in the Teg12 
structures, underscoring the 
conformational flexibility of these 
residues.  However, the observed 
conformation of this region in the current 
Teg14 structure, where a greater 
proportion of the region is helical 
(Trp34-Val40), may be preferred, as it is 
also observed in the Teg12 ternary 
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complex, as well as in the three different structures of StaL (Figure 7.2). 
Met128-Gly132 of V2 and a large region (Gln215-Asp240) that fully 
encompasses V3 could not be modeled in the electron density map and are presumed to 
be disordered.  The V3 loop is part of a larger motif we have termed the GHL 
(glycopeptide helix loop), and is believed to be the main determinant of substrate 
specificity.  N-terminal to V3 is the helical portion of the GHL.  The Teg14 GHL helix 
adopts the bent conformation observed in the Teg12 ternary structure and StaL structures, 
where there is also an absence of a glycopeptide in the active site (Figure 7.2).  We have 
proposed that unwinding of the GHL helix from a straight to bent conformation may help 
to bring substrate into the active site pocket.  Cys201 of the GHL helix makes a disulfide 
cross-link to Cys20 of helix 1.  This disulfide occurs exactly at the point where the GHL 
helix unwinds from the straight to the bent conformation (compare the Teg12 binary 
structure with the other structures in Figure 7.2).  The portion of the GHL helix that 
displays conformational diversity is directly C-terminal to Cys201.  It is unclear whether 
this disulfide plays a functional role, as Cys201 corresponds to Ser203 in Teg12.  
However, we have suggested that the lack of a disulfide in Teg12 could explain why the 
region C-terminal to Ser203 was disordered in the Teg12 apo structure, as the lack of a 
disulfide could impart more flexibility to the protein.  A disulfide is also present at this 










Figure 7.2 (adjacent page)  Comparison of Teg12, Teg14, and StaL crystal structures.  (A) Teg12 apo, (B) 
Teg12 binary complexed with the teicoplanin aglycone, (C) Teg12 ternary complexed with PAP and the 
teicoplanin aglycone, (D) StaL apo, (E) StaL complexed with PAP, (F) StaL sulfate, (G) Teg14 apo.  
Regions of sequence variability are colored blue (V1), red (V2), and green (V3).  The flexible GHL helix is 
colored orange.  Residues 28 to 43 (Teg12, Teg14, and StaL) encompass V1 (blue).  The remainder of 













The loop region (Met102 to Asp108) connecting helices 5 and 6 showed a lack of 
well ordered electron density, and we were unable to place residues in this portion of the 
model.  These residues were ordered in our Teg12 structures, ordered in the StaL-PAP 
and StaL-sulfate structures, but disordered in the StaL-apo structure.  Electron density 
picked up again at Asp109, though the region Asp109 to Phe116 displayed a high degree  
of flexibility, as evidenced by the unusually high temperature factors (above 100) and 
lack of side chain information for several residues.  The N-terminal vector derived-tag, 
portions of which could be modeled in all three Teg12 structures, is entirely disordered in 
Teg14. 
 
The Teg14 Active Site 
Teg14 was crystallized in its apo form.  However, during refinement two regions 
of prominent electron density were observed in the active site cavity.  One of these 
regions was easily assignable to a molecule of CHES, a buffer component of the 
crystallization solution.  The CHES molecule is oriented in much the same way as PAP is 
in the Teg12 ternary and StaL-PAP structures.  The majority of the residues important for 
binding PAP also coordinate CHES (Figure 7.3A).  Interactions between CHES and the 
protein are primarily mediated through Van der Waals contacts, though there are several 
key hydrogen bonds.  The hydroxyl oxygen of Tyr165 (Tyr167 in Teg12 and Tyr163 in 
StaL) hydrogen bonds with the nitrogen of CHES.  This tyrosine is in the same general 
vicinity in the Teg12 and StaL structures, but is located too far from PAP to hydrogen 
bond with either the 3’-phosphate or oxygen from the ribose.  Mutation of Tyr167 in 
Teg12 renders the protein insoluble, implicating a role for it in protein stability.  
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Backbone nitrogens from Ala13, Gly14, Asn15, and Thr16 of the 5’-phosphosulfate-
binding motif (5’-PSB), and from Trp17 are all within contact distance of the sulfate 
from CHES.  The cyclohexyl ring roughly parallel stacks with Trp17, mimicking how the 
adenine of PAP stacks with Trp17 in Teg12 and StaL.  Leu203 and Met206 (Leu205 and 
Met208 in Teg12 and Leu198 and Met201 in StaL) of the GHL helix cover the top of the 




Figure 7.3)  A comparison of the Teg14 (A) and Teg12-PAP (B) active sites.  Several of the key residues 
that contact PAP in Teg12 also coordinate CHES in Teg14.  
  
The second region of electron density that was enhanced during refinement 
proved more difficult to assign.  This density is in the immediate vicinity of the hydroxyl 
of Ser98, a residue which is part of the 3’-phosphate-binding motif (3’-PB) and important 
for binding PAPS.  Several small molecules and ions were modeled into the density and 
subjected to refinement in order to identify the best fit.  We initially thought that sulfate 
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could be correct, as the density was somewhat spherical and sulfate could have been 
present in the crystallization buffer from the hydrolysis of CHES.  However, when sulfate 
was placed in the model and refined, the resulting b-factors were in the 140 range.  The 
b-factor for the adjacent side chain oxygen from Ser98 is 90.5.  Imidazole was also 
attempted and gave b-factors around 90, but did not fit the density well.  A chloride ion 
gave the lowest b-factor of 82, but did not satisfy all of the density.  Ultimately glycerol 
was chosen as the ligand that best fit the density, and gave refined b-factors of around 90 
(Figure 7.3A).  Only three residues make significant contacts with the putative glycerol, 
Lys12, Arg90, and Ser98.  Of these, only Ser98 is within hydrogen bonding distance.  A 
large portion of the glycerol is exposed to the solvent region.  Although a water molecule 
is within 3.3 Å of a glycerol oxygen, the solvent overall in this region is poorly ordered.  
This fact could explain the high temperature factors observed for glycerol.  In its position 
around Ser98, the glycerol appears to act as a surrogate for the 3’-phosphate of PAPS.  A 
StaL-sulfate structure has a sulfate modeled in the location where we have modeled 
glycerol. 
Teg-like sulfotransferases are thought to catalyze the sulfonation reaction through 
an in-line attack mechanism by utilizing histidine as a general base.  In the Teg14 
structure, His67 is positioned approximately 7 Å from the sulfate of the ordered molecule 
of CHES (Figure 7.4).  A well ordered water molecule occupies the intermediate space 
where the sulfate from PAPS would be, and is within hydrogen bonding distance to 
His67.  Water also occupies this space in the Teg12 binary and ternary structures (not in 
Teg12-apo), and in the StaL apo structure (not in StaL-PAP).  A sulfate takes the place of 
the His67 water in the StaL-sulfate structure.  In all three Teg12 structures, all three StaL 
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structures, and the Teg14 structure, the basic ε nitrogen of the imidazole ring from His67 
is positioned facing Ser9 and within hydrogen bonding distance.  His67 is thought to 
abstract a proton from Ser9 during the sulfonation reaction. 
 
 
Figure 7.4)  The relation of CHES to the proposed active residues His67 and Ser9 in the Teg14 active site.  
The side chain of His67 is approximately 7 Å from the sulfate of CHES.  Water molecules are shown as 











One of the goals of synthetic biology is to engineer metabolic pathways and 
individual proteins in order to generate small molecules that are not accessible to 
synthesis through traditional organic chemistry (Keasling, 2008).  We initially embarked 
on structural studies of the TEG pathway sulfotransferases not only to improve our 
understanding of the sulfation mechanism, but also with the idea of eventually 
engineering this group of enzymes to accept a broader range of glycopeptide scaffolds 
and/or co-substrates.  The TEG gene cluster is predicted to encode the biosynthesis of a 
heptapeptide (hydroxyphenylglycine (Hpg)-betahydroxytyrosine (Bht)-
dihydroxyphenylglycine (Dpg)-Hpg-Hpg-Bht-Dpg) that is oxidatively cross-linked into 
the four macrocycles seen in teicoplanin-like glycopeptides.  This TEG derived, 
oxidatively cross-linked heptapeptide skeleton only differs from the teicoplanin aglycone 
by the substitution of Bht for Tyr at the 2nd position in the peptide core.  We have 
already shown that the Teg sulfotransferases can utilize the teicoplanin aglycone as a 
substrate (Banik and Brady, 2008).  Each Teg enzyme sulfates teicoplanin at one of three 
different positions to produce a unique monosulfated teicoplanin derivative.  In 
combination, two Teg enzymes can produce 3 different disulfated teicoplanins, and when 
all three Teg enzymes are used in conjunction, a trisulfated teicoplanin is produced (see 
Chapter 6, Figure 6.1).  It is possible that the Teg sulfotransferases can accept, or through 
precise mutagenesis be engineered to accept glycopeptide scaffolds other than their 
predicted substrate and teicoplanin.  The Teg12 binary structure shows that a large 
portion of teicoplanin is exposed to solvent.  One could envision a teicoplanin-like 
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derivative, with additional prosthetic groups attached to either the Dpg at position 3 or 
the Hpg at position 4, that Teg12 could still accommodate in the active site (Figure 7.5). 
 
Figure 7.5)  A surface rendering of the Teg12 binary structure complexed with the teicoplanin aglycone.  
Residues of the aglycone are labeled, and the * indicate residues whose side chains face the open solvent.  
Active site residues of Teg12 are shown as sticks and colored yellow. 
 
Regarding the co-factor, from our structural studies of Teg12 and Teg14, it is 
clear that a number of co-substrates in addition to PAPS are potentially accessible to the 
active site (aspartame in the case of Teg12 and CHES in the case of Teg14).  Whether co-
substrates containing anionic substituents other than sulfate could be used to add 
functional groups to glycopeptide scaffolds will require experimentation.   
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Attempts to obtain co-crystals of Teg14 with the teicoplanin aglycone, the 
monosulfated teicoplanin products of Teg12 and Teg13, or the disulfated teicoplanin 
product of Teg12 and Teg13 have to date been unsuccessful.  Therefore, at present we do 
not know the precise orientation of teicoplanin (either the non-sulfated or various sulfated 
forms) in the Teg14 active site.  However, we do know that Teg14 sulfates the hydroxyl 
from the Hpg at position 4 of teicoplanin (Banik and Brady, 2008), and therefore that 
residue 4 must at some point in the reaction cycle be in the direct vicinity of the active 
site His67.   
Another possibility, although unlikely, is that the co-substrate PAPS and 
teicoplanin do not occupy the active site simultaneously during the sulfonation reaction.  
The orientation of teicoplanin in the active site of the Teg12 binary structure is most 
likely representative of a biological relevant conformation.  This interpretation of the 
structure is supported by alanine scanning mutagenesis experiments, which demonstrated 
that residues contacting the aglycone, when mutated to alanine, have a deleterious effect 
on product conversion.  However, although the binary conformation is most likely 
biologically relevant, a composite of the Teg12 binary and ternary (bound to PAP in the 
active site) active site indicate that PAP and the aglycone can not occupy their 
crystallized conformations simultaneously, as there would be considerable clashes 
between PAP and the C-terminus of the aglycone.  If PAPS were first to donate a sulfuryl 
group to the protein, producing a sulfo-His intermediate as in the case of bacterial 
arylsulfate sulfotransferases, for example (Malojčić et al., 2008), and then dissociate from 
the protein prior to recruitment of the aglycone to the active site, then the conformations 
of the Teg12 binary and ternary structures would not be forced to co-exist. 
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Materials and Methods 
 
Cloning Teg14 From an Environmental DNA Library 
Teg14 (Sulf3) was pcr amplified (30 cycles of 95° C for 30s, 60° C for 30s, and 
72° C for 90s; FailSafe system from Epicentre) from eDNA clone D30 with the following 
forward and reverse primers:  Sulf3For (BclI):  GCGCTGATCAATGAACGGTATTCG 
ATGGATC, and Sulf3Rev (HindIII):  GCGCAAGCTTACAATCCGCCCGTTAGCC 
GGC.  The amplified product was doubly digested with BclI/HindIII and ligated into 
BamHI/HinDIII digested pET28a (Banik et al., 2008). 
 
Protein Expression and Purification 
pET28a-Teg14 was transformed into E. coli BL21 (DE3) for protein expression.  
Small-scale overnight cultures were used to inoculate (1:1,000 dilution) 1-L cultures of 
LB plus 50µg/ml kanamycin.  The cultures were grown at 37° C until the density reached 
an OD600 of 0.6, at which point the temperature was reduced to 20 °C.  After 1 h, protein 
expression was induced with 0.5mM IPTG.  After 14-16 h the cultures were harvested by 
centrifugation (3,200 x g for 30 min).  The cell pellet was resuspended in 40 ml of lysis 
buffer (50 mM HEPES, pH 7.5, 0.5 M NaCl, 5% (vol/vol) glycerol, 20 mM imidazole, 
pH 8, 10 mM β-mercaptoethanol, and 0.5% Triton X-100) and the cells were lysed by 
sonication.  Crude cell lysates were centrifuged at 25,000 x g for 30 min, and the 
supernatants were then incubated for 15 min (24 °C) with 1 mL of Ni-NTA resin 
(equilibrated with lysis buffer).  After 15 min the slurry was loaded onto a column, 
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washed with 40 mL of lysis buffer, followed by 40 mL of wash buffer (50 mM HEPES, 
pH 7.5 0.5 M NaCl, 5% (vol/vol) glycerol, 20 mM imidazole, pH 8, and 10 mM β-
mercaptoethanol), and finally eluted with 15 mL of elution buffer (50 mM HEPES, pH 
7.5, 0.5 M NaCl, 5% (vol/vol) glycerol, 125 mM imidazole, pH 8, and 10 mM β-
mercaptoethanol).  The eluted protein was collected into 7 ~2 mL fractions.  The highest 
concentrated 2 to 3 fractions, as determined by absorbance at 280 nm, were pooled for 
use in crystallization.  The protein was concentrated to 20mg/mL and buffer exchanged 3 
times into crystallization buffer (20 mM HEPES, pH 7.5, 5% (vol/vol) glycerol, 200 mM 
NaCl, 5 mM DTT) using a 20 mL 30,000 MWCO Vivaspin concentrator (Vivascience).  
No attempt was made to remove the N-terminal His6-tag, resulting in an additional 34 
vector derived amino acids appended to the N-terminus of the Teg14 protein sequence. 
 
Crystallization and X-ray diffraction 
Teg14 at 20mg/mL was screened at 22 °C for crystals using the JCSG suites 
(cores I-IV) from Qiagen.  All screening was performed in 24 well trays (Qiagen) using 
the hanging drop method.  Crystallization drops contained a 1µl:1µl mixture of protein 
and precipitant solutions over a 500 µl reservoir volume.  Three crystals appeared 
overnight in condition JCSG core II, A3 (1.0 M Sodium citrate, 0.1 M CHES, pH 9.5), 
and grew to a maximal size of approximately 300 µM x 300 µM x 300 µM in 4 days.  
Diffraction quality from two of the crystals was impaired while searching for suitable 
cryo conditions.  The third crystal, which was harvested from the crystallization drop 
using a cryoloop (Hampton Research), briefly (<1 min) soaked in reservoir solution plus 
30% glycerol, and flash-cooled directly in a liquid nitrogen cryo stream at 100K, 
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diffracted well beyond 2.5 Å resolution.  These crystals have proven to be irreproducible.  
Diffraction data from the Teg14 crystal was measured using an R-AXIS IV++ area 
detector connected to a Rigaku/MSC MicroMax-007 HF Cu rotating-anode generator 
(wavelength 1.5418 Å) equipped with Varimax confocal Max-Flux optics at The 
Rockefeller University.  The crystal to detector distance was 200mm.  99, 10 min 
exposure images with 0.5° oscillations per frame were collected.  Diffraction data was 
processed and scaled to 2.7 Å using the HKL-2000 package (Otwinowski & Minor, 
1997).  The default values for profile fitting radius, box size, spot radius were used during 
integration.  For scaling, 10 resolution zones were used with an error scale factor of 1.3 
(default).  The error model was adjusted for the individual zones, from zone 1 to 10 as 
follows: 0.05, 0.07, 0.09, 0.10, 0.12, 0.12, 0.12, 0.11, 0.11, and 0.11.  The Teg14 crystal 
belongs to the trigonal space group P3121, with unit-cell parameters a = b = 112.19 Å, c 
= 74.81 Å, α = β = 90.00°, γ = 120.00°.  A single Teg14 monomer, including the 34 
vector derived residues, two molecules of glycerol and a single molecule of CHES (N-
Cyclohexyl-2-aminoethanesulfonic acid) buffer (total molecular weight of 34,822 
Daltons) in the asymmetric unit gave a packing density, VM (Matthews, 1968), of 3.90 
Å3 Da-1, corresponding to a solvent content of 68.43%.  Diffraction data analysis 
statistics are given in Table 7.1.  
 
Structure Determination and Refinement 
The Teg14 structure was solved by molecular replacement with the program 
Phaser (Storoni et al., 2004; McCoy et al., 2005).  The recently reported Teg12 ternary 
structure (Bick et. al., 2010), devoid of all flexible loops and small molecule substrates, 
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was used as a search model.  The ternary structure was chosen as the search model 
because it is the highest resolution structure from the group of three Teg12 structures 
reported.  Teg12 has a sequence identity of 82.9% with Teg14.  Phaser gave a single clear 
solution with a rotational Z score of 13.3, translational Z score of 33.0, and log-likelihood 
gain of 1,278.  No clashes were observed in the solution.  A single Teg14 monomer was 
identified in the asymmetric unit.  Rigid body refinement of the molecular replacement 
solution using Phenix.refine (Afonine et al., 2005) gave an R and Rfree of  0.410 and 
0.415, respectively.  Manual rebuilding of the model using the resulting 2|Fo| - |Fc| and 
|Fo| - |Fc| maps was carried out in Coot (Emsley & Cowtan, 2004).  Multiple rounds of 
restrained refinement were carried out using Phenix.refine, employing the translation-
libration-screw (TLS) protocol and 2 atomic displacement parameter (ADP) groups per 
residue (Winn et al., 2001; Afonine et al., 2007).  Teg14 was partitioned into 15 TLS 
groups as follows: group1-residues 0-12, 83-90, 57,67, and 157-165 (the beta sheet core), 
group2-residues 166-170, group 3-residues 171-186, group 4-residues 187-203, group 5-
residues 204-214, group 6-residues 13-30 and the active site CHES, group 7-residues 31-
42, group 8-residues 43-56, group 9-residues 68-82, group 10-residues 91-101, group 11-
residues 109-127, group 12-residues 133-156, group 13, residues 241-248, group 14-
residues 249-261, and group 15-residues 262-275 (Figure 7.6).  Side chain atoms for 
which there was no observable density were removed from the model.  After all protein 
residues were assigned, the water picking protocol in Phenix.refine was used to identify 
density corresponding to waters.  Several waters were then added manually.  Coot 
identified five of these waters as “unusual”, however manual inspection suggested they 
were reasonably assigned.  Both X-ray to stereochemistry (“optimize wxc”) and X-ray to  
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Figure 7.6)  Teg14 colored according to the groups used for TLS refinement in Phenix.refine.  The groups 
are numbered from 1 to 15 (see the methods section for the residues for each group).  Regions of disorder 
are connected with grey dots, and the number of disordered residues is indicated. 
 
ADP (“optimize wxu”) weights were optimized during the final round of refinement.  
The model converged to a final Rwork and Rfree of 19.55 and 23.56, respectively.  The 
structure was validated using the Molprobity server at Duke University (Davis et al., 
2007), the results of which along with refinement statistics are presented in Table 7.1.  
All figures of the protein model were generated using the program PyMol (Delano 




Data Collection  
   Space Group P3121 
   Unit-cell parameters (Å, °) a = b = 112.03, c = 74.72, α = β = 90.0, γ = 120.0 
   Temperature 100K 
   Matthews coefficient (Å3 Da-1) 3.89 
   Solvent content (%) 68.38 
   Resolution (Å) 25.00 – 2.70 (2.80 – 2.70) 
   Wavelength (Å) 1.5418 
   Rmerge (%) 0.073 (0.494) 
   I/σ(I) 14.6 (2.5) 
   Completeness (%) 95.8 (93.1) 
   Reflections (observed) 39,851 
   Reflections (unique) 14,590 
   Redundancy 2.7 (2.2) 
Refinement  
   Resolution (Å) 22.79 – 2.70 
   Reflections 13,643 
   Rwork/Rfree (%) 19.55/23.56 
   No. monomers/AU 1 
   No. non-H atoms 1,876 
   Protein 1,797 
   Ligand 25 
   Water 54 
B factors (Å2) 59.31 
   Protein 59.19 
   Ligand 73.02 
   Water 57.19 
R.m.s. deviations  
   Bond lengths (Å) 0.004 
   Bond angles (°) 0.805 
   Dihedral angles (°) 14.59 
Molprobity validation  
   Clashscore (All-atom contacts) 20.8 (82nd percentile) 
   Poor rotamers  0.57% (Arg127) 
   Ramachandran outliers 0.00% 
   Ramachandran favored 97.39% 
   Cβ deviations > 0.25Å 0 
   Molprobity score 1.93 (98th percentile) 
   Residues with bad bonds 0.00% 
   Residues with bad angles 0.42% (Pro58) 
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